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Fast signal propagation and long-term integrity of myelinated axons rely on precise 
axo-glial interactions. A role for myelin-associated peroxisomes in facilitating axonal 
support by glial cells was demonstrated in a mouse model with peroxisome dysfunction 
specifically in myelinating glia (Cnp-Cre::Pex5flox/flox). This Cnp-Pex5 mouse model was 
used in the current thesis to analyze the role of peroxisomes in myelin maintenance 
and Schwann cell (SC)-axon interaction. Here, a critical function of SC lipid metabolism 
in axonal conduction was proven by ex vivo electrophysiology, showing reduced 
conduction velocity and decreased amplitudes before behavioral deficits occurred. 
Unexpectedly, analysis of myelin sheath thickness, compaction, and protein 
composition excluded dysmyelination as the underlying reason of nerve impairment. 
Furthermore, the overall number and distribution of myelinated axons was normal. 
Vesicular accumulations within mutant paranodes could have perturbed paranodal 
junctions, potentially causing nerve dysfunction. However, axo-glial contact sides at 
this region were intact. Immunofluorescent staining revealed early-onset redistribution 
of juxtaparanodal Kv1.1 channels. Nevertheless, the majority of Kv1-clusters was 
normal in the postnatal phase, and their progressive mislocalization suggested a 
problem in the maintenance rather than formation. In addition, the Kv1-anchoring 
protein TAG-1 showed a similar pattern and colocalized with ectopic Kv1.1 ion 
channels. Within membranes, TAG-1 is associated with gangliosides, a class of 
glycosphingolipids that were massively perturbed in PEX5 mutant nerves as revealed 
by lipid mass spectrometry and by (immune-) fluorescent staining. Thus, gangliosides 
were abundantly present in enlarged vesicles, several of which were identified as 
lysosomes. Finally, lysosomal marker proteins and enzymatic activities were 
dramatically increased in mutant nerves, which are typical characteristics of lysosomal 
storage disorders. Most interestingly, similar pathological features were observed in 
aged Abcd1-/- mice, a disease model of human adrenomyeloneuropathy, suggesting 
a common pathomechanism in disorders of peroxisomal β-oxidation. In summary, this 
work revealed secondary defects of lysosomes as a consequence of peroxisomal 
dysfunction in vivo and the importance of SC lipid metabolism for normal nerve 
function, independent of myelin. Since abnormal lipid metabolism is related to several 
other peripheral neuropathies, this knowledge may provide new therapeutic strategies 
for other diseases.




1.1 The peripheral nervous system 
The peripheral nervous system (PNS), comprising the somatosensory and 
autonomous nervous system, represents the interface between the central nervous 
system (CNS) and the inner and outer environment. Accordingly, it transmits nerve 
impulses from sensory receptors to the CNS (afferent nerve fibers) and signals back 
to muscles and glands (efferent nerve fibers). Interconnections between different 
compartments are made by electrical and chemical synapses. One of the best-studied 
chemical synapse is the neuromuscular junction that connects motor neurons with 
muscle fibers (Hirsch, 2007). The sciatic nerve is the largest peripheral nerve. Due to 
its easy accessibility and simplicity, it is an appropriate model to study interactions 
between axons and their myelinating Schwann cells and is well suited to investigate 
neurodegeneration in disease situations. 
 
1.1.1 Myelin formation and composition 
Myelination of axons facilitated the evolution of complex nervous systems by reducing 
energy consumption and accelerating signal propagation (Waxman, 1980; Tasaki 
1939). Axons in the peripheral nervous system are myelinated by Schwann cells (SCs). 
SC precursors originate from neural crest cells and develop into immature SC, which 
approach axons (Jessen and Mirsky, 1992). Axonal signals further trigger SC 
proliferation and differentiation (Salzer and Bunge, 1980; Pereira et al., 2012). In 
contrast to oligodendrocytes in the CNS, Schwann cells myelinate only one single 
axonal segment. This one-to-one relation is established through radial sorting during 
late embryonic development and shortly after birth (Fig. 1; Jessen and Mirsky, 1999). 
Thereby, small caliber axons (≤ 1 µm) remain engulfed, but not myelinated, forming 
Remak bundles (Jessen and Mirsky, 2005; Pereira et al., 2012). These are unique to 
peripheral nerves and harbor unmyelinated C-fibers, which have a slow conduction 
velocity (0.5-2.0 m/s) and convey sensory stimuli (e.g. pain and heat; Griffin and 
Thompson, 2008). In contrast, large caliber axons (>~1 µm) are associated with pro-
myelinating SC.  





Fig. 1: Schwann cell differentiation during development 
This scheme illustrates the Schwann cell (SC) lineage (left). SC progenitors develop into immature SC around 
embryonic day 15 (E15) and E17 in mice. These further differentiate into pro-myelinating or non-myelinating SC 
around birth (postnatal day 0, P0). Pro-myelinating SC further mature postnatally into myelinating SC. EM pictures 
(right) demonstrate a myelinating SC in close contact to an axon (Ax, top) or a non-myelinating SC engulfing several 
axons (bottom; scale bar, 500 nm; modified from (Scherer, 1997) 
 
Myelination occurs postnatally and is finished at around postnatal day 30 (P30; 
(Garbay et al., 2000). It is controlled by complex axo-glial interactions (Pereira et al., 
2012). Thus, myelin sheath thickness and internodal lengths are proportional to the 
axonal diameter, ensuring optimal nerve conduction (Waxman, 1980). Later studies 
showed that the neuronal growth factor neuregulin 1 (NRG1) type III binds to the glial 
receptor ErbB thereby regulating SC differentiation and myelin thickness in the PNS 
(Garratt et al., 2000; Michailov et al., 2004; Brinkmann et al., 2008). Myelin sheath 
thickness can be calculated by the ratio of the axonal diameter divided by the complete 
fiber diameter, which is termed the “g-ratio”.  
Myelin sheaths are specialized plasma membranes of Schwann cells. They are highly 
abundant in lipids (70-80% of dry mass), mainly composed of cholesterol (20-30%), 
galactosphingolipids (e.g. cerebrosides; sulfatides and gangliosides), phospholipids 
(e.g. plasmalogens), and saturated very long-chain fatty acids (Garbay et al., 2000). 
Furthermore, myelin sheaths can be differentiated into compact and non-compact 
compartments with characteristic and non-overlapping protein profiles. Compact 
myelin comprises the major part and is highly abundant in glycoproteins (e.g. protein 
zero, P0 and peripheral myelin protein 22, PMP22, Quarles, 2002). P0 is the major 
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myelin protein (50-70%) in the PNS and is essential for myelin compaction (Greenfield 
et al., 1973; Wiggins et al., 1975; Giese et al., 1992). Beside glycoproteins, basic 
proteins (e.g. myelin basic protein, MBP and protein 2, P2) are the second most 
abundant class of peripheral myelin proteins (Garbay et al., 2000). Other proteins, such 
as 2’, 3’-cyclic nucleotide 3’-phosphodiesterase (CNP) and proteolipid proteins 
(PLP/DM20), both abundant in CNS, only represent 0.5% of total PNS myelin 
(Uyemura et al., 1972; Pham-Dinh et al., 1991; Patzig et al., 2011). 
 
1.1.2 Non-compact myelin and metabolic support of axons  
Axonal access to extracellular metabolites is limited by insulating myelin sheaths. 
Additionally, peripheral nerves become quite long (e.g. sciatic nerve) and axons are 
thereby isolated from their neuronal cell bodies. Thus, they particularly rely on 
metabolic support by Schwann cells. There is strong evidence that glial cells ensure 
axonal long-term survival and integrity independent of myelin (Wilkins et al., 2003; 
Nave, 2010b; Ghosh et al., 2011; Fünfschilling et al., 2012; Viader et al., 2013). This 
is further emphasized by several myelin deficiencies resulting in axonal degeneration 
(Ferguson et al., 1997; Garbern et al., 2002; Lappe-Siefke et al., 2003; Nave et al., 
2007; Griffiths, 2011). Metabolic exchange between axons and Schwann cells is 
facilitated by cytoplasmic channels at regions of non-compact myelin, such as 
paranodal loops, Schmidt-Lanterman incisures (SLI), and the outer and inner mesaxon 
(Arroyo and Scherer, 2000). These regions form a transport network that provides short 
pathways through the myelin sheath (Fig. 2). Moreover, autotypic adherens, tight, and 
gap junctions connect adjacent Schwann cell membranes and thereby enable rapid 
intracellular signaling and transport (Spiegel and Peles, 2002).  
Paranodal loops connect the adaxonal myelin to the axolemma at each end of a myelin 
segment (Arroyo and Scherer, 2000). Heterotypic septate-like junctions between 
axons and paranodal loops enable fast exchange between axonal and SC cytoplasm 
(Fannon et al., 1995; Einheber et al., 1997). Another route for short diffusion through 
the myelin sheath are Schmidt-Lanterman incisures, funnel-shaped interruptions in the 
compact myelin of primarily peripheral fibers (Hall and Williams, 1970; Ghabriel and 
Allt, 1981). They are highly dynamic, thus supposed to protect peripheral nerves from 
mechanical stress by providing flexibility (Singer and Bryant, 1969). Also, the number 
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of incisures depends on the fiber diameter (Ghabriel and Allt, 1981). SLI are highly 
enriched in myelin-associated glycoprotein (MAG) that is essential for CNS myelination 
and glial integrity, and ensures the viability of myelinated axons in the PNS (Trapp et 
al., 1989; Trapp, 1990; Pan et al., 2005). Interestingly, SLI are increased in several 
myelin abnormalities and axonal changes, suggesting a compensatory mechanism to 
ensure axo-glial communication (Gould et al., 1995; Hoshi et al., 2007).  
 
Fig. 2: Scheme of a peripheral myelinated axon highlighting regions of non-compact myelin 
Regions of non-compact myelin (dark purple) provide a short transport route through compact myelin (light purple) 
and towards the periaxonal space (yellow). Axo-glial interactions are especially pronounced at paranodal junctions 
(red stripes) and Schmidt-Lanterman incisures (SLI). Unrolled Schwann cell sheaths indicate SLI that spiral around 
axons and are interconnected by gap junctions (inset, adapted from Nave 2010). 
 
Besides metabolic support of axons, SC are capable of taking up axonal material at 
paranodes via an axon-Schwann cell network (ASN, (Gatzinsky et al., 1997). Like SLI 
these ASNs are highly associated with lysosomes and are therefore supposed to serve 
as disposal sites for non-degradable axonal material (Gatzinsky and Berthold, 1990; 
Gatzinsky et al., 1997). This seems to be particularly important during aging and 
peripheral neuropathies.  
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1.1.3 Molecular domains of myelinated axons 
Myelinated axons are composed of distinct molecular domains that result from complex 
axonal interactions with polarized myelinating Schwann cells (Pereira et al., 2012). 
Hence, the inner (adaxonal) Schwann cell membrane and the underlying axolemma 
are organized into node, paranode, juxtaparanode, and internode. Each of these 
regions comprises specific ion channels, cell adhesion molecules and cytoskeletal 
adaptor proteins (Arroyo and Scherer, 2000; Salzer et al., 2008; Faivre-Sarrailh and 
Devaux, 2013). This molecular and functional differentiation provides the basis for fast 
signal propagation and reduced energy consumption through saltatory conduction 
(Tasaki 1939). Disruption of axo-glial interaction leads to severe alterations in the 
molecular and structural organization of axons, including shifted ion channel 
distribution (Dupree et al., 1999; Bhat et al., 2001; Ishibashi et al., 2002; Rios et al., 
2003).  
Nodes of Ranvier are short (~1 μm) interruptions in the myelin sheath, where action 
potentials are generated (Huxley and Stämpeli, 1949; Waxman and Ritchie, 1985). 
Therefore, they are highly enriched in voltage-gated sodium (Nav1.6; Salzer et al., 
2008) and potassium (Kv7.2; Devaux et al., 2004) channels. The assembly and the 
maintenance of nodal ion channels is controlled by axonal cell-adhesion molecules 
(CAMs) NrCAM and neurofascin 186 (NF186; Davis et al., 1996). NF186 further 
interacts with gliomedin, which is secreted by Schwann cell microvilli to promote node 
formation (Eshed et al., 2005; Labasque et al., 2011). The whole complex is stabilized 
and linked to the axonal cytoskeleton via scaffolding proteins ankyrin G (ANKG; 
Jenkins and Bennett, 2002) and βIV spectrin (Fig. 3A; Komada and Soriano, 2002; 
Yang et al., 2004). Nodes are flanked by paranodal loops that form axo-glial septate-
like junctions (transverse bands), attaching the myelin sheath to the axon (Rosenbluth, 
2009). Paranodal junctions are formed by a complex of axonal contactin/contactin-
associated protein (CASPR) and glial neurofascin 155 (NF155; Einheber et al., 1997; 
Boyle et al., 2001; Bhat et al., 2001; Rios et al., 2003). This complex is further anchored 
to the axonal cytoskeleton via 4.1B protein (Fig. 3B; Cifuentes-Diaz et al., 2011). 
Paranodal junctions provide a partial diffusion barrier between the node and the 
juxtaparanode. Thereby, the electrical activity is separated from the internodal region, 
and lateral diffusion of axonal membrane proteins is prevented (Rios et al., 2003; 
Rosenbluth, 2009). Accordingly, disruption of paranodal junctions provokes a 
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displacement of juxtaparanodal proteins into the paranode (Boyle et al., 2001; Bhat et 
al., 2001; Ishibashi et al., 2002).  
The juxtaparanode is located underneath the compact myelin sheath, adjacent to the 
paranodal region (Arroyo and Scherer, 2000). It is enriched in delayed rectifier Shaker-
type K+ channels, mainly composed of Kv1.1/Kv1.2 heteromultimers and their 
cytoplasmic Kvβ2 subunit (Wang and Tempel, 1993; Rasband et al., 1998). These 
voltage-gated K+ channels are supposed to be important for stabilizing conduction and 
maintaining the internodal resting potential, therby ensuring nerve excitability (Sherratt 
et al., 1980; Smart et al., 1998; Vabnick et al., 1999; Chi and Nicol, 2007). During 
myelination, K+ channels are clustered at around P14 dependent on the axonal 
adhesion molecule CASPR2 (Poliak et al., 1999; Hivert et al., 2016). Juxtaparanodal 
anchoring and maintenance are further mediated by interaction of CASPR2 with the 
GPI-anchored transient axonal glycoprotein-1 (TAG-1 or Contactin-2) that is expressed 
by both Schwann cells and axons (Fig. 3C; Traka et al., 2002; Poliak and Peles, 2003; 
Savvaki et al., 2010). It has been shown that juxtaparanodal localization of CASPR2 
and TAG-1 is interdependent and deficiency in either protein causes a localization of 
K+ channels evenly distributed along internodes (Poliak and Peles, 2003). 
 
 
Fig. 3: Molecular organization of myelinated peripheral nerve fibers 
A node of Ranvier (A), the paranode (B), and the juxtaparanode (C) contain distinct ion channels, cell adhesion 
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1.1.4 Ganglioside metabolism and function 
Gangliosides are acidic glycosphingolipids that contain sialic acids and are most 
abundant in the nervous system (Sonnino et al., 2006; Schnaar et al., 2014). They are 
synthesized from ceramide in the Golgi apparatus and are further transported through 
vesicles towards plasma membranes (Maccioni, 2007). Gangliosides are primarily 
located in the outer leaflet of plasma membranes, where they form and stabilize lipid 
rafts through lateral segregation (Prioni et al., 2004; Schnaar et al., 2014). During brain 
development, complex gangliosides are synthesized by sequential addition of sialic 
acids to the simple GM3 ganglioside via glycosyl- and sialyltransferases. Dependent 
on the number of sialic acid residues they are further divided into 0-, a-, b- and c-series 
gangliosides (Garratt et al., 2000; Yu et al., 2011). However, the adult nervous system 
is highly abundant in a-series (GM1 and GD1a) and b-series (GD1b and GT1b) 
gangliosides (Fig. 4A; Tettamanti et al., 1973).  
Gangliosides substantially regulate membrane organization, intercellular adhesion, 
and signaling (de Chaves and Sipione, 2010; Schnaar et al., 2014). Moreover, they 
are critical for axo-glial interactions. Accordingly, ablation of complex gangliosides 
results in central and peripheral demyelination and axonal degeneration (Sheikh et al., 
1999; Ma et al., 2003; Pan et al., 2005). Furthermore, GM1 and GD1a are particularly 
essential for molecular organization and maintenance of myelinated axons (Fig. 4B). 
Thus, GM1 is highly abundant at paranodes, facilitating paranodal junction formation 
through glial NF155 and axonal CASPR (Howell et al., 2006; Susuki et al., 2007). 
Strong evidence implies that GM1 influences juxtaparanodal clustering of Kv1.1 by 
interacting with TAG-1 (Kasahara et al., 2000; Loberto et al., 2003; Labasque and 
Faivre-Sarrailh, 2010). In addition, myelin stability and axonal integrity is influenced by 
the interaction of axonal gangliosides (GD1b and GT1b) with MAG (Fig. 4B; Pan et al., 
2005). A major role of gangliosides for nervous system integrity is further illustrated by 
Guillain-Barré syndromes (GBS). This group of autoimmune disorders is caused by 
immune responses against axonal or Schwann cell gangliosides, leading to severe 
peripheral neuropathies (Hughes and Cornblath, 2005; Kaida et al., 2009; van Doorn 
et al., 2008). Furthermore, deficiencies of ganglioside catabolism manifest as 
lysosomal storage disorders (Jeyakumar et al., 2005; Ballabio et al., 2009; Platt et al., 
2012). 




Fig. 4: Synthesis of brain gangliosides and their function in axo-glial interaction at nodes 
A) Biosynthesis of complex brain gangliosides (a- and b-series) from ceramide.  
B) Gangliosides regulate axo-glial interaction and membrane organization at nodes of Ranvier.  
(adapted from Chaves et al., 2010) 
 
 
1.2 Lysosomes in the nervous system 
Lysosomes are electron dense, acidic organelles that are indispensable for the 
degradation of extracellular and intracellular material that is taken up by endocytosis 
or autophagy. Thus, lysosomes are highly involved in lipid metabolism and membrane 
dynamics (Singh et al., 2009; Settembre et al., 2014). Their consequential importance 
for myelin maintenance is emphasized by lysosomal disorders that frequently display 
a neurodegenerative phenotype accompanied with demyelination (Jeyakumar et al., 
2005; Faust et al., 2010).  
1.2.1 The endosomal-autophagic-lysosomal system 
Protein degradation and recycling is essential for membrane dynamics and cellular 
integrity. Thus, the endosomal-autophagic-lysosomal system maintains cellular 
homeostasis and contributes to various cellular processes (Grant and Donaldson, 
2009; Hu et al., 2015). Deficiencies in this system are associated with 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease or 
lysosomal storage disorders (Vellodi, 2005; Rubinsztein, 2006; Neefjes and van der 
Kant, 2014).  
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The endosomal-lysosomal system forms a highly dynamic and interconnected network 
of distinct specialized membrane-enclosed compartments (Fig. 5; Hu et al., 2015). 
Extracellular material, membrane proteins, lipids, and ligands are internalized by 
endocytosis or phagocytosis and are transported to early endosomes via endocytic 
vesicles (Mousavi et al., 2004; Hu et al., 2015). Early endosomes (EE) are primarily 
located in the cellular periphery and are mainly involved in cargo sorting and recycling 
(Grant and Donaldson 2009). This is regulated by Rab GTPases (Huotari and 
Helenius, 2011). Thus, Rab5 mediates EE maturation and conversion to late 
endosomes (LE) by recruiting Rab7 (Meresse et al., 1995; Rink et al., 2005). 
Furthermore, endosome maturation includes a spectrum of morphological and 
molecular changes, such as acidification through vacuolar ATP-ase (Beyenbach and 
Wieczorek, 2006; Marshansky and Futai, 2008). Accordingly, mild pH in EE (6.8-5.9) 
enables conformational changes in proteins, whereas low pH in LE (6-4.9) and 
lysosomes (~4.5) facilitates hydrolysis and inactivation of pathogens (Maxfield and 
Yamashiro, 1987). During maturation, LE become round, acquire intraluminal vesicles, 
and move to perinuclear regions, where they undergo transient fusion to form 
multivesicular bodies (Huotari and Helenius, 2011). Finally, LE fuse with lysosomes to 
form endolysosomes, which are capable of degrading cargo through hydrolysis (Tjelle 
et al., 1996; Mullock et al., 1998). Lysosomal components (e.g. hydrolases and 
membrane proteins) are transported from the trans-Golgi network (TGN) to lysosomes 
by LE, primarily through mannose-6-phosphate receptor binding (Griffiths and Simons, 
1986; Ghosh et al., 2003).  
Lysosomes degrade intracellular material through autophagy (Fig. 5). This self-
digestive pathway is activated by starvation, oxidative stress or protein aggregation to 
assure cellular integrity (Mizushima et al., 2003; Singh et al., 2009; Huang et al., 2011). 
Accordingly, dispensable or damaged organelles, misfolded proteins, and foreign 
microorganisms are degraded through autophagy, which can be inhibited by mTOR 
signaling (Noda and Ohsumi, 1998; Levine and Kroemer, 2008; Jung et al., 2010). The 
pathway is initiated by the formation of an isolation membrane (phagophore) that 
further engulfs cytoplasmic material. By this procedure a double-membranous 
autophagosome is generated, which fuses with lysosomes to form an autolysosome 
that is capable of degrading sequestered material (Levine and Kroemer, 2008).  




Fig. 5: The endosomal-autophagic-lysosomal system 
Extracellular material is endocytosed and transported by the endocytic pathway either to lysosomes for degradation, 
or to early endosomes for recycling. Intracellular material is degraded by lysosomes through the autophagy pathway 
(taken from Jeyakumar et al., 2005) 
 
1.2.2 Lysosomal storage disorders 
Lysosomal storage disorders (LSDs) are single gene defects that are predominantly 
caused by deficiencies in lysosomal hydrolases. Consequently, their target substrates 
start to accumulate first within lysosomes and later also in other cellular compartments 
(Vellodi, 2005; Platt et al., 2012). It is suggested that lysosomes enlarge and increase 
in number to compensate this accumulation (Levine and Kroemer, 2008; Jeyakumar 
et al., 2005). Autophagy is severely reduced upon lysosomal storage (Settembre et al., 
2008). As a result, cellular homeostasis is altered and other organelles, such as 
mitochondria and peroxisomes, are impaired (Schedin et al., 1997; Haq et al., 2006; 
Jennings et al., 2006; Ballabio et al., 2009). This subsequently causes CNS 
neurodegeneration and inflammation already in early childhood (Wraith, 2002; Vitner 
et al., 2010). Accordingly, lysosomal storage disorders account for about 45% of cases 
with infantile neurodegeneration (Verity et al., 2009).  
One of the best-studied group of lysosomal storage disorders are 
glycophingolipidoses, such as Gaucher disease, GM1 gangliosidosis, Tay-Sachs 
disease or metachromatic leukodystrophy (Levine and Kroemer, 2008; Jeyakumar et 
al., 2005). Studies on these disorders showed that sphingolipid trafficking and recycling 
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is highly impaired (Chen et al., 1999). Furthermore, distribution of lipid raft-associated 
proteins is potentially altered, resulting in signaling defects (Levine and Kroemer, 2008; 
Jeyakumar et al., 2005, Ballabio et al., 2009). Moreover, glycosphingolipid storage 
changes calcium homeostasis and could elicit an unfolded protein response and 
inflammatory responses (Korkotian et al., 1999; Jeyakumar et al., 2003; Tessitore et 




1.3 Peroxisomes in the nervous systems 
Peroxisomes are ubiquitous, single membrane-enclosed organelles that are highly 
abundant in all nervous system cell types. Due to their small size in the brain, they are 
also termed “microperoxisomes” (De Duve and Baudhuin, 1966; Kassmann, 2014). 
Interestingly, they show a broad heterogeneity suggesting distinct functions within 
different cell types of the nervous system (Ahlemeyer et al., 2007). Nevertheless, 
peroxisomes are rather associated with myelin than axons in peripheral nerves 
(Kassmann et al., 2011). Peroxisomal disorders frequently show considerable 
alterations of the nervous system, indicating the crucial function of peroxisomes for 
myelin maintenance and axonal integrity (Steinberg et al., 2006; Wanders and 
Waterham, 2006; Barry et al., 2013). This is most probably due to their particular role 
in lipid metabolism and scavenging of reactive oxygen species (Wanders and 
Waterham, 2006).  
 
1.3.1 Peroxisome biogenesis  
Modes of peroxisome biogenesis were highly debated during the last decades. 
Whereas the model of autonomous division through growth and fission is well accepted 
(Schrader et al., 2012), data supporting de novo generation of peroxisomes from the 
endoplasmatic reticulum (ER) is still contradictory (Ma et al., 2011; Nuttall et al., 2011). 
Due to a lack of own DNA, all peroxisomal proteins are nuclear-encoded and have to 
be shuttled into peroxisomes (Alberts et al., 2002). The majority of peroxisomal 
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membrane proteins (PMPs, class I) are directly imported into peroxisomes dependent 
on PEX19, PEX3 and PEX16 (Fig. 6A; Ghaedi et al., 2000; Fang et al., 2004; 
Matsuzaki and Fujiki, 2008). Only a minor portion of PMPs (class II) is independent on 
PEX19 and is supposed to require ER contribution (Hoepfner et al., 2005; Kim et al., 
2006; van der Zand et al., 2010). Peroxisomal matrix proteins are synthesized on 
cytosolic ribosomes and are imported post-translationally into peroxisomes (Goldman 
and Blobel, 1978). This peroxisomal protein import depends on specific peroxisomal 
targeting signals (PTS1, C-terminal or PTS2, N-terminal; Gould et al., 1987; Swinkels 
et al., 1991). The majority of matrix proteins (> 90%) contains a PTS1, which is 
recognized by the cytosolic PEX5 protein (Gould and Valle, 2000; Stanley et al., 2006). 
After receptor-cargo binding, PEX5 associates with the docking complex (mainly 
PEX14 and PEX13) in the peroxisomal membrane (Fig. 6B; Platta and Erdmann, 2007; 
Meinecke et al., 2010). In contrast to other organelles, peroxisomes are capable of 
importing folded and oligomeric proteins (McNew and Goodman, 1994). After protein 
translocation, PEX5 is released and recycled or degraded (Platta et al., 2007). 
 
 
Fig. 6: Peroxisomal protein import 
A) The import of most peroxisomal membrane proteins depends on PEX19, PEX3 and PEX16. 
B) The majority of peroxisomal matrix proteins are imported via PEX5 trough PTS1 recognition.  
(adapted from Platta and Erdmann 2007) 
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1.3.2 Peroxisomal lipid metabolism 
The importance of peroxisome function for human physiology is emphasized by fatal 
consequences of peroxisomal defects (Wanders, 2004a; Steinberg et al., 2006). 
Accordingly, patients with peroxisomal β-oxidation defects frequently pheno-copy 
symptoms of patients with biogenesis defects (Baes and van Veldhoven, 2012). Like 
mitochondria, peroxisomes are capable of degrading fatty acids (FA) through β-
oxidation (Reddy and Mannaerts, 1994; Wanders and Waterham, 2006). These fatty 
acids either derive from exogenous diet or endogenous lipid breakdown, for example 
in lysosomes. Notably, peroxisomes and mitochondria have certain substrate 
specificities. Thus, pristanic acids, long-chain dicarboxylic acids, di-and 
trihydroxycholestanoic acids (DHCA and THCA), and very-long-chain fatty acids 
(VLCFA, ≥ C22) are solely degraded by peroxisomal β-oxidation (Wanders, 2004a). 
Briefly, it starts with dehydrogenation of CoA-esters by two acyl-CoA oxidases 
(ACOX1/2), followed by hydration and another dehydrogenation performed by an 
enoyl-CoA hydratase (D-bifunctional protein, DBP or multifunctional protein, MFP2). 
Finally, fatty acids are cleaved by thiolases (ACAA1, SCPx). Unlike mitochondria, 
peroxisomes can only chain-shorten fatty acids and their products have to be further 
degraded by mitochondria (Bremer and Norum, 1982). Furthermore, hydrogen 
peroxide (H2O2) and other reactive oxygen species (ROS) are produced as by-
products of beta-oxidation. Hence, peroxisomes contain several reducing enzymes, 
such as catalase, superoxide dismutase (SOD1), and glutathione peroxidase to 
prevent oxidative stress (Singh et al., 1994; Schrader and Fahimi, 2004). Besides fatty 
acid beta-oxidation, peroxisomes are involved in the synthesis of for example bile 
acids, docosahexaenoic acids, and plasmalogens (Brites et al., 2004). The latter are 
ether phospholipids, highly abundant in myelin (Braverman et al., 2012).  
 
1.3.3 Peroxisomal disorders and their impact on the nervous system 
Peroxisomal disorders are basically divided into single enzyme or protein deficiencies 
and biogenesis defects (Gould and Valle, 2000; Steinberg et al., 2006; Wanders and 
Waterham, 2006). The latter most notably comprises the Zellweger spectrum 
disorders, of which the Zellweger syndrome is the most severe (Bowen et al., 1964). It 
is caused by mutations in various PEX genes, especially PEX1 (Reuber et al., 1997). 
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Since peroxisomes are ubiquitous organelles, Zellweger patients display multiple 
congenital defects in almost every organ system. Neurological alterations include 
neuronal migration defects, eye abnormalities, and absence of deep tendon reflex 
(Steinberg et al., 2006). Patients are mainly diagnosed through elevated VLCFA 
plasma levels and deficient erythrocyte plasmalogens (Wanders, 2004b). Due to their 
severe symptoms, affected children usually die within the first year after birth. 
X-linked adrenoleukodystrophy (X-ALD) is the most frequent single peroxisomal 
protein disorder in children (Bezman and Moser, 1998; Berger and Gärtner, 2006). It 
is caused by loss-of-function mutations in the X-chromosomal ABCD1 gene, which 
encodes a peroxisomal ATP-binding cassette transporter protein (ABCD1; Mosser et 
al., 1993). ABCD1 imports CoA-activated VLCFA into peroxisomes (van Roermund et 
al., 2008; Wiesinger et al., 2013). Consequently, X-ALD patients show elevated levels 
of especially C26:0 fatty acids due to impaired peroxisomal β-oxidation (Kemp and 
Wanders, 2010; Wiesinger et al., 2013). Although, VLCFA accumulation is supposed 
to trigger various cytotoxic effects (Singh and Pujol, 2010; Berger et al., 2014), the 
underlying molecular mechanism that eventually causes myelin abnormalities, axon 
degeneration and neuroinflammation are still under investigation. Furthermore, there 
is no general genotype-phenotype correlation and the disease shows a high 
phenotypic variance (Moser et al., 2007; Ferrer et al., 2010). Thus, patients may 
display one of two major clinical phenotypes: The cerebral childhood form (CCALD) is 
characterized by early-onset and fast progressive inflammatory cerebral 
demyelination, while adrenomyeloneuropathy (AMN) is a late-onset, slowly 
progressive disease mainly affecting spinal cord and peripheral nerves (Engelen et al., 
2012). To better understand the molecular mechanisms that induce 
neurodegeneration, ABCD1-deficient mice have been generated by three independent 
groups (Forss-Petter et al., 1997; Kobayashi et al., 1997; Lu et al., 1997). These mice 
develop late-onset AMN-like symptoms, but fail to show cerebral demyelination or 
neuroinflammation (Forss-Petter et al., 1997; Lu et al., 1997; Pujol et al., 2002). 
To study the role of peroxisomes, especially in the nervous system, cell type-specific 
mouse models have been generated (Baes and van Veldhoven, 2012). Depletion of 
peroxisomes from all neural progenitor cells, using the Nes-Cre::Pex5flox/flox mice, 
results in severe neuropathological symptoms including de- and dysmyelination, axon 
loss and neuroinflammation (Hulshagen et al., 2008). Astonishingly, those 
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characteristics are absent in mice with peroxisome-deficient neurons (Nex-
Cre::Pex5flox/flox mice) or astrocytes (Gfap-Cre::Pex5flox/flox mice; (Bottelbergs et al., 
2010). These results suggest rather a minor role for peroxisomes especially in neurons, 
which might potentially be explained by the fact that myelinating glia provide trophic 
support for axons (Nave, 2010b; Fünfschilling et al., 2012). In line with this hypothesis, 
ablation of functional peroxisomes from oligodendrocytes (Cnp-Cre::Pex5flox/flox mice) 
results in neuropathological symptoms comparable to Nes-Cre::Pex5flox/flox mice. In 
detail, Cnp-Cre::Pex5flox/flox mice show axonal loss, cerebral demyelination and 
neuroinflammation (Kassmann et al., 2007). Later studies of Cnp-Cre::Pex5flox/flox mice 
further revealed a peripheral neuropathy, characterized by secondary axonal loss, 
reduced nerve conduction velocity, and muscle dystrophy. Moreover, these mice 
develop pathologically enlarged paranodes and axonal swellings, containing vesicular 
accumulations (Kassmann et al., 2011). Thus, the comparison of the different 
conditional PEX5 knockout mouse models highlights the essential function of 
peroxisomes in myelinating glial cells and demonstrates the importance of glial lipid 
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1.4 Aim of this study 
Axonal integrity relies on metabolic support by myelinating glial cells. A role for myelin-
associated peroxisomes to facilitate this particular function became evident from the 
specific ablation of peroxisomal function from oligodendrocytes and Schwann cells in 
mice (Cnp-Cre::Pex5flox/flox). Considering peroxisomal abundance within Schwann 
cells, especially at non-compacted regions, we hypothesized a role for peroxisomal 
lipid metabolism in SC-mediated axonal support. Accordingly, we checked for 
disturbed axo-glial interactions and axonal alterations as possible results of 
peroxisomal dysfunction. Studies of Cnp-Cre::Pex5flox/flox mice revealed a crucial role 
of peroxisomes in myelin maintenance and axonal integrity for the CNS. Therefore, the 
first aim of this thesis was to examine, whether peroxisomal dysfunction in SC 
provokes comparable demyelination and neurodegeneration in the PNS. To this end, 
structural and molecular analysis of myelin, as well as investigation of axonal 
distribution, was performed on sciatic nerves. Also, functional sensory and motor nerve 
impairment was assessed by electrophysiology and behavioral tests. Finding no 
considerable demyelination or axonal loss, but early-onset electrophysiological 
alterations, the second and major part of this project was to examine potential defects 
of axo-glial interaction and their impact on the molecular organization of nodes of 
Ranvier. The detection of ectopic ion channels and their corresponding anchor proteins 
drew attention to the metabolism and the distribution of gangliosides, lipids important 
for the normal juxtaparanodal localization of these proteins. Given the fact that the 
fraction of VLCFA-bound gangliosides was abnormally enriched and gangliosides were 
accumulated in cellular vesicles reminiscent of lysosomal storage disorders, we 
suspected secondary alterations of the endosomal-lysosomal compartment due to 
deficient peroxisomal β-oxidation. Hence, fluorescent teased fiber staining, enzyme 
activity tests, and electron microscopy were performed to analyze the origin of vesicles 
of paranodal swellings. Although the Cnp-Cre::Pex5flox/flox mouse model is eligible to 
investigate the role of peroxisomes in SC, it is not directly related to human 
peroxisomal defects. To finally transfer our findings to a more disease-related model, 
ABCD1-deficient mice were comparatively analyzed with respect to the 
neuropathological phenotype. 




2.1 Ablation of PEX5 from Schwann cells  
2.1.1 Disturbed import of peroxisomal proteins 
Cnp-Cre mediated ablation of peroxin 5 (PEX5) from myelinating cells was used to 
study the function of peroxisomes for myelination and axon integrity. As PEX5 is the 
major import receptor of peroxisomal proteins, PEX5-deficient cells lack the majority of 
enzymes within peroxisomes, resulting in a complete disruption of peroxisome function 
(Gould and Valle, 2000). Peroxisomes are highly abundant in the myelin compartment 
and PEX5-deficiency in oligodendrocytes causes severe myelin and axon alterations 
(Kassmann et al., 2007). To prove excision of PEX5 also from Schwann cells (SC), 
polymerase chain reaction (PCR) on tail DNA was performed. Effective Cre-mediated 
recombination was evidenced by a 340 bp amplicon, which was absent in control 
animals (Fig. 7A). Pex5 mRNA expression was reduced by 50% in sciatic nerve lysates 
as indicated by quantitative real-time PCR (Fig. 7B). Remaining mRNA expression 
likely resulted from non-Schwann cell nuclei in the PNS. To verify the functional lack 
of PEX5 from Schwann cells, teased sciatic nerve fibers were fluorescently stained for 
peroxisomal membrane protein 70 (PMP70), and the intra-peroxisomal enzyme, 
catalase. The two proteins showed a punctate pattern and high degree of colocalization 
especially around SC nuclei in control nerves. In contrast, PEX5-deficient nerves 
showed less PMP70-positive puncta and revealed cytoplasmic localization of catalase 
(Fig. 7C). This observation indicates defective import of peroxisomal proteins, resulting 










Fig. 7: PEX5 ablation from Schwann cells disrupts import of peroxisomal proteins 
A) Polymerase chain reaction (PCR) on genomic DNA, isolated from mouse tails. Conditional mutants (cKO) show 
a band at 340 bp after Cre-mediated excision of Pex5 floxed exons 11-14, which is absent in controls (CTR).  
B) qRT-PCR on cDNA from total sciatic nerve lysates. mRNA expression of Pex5 is reduced by 50% in conditional 
mutants (n=6 per genotype, error bars: mean + s.e.m, **p < 0.01, Student’s T-test).   
C) Immunofluorescent teased sciatic nerve fiber staining from 9 months old animals. Peroxisomal membrane protein 
70 (PMP70, green) and peroxisomal enzyme catalase (red) show punctate staining around Schwann cell nuclei 
(DAPI, blue) in controls. Conditional mutants show less PMP70-positive puncta and cytoplasmic catalase. Scale 
bar, 10 µm. 
D) Schematic model of normal (left) and disturbed (right) protein recognition and peroxisomal import by PEX5 via 
the peroxisomal targeting signal 1 (PTS1).  
 
2.1.2 Disturbed peroxisomal lipid metabolism 
Peroxisomes play an essential role in lipid metabolism (Wanders, 2004a). They 
exclusively degrade very long-chain fatty acids (VLCFA; Wanders and Waterham, 
2006) and are involved in the synthesis of for example ether phospholipids (e.g. 
plasmalogens; Brites et al., 2004). Defects in either peroxisome biogenesis or single 
enzymes disturb peroxisomal function (Wanders, 2004b; Steinberg et al., 2006). 
Accordingly, patients with peroxisomal disorders frequently display reduced 
plasmalogen levels and/or accumulation of β-oxidation substrates, especially of 
VLCFA (Kemp and Wanders, 2010; Singh and Pujol, 2010).  
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To evaluate peroxisomal function in SC, lipid mass spectrometry was performed on 
sciatic nerve lysates of 9 months old animals. Plasmalogens were highly abundant in 
control nerves (Fig. 8A top, green arrows), whereas the same plasmalogens were 
hardly detectable in mutant nerves (Fig. 8A bottom, red arrows). Quantification of 
plasmalogen (PEP-) and its precursor alkylated phosphatidylethanolamines (PEO-) 
revealed a reduction of almost 70%. Accordingly and as reported from patients, 
phosphatidylethanolamines were increased 4-fold in mutant nerves (Fig. 8B). Besides 
reduced plasmalogen levels, accumulation of especially VLCFA (C26:0 and C24:0 
respectively) is a key feature of peroxisomal disorders (Poulos et al., 1988; Engelen et 
al., 2012). Lipid mass spectrometry showed a significant increase of cholesterol in 
membrane fractions (Fig. 8C) as well as elevated C26/C22 and C26/24 ratios in nerve 
lysates (Fig. 8D). Taken together, these data confirm peroxisomal dysfunction due to 
PEX5-deficiency in myelinating SC. 
 




Fig. 8: PEX5 ablation from Schwann cells disturbs peroxisomal lipid metabolism 
A) Quantitative lipid mass spectrometry of sciatic nerve lysates from 9 months old mice. Plasmalogens (pl-PE) are 
abundant in control nerves (top, green arrows), whereas mutant nerves lack those plasmalogens (bottom, red 
arrows) and have increased peaks of phosphatidylethanolamines (PE, red arrow heads). 
B) Quantification of lipid mass spectrometry. Plasmalogen (PEP-) and its precursor alkylated 
phosphatidylethanolamines (PEO-) are significantly reduced, whereas phosphatidylethanolamines (PE) are 
increased 4-fold in mutant nerves. (n=6 per genotype, error bars: mean + s.e.m, ***p < 0.005, Student’s T-test).   
C) Lipid mass spectrometry reveals significantly elevated cholesterol levels in membrane fractions of 9 months old 
Cnp-Cre::Pex5flox/flox sciatic nerves. (n=6 per genotype, error bars: mean + s.e.m, ***p < 0.001, Student’s T-test). 
D) Mass spectrometry of very long-chain fatty acids (VLCFA, C26:0) in nerve lysates from 9 months old animals. 
Mutant nerves show significantly increased ratios of C26:0/C22:0 (left graph) and C26:0/C24:0 (right graph). (n=6 
per genotype, error bars: mean + s.e.m, *p < 0.05, ***p < 0.001, Student’s T-test). 
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2.2 Impact of peroxisomal dysfunction on nerve function 
2.2.1 Electrophysiological analysis indicates early sciatic nerve dysfunction 
PEX5 conditional mutants start to develop neurological impairment (e.g. ataxia) 
already at 3 months of age (Kassmann et al., 2007). In vivo sciatic nerve recordings 
revealed reduced nerve conduction velocities and decreased amplitudes that are likely 
related to the observed motor problems (Kassmann et al., 2011). To exclude a possible 
influence of a pathology of neuromuscular junctions as underlying cause of altered 
electrophysiology, we performed ex vivo electrophysiological recordings using nerves 
from 2 months old animals. Therefore, sciatic nerves were dissected and both ends 
engulfed by suction electrodes (Fig. 9A). Nerves were stimulated with different current 
intensities (0.13-0.3 mA). Compound action potentials (CAP) as well as nerve 
conduction velocity (NCV) were significantly decreased in mutant nerves. In detail, 
amplitudes were reduced by up to 30% at stimulation intensities above 0.15 mA and 
nerve conduction speed was diminished from approximately 38 m/s in controls to 28 
m/s in mutants (Fig. 9B). Mutants also required higher stimulation intensities (155 µA) 
compared to controls (135 µA) to elicit a signal, indicating an elevated threshold (Fig. 
9C). Moreover, responses of mutant nerves did not show a clear slope at stimulus 
intensities above 220 µA and only reached a peak amplitude that was 50% less than 
that of controls (Fig. 9D).  
In conclusion, PEX5-deficiency in SC causes massive nerve dysfunction already at 2 
months of age, which is characterized by decreased amplitudes, increased latencies, 
and fast response saturation. Thus, ex vivo electrophysiology revealed functional 
nerve impairment already at an early stage of disease progression, before the onset of 
clinical features (Kassmann et al., 2007). In contrast, in vivo measurements resulted 
in less pronounced differences, which showed a reduction of amplitudes not earlier 
than at 6 months of age (Kassmann et al., 2011). Accordingly, the ex vivo approach is 
a more sensitive method to analyze nerve alterations in animal models than in vivo 
recordings. 





Fig. 9: Functional impairment in 2 months old Cnp-Cre::Pex5flox/flox sciatic nerves 
A) Image of ex vivo electrophysiology setup with two suction electrodes engulfing the dissected sciatic nerve (inset, 
arrow). 
B) Representative nerve responses at stimulation intensities of 0.17 mA and 0.22 mA. Responses of conditional 
mutants (red) are slower and weaker, compared to control nerves (black). Quantification of compound action 
potentials (CAP) demonstrates a reduction of about 30% in mutant nerves and significantly reduced nerve 
conduction velocities (NCV, each curve represents mean nerve responses of one animal across intensities, n=4, 
error bars: means ± s.e.m). 
C) Mean sciatic nerve responses elicited with 0.15 mA and 0.155 mA stimulation intensities reveal highly reduced 
excitability in mutants. Percentage of nerves that show a significant response at low intensities (≤ 0.155 mA) is 
severely reduced in mutant nerves.  
D) Peak amplitudes plotted against increasing stimulus intensity indicates earlier response saturation of mutant 
nerves. (n=4, error bars: means ± s.e.m, two-way ANOVA). 
 
  Results 
38 
 
2.2.2 Tendency of more neuromuscular junctions in aged Cnp-Cre::Pex5flox/flox  
Neuromuscular junctions (NMJs) transmit signals from peripheral nerves towards their 
innervating muscles. Moreover, they are highly dynamic and have a high capacity to 
compensate disease- or age-related alterations in muscle innervation (Naguib et al., 
2002). Interestingly, ex vivo electrophysiology revealed functional impairment already 
early during disease progression (Fig. 9). Hence, less pronounced results from in vivo 
measurements may result from potential compensatory effects of NMJs. To investigate 
the number of NMJs, cryo sections of gastrocnemius muscles from 9 months old 
animals were stained for α-bungarotoxin, which irreversibly binds to nicotinic 
acetylcholine receptors (Fig. 10A; (Oswald and Freeman, 1981). Cnp-Cre::Pex5flox/flox 




Fig. 10: Number of NMJs is slightly enhanced in gastrocnemius muscles of Cnp-Cre::Pex5flox/flox 
A) Representative image of immunofluorescent staining of neuromuscular junctions (NMJs) in cryo sections of 
gastrocnemius muscle, using α-bungarotoxin. NMJs are arranged in rows (inset). Scale bar, 1mm; 100 µm (inset). 
B) Quantification of the number of NMJs per mm2 demonstrates a trend towards more NMJs in muscles of 9 months 
old Cnp-Cre::Pex5flox/flox mice. (n=7, error bars: mean ± s.e.m, p=0.078, Student’s T-test). 
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2.2.3 Analysis of sensory impairment 
Behavioral analysis of Cnp-Cre::Pex5flox/flox mice revealed progressive motor 
impairment (Kassmann et al., 2007). Since sciatic nerves are composed of a mixture 
of sensory and motor fibers, the question arose whether sensory nerve fibers are 
affected as well. To this end, mechanical and thermal sensation was assessed in aged 
(> 9 mo) Cnp-Cre::Pex5flox/flox and control mice (Fig. 11A-B). Conditional mutants 
showed a hypersensitivity in response to mechanical stimuli, indicated by their paw 
withdrawal already at lower force applications (Fig. 11A). In contrast, thermal 
stimulation with an infrared laser did not show comparable results. Here, mutant mice 
exhibited slightly delayed responses, which were highly variable and not significant 
(Fig. 11B). In summary, only the mechanical, but not the thermal test depicted sensory 
differences in conditional mutant mice. Together, both tests suggest discrete 
alterations of different sensory receptors.  
 
 
Fig. 11: Impaired pressure, but not heat sensation in 9 months old Cnp-Cre::Pex5flox/flox 
A) Behavioral assessment of pressure sensation using the dynamic plantar aesthesiometer. The mechanical 
sensitivity threshold of hind paws is determined by the use of electronic von Frey filaments (white arrow). 
Quantification of mechanical force that is needed to induce hind paw lifting reveals that conditional mutants respond 
at lower forces (4.006x g, white) than controls (5.779x g, black). (CTR n=17, cKO n=16; error bars: mean ± s.e.m, 
***p < 0.001, Student’s T-test).  
B)  Behavioral assessment of heat sensation using the plantar Hargreaves test. The sensitivity threshold is 
determinated by stimulating the hind paw with an electronic punctual infrared heat (white arrow). Quantification of 
time that is needed to lift the hind paw shows comparable values for controls (6.37 s, black) and conditional mutants 
(7.44 s, white). (CTR n=18, cKO n=16, error bars: mean ± s.e.m, n.s. not significant, Student’s T-test). 
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2.3 Impact of peroxisomal dysfunction on nerve integrity 
2.3.1 No considerable demyelination or deficient myelin compaction 
Peroxisomal defects are prone to cause myelin alterations (Steinberg et al., 2006; 
Faust et al., 2010; Hanson et al., 2014). This is in line with the fact that peroxisomes 
are highly associated with myelin sheaths and that their abundance and activity is 
enhanced during the peak of myelination (Adamo et al., 1986; Kassmann, 2014). Due 
to high lipid contents (>70% of dry mass) of myelin sheaths and the pivotal role of 
peroxisomes in lipid metabolism, peroxisomes are presumably important for myelin 
formation and maintenance (Adamo et al., 1986; Kassmann, 2014).  
Cnp-Cre::Pex5flox/flox mice develop progressive CNS demyelination, starting at around 
4 months of age in the corpus callosum (Kassmann et al., 2007). Interestingly, we 
observed electrophysiological alterations of sciatic nerves already at 2 months of age 
(Fig. 9). To investigate, whether reduced nerve conduction velocities resulted from 
demyelination, ultrastructural and molecular analysis of sciatic nerves was performed. 
Semithin cross sections were stained for methylene blue/ azure II blue, to label the 
lipid-rich myelin sheaths. Examination of these complete nerve cross sections did not 
reveal apparent demyelination, neither in 2 months nor in severely affected 9 months 
old conditional mutants. However, axons with thinner myelin were occasionally 
observed in nerves from aged animals (Fig. 12A). To further evaluate myelin thickness, 
g-ratio analysis (axonal diameter divided by the complete fiber diameter) was 
performed on electron-microscopic images (Fig. 12B). Quantification of g-ratio 
demonstrated similar values for controls and conditional mutants at either age (2 and 
>9 months; Fig. 12C). Next, sciatic nerve cross sections were stained for P0, the most 
abundant myelin protein in the PNS (Greenfield et al., 1973), showing no obvious 
difference between controls and conditional mutants (Fig. 12D). Furthermore, electron 
microscopy of ultrathin cross sections demonstrated normal myelin compaction in 9 
months old conditional mutant nerves (Fig. 13A). To investigate possible molecular 
differences, sciatic nerve lysates of 2 months old animals were analyzed by western 
blotting (Fig. 13B). This confirmed normal protein abundance of P0 in mutant nerves. 
Also, other important peripheral myelin proteins (P2 and PMP22) were normal. Only 
PLP comprising about 0.2% of all proteins in PNS myelin (Patzig et al., 2011), was 
significantly reduced by 42% (Fig. 13C). 
  Results 
41 
 
These data suggest that electrophysiological changes are not provoked by deficient 
myelin compaction or myelin loss, particularly not during early disease progression. 
Moreover, in contrast to the CNS, where demyelination is an early consequence of 
peroxisome deficiency, peripheral nerves do not show considerable myelin alterations.  
 
 
Fig. 12: Normal myelin thickness in Cnp-Cre::Pex5flox/flox sciatic nerves 
A) Methylene blue/ azur II blue stained semithin cross sections of sciatic nerves from 2 and > 9 months old mice 
occasionally depicts thinner myelin in aged conditional mutants (arrow head). Scale bar: 10 µm.  
B) Principle of g-ratio analysis (axonal diameter divided by complete fiber diameter), a method to measure myelin 
sheath thickness. 
C) g-ratio values are comparable between controls (black) and mutants (red) for all axonal diameters in young (2 
mo) and aged (> 9 mo) nerves. Quantification of mean g-ratio depicts similar values for controls (2 mo, 0.533; >9 
mo, 0.54) and mutants (2 mo, 0.51; >9 mo, 0.53). (n=3-4, ≥ 100 randomly chosen axons per animal, error bars: 
mean + s.e.m, n.s. not significant, Student’s T-test). 
D) Chromogenic immune-staining for myelin protein zero (P0) on paraffin-embedded sciatic nerve cross sections. 
Scale bar, 10 µm.  




Fig. 13: Normal myelin compaction and protein composition in Cnp-Cre::Pex5flox/flox sciatic nerves 
A) Electron micrographs of sciatic nerve cross sections from 9 months old mice show normal myelin compaction in 
conditional mutant nerves. M, myelin; Ax, axon. Scale bar, 10 nm. 
B) Western blot analysis of myelin protein abundance in sciatic nerve lysates from 2 months old mice. Alpha-tubulin 
was used as loading control.  
C) Quantification of major peripheral myelin protein abundance (P0, P2, PMP22, and DM20, PLP) reveals only a 
significant reduction for PLP in mutant nerves. (n=4 per genotype, error bars: mean + s.e.m, n.s. not significant, *p 
< 0.05, Student’s T-test). 
 
 
2.3.2 Axon degeneration is not a substantial feature of sciatic nerve pathology 
Myelinated axons depend on metabolic support by glial cells (Nave, 2010a; 
Fünfschilling et al., 2012). It has been shown that peroxisome-deficient 
oligodendrocytes fail to maintain axon integrity, resulting in axon degeneration 
independent of demyelination (Kassmann et al., 2007). Furthermore, 
electrophysiological recordings revealed reduced amplitudes already at 2 months of 
age, suggesting axonal loss (Fig. 9B). To investigate whether axons start to 
degenerate also in the PNS in the absence of demyelination, complete sciatic nerve 
cross sections were analyzed. Quantification of axon distribution revealed no 
significant differences between controls and Cnp-Cre::Pex5flox/flox nerves at 2 months 
of age (Fig. 14A). Astonishingly, even severely impaired 9 months old mutants 
displayed normal distribution of axons (Fig. 14A). There was also no specific loss of 
small caliber (Ø < 3 µm) or big caliber (Ø ≥ 5 µm) fibers (Fig. 14B). Although, aged 
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conditional mutants showed less large-caliber axons (Ø ≥ 5 µm) than controls, this was 
highly variable between animals and not significant (Fig. 14C). Moreover, the overall 
number of axons was similar to that of controls in young and old mutant nerves (Fig. 
14D). Taken together, these data suggest other nerve alterations, besides axonal 
degeneration, resulting in electrophysiological differences already at 2 months of age.  
 
 
Fig. 14: Normal distribution and number of myelinated axons in Cnp-Cre::Pex5flox/flox sciatic nerves 
A) Analysis of axon distribution in complete cross sections of sciatic nerves from 2 months (left) or 9 months old 
(right) mice. Percentage of axons having a certain diameter is similar between controls (black) and mutants (red). 
(2 months, n=4 (CTR), n=3 (cKO); >9 months, n=4 per group; error bars: mean ± s.e.m; Two-way ANOVA followed 
by Bonferroni test). 
B-C) Percentage of small (Ø < 3 µm) and big (Ø ≥ 5 µm) axons per nerve is comparable between 2 months or 9 
months old conditional mutants and controls. (2 months, n=4 (CTR), n=3 (cKO); >9 months, n=4 per group; error 
bars: mean + s.e.m; n.s. not significant; Student’s T-test). 
D) Number of myelinated axons per nerve is comparable between controls and conditional mutants. (2 months, n=4 
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2.3.3 Mild macrophage activation with occasional T-cells infiltration 
Neuroinflammation is a frequent observation in neurodegenerative diseases (Amor et 
al., 2010). Furthermore, activated microglia and macrophages, as well as gliosis and 
T-cell infiltration, were early findings in the CNS of Cnp-Pex5-deficient mice 
(Kassmann et al., 2007). To detect neuroinflammatory processes, longitudinal paraffin-
embedded sciatic nerve section of 2 and 9 months old mice were stained for MAC-3 
and CD3 using DAB. MAC-3, a marker for macrophages, was moderately elevated in 
2 and 9 months old conditional mutants (Fig. 15A). To get a more precise insight into 
the number of activated macrophages in sciatic nerves, semithin cross sections were 
stained for methylene blue/ azure II to visualize lipid-laden macrophages (Fig. 15B). 
These were rarely observed in nerves of young (2 months) conditional mutants, but 
about 3-fold elevated at 9 months (Fig. 15C). Invading T-cells were visualized by 
chromogenic staining for CD3 on longitudinal sections. CD3-positive cells were absent 
from 2 months old mutants and were occasionally found within nerves of 9 months old 
controls and mutants (Fig. 15E). In conclusion, we suggest only a minor impact of 
neuroinflammation especially at early stages of the pathology in mutant nerves. 
 
 





Fig. 15: Moderate neuroinflammation in Cnp-Cre::Pex5flox/flox sciatic nerves  
A) Chromogenic staining of longitudinal paraffin-embedded sciatic nerve sections from 2 and 9 months old mice 
shows slightly increased MAC-3 abundance in conditional mutants. Scale bar, 50 µm. 
B) Semithin cross section from 9 months old conditional mutant sciatic nerve, stained for methylene blue/ azure II, 
depicts a lipid-laden macrophage (arrow). Scale bar, 10 µm. 
C)  Quantification of lipid-laden macrophages per nerve shows a minor increase of macrophages in 2 months old 
conditional mutant mice, which becomes significant in 9 months old conditional mutants. n=4 per group; error bars: 
mean + s.e.m; **p < 0.01; Student’s T-test). 
D) Chromogenic staining of longitudinal paraffin-embedded sciatic nerves sections from 2 and 9 months old mice 
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2.4 Molecular composition of nodes of Ranvier 
2.4.1 Normal formation of nodes and paranodal junctions 
Neither myelin formation/compaction (Fig. 12 and 13), nor axon degeneration (Fig. 14) 
appeared to be a substantial feature of PNS pathology. Fast signal propagation is 
enabled by restriction of action potential generation to nodes of Ranvier. This is 
facilitated by high molecular and structural organization of myelinated axons through 
axo-glial interaction (Arroyo and Scherer, 2000; Salzer et al., 2008). Consequently, 
defects in this interplay especially at paranodes are a potential cause of impaired 
conduction due to leak currents (Arancibia-Carcamo and Attwell, 2014). Therefore, the 
integrity of paranodal junctions was investigated. Immunofluorescent teased fiber 
staining for axonal contactin associated protein (CASPR) and glial neurofascin 155 
(NF 155) showed clear colocalization of both proteins at paranodes (Fig. 16A). Also, 
ultrastructural analysis by electron microscopy revealed intact transverse bands, 
septate-like junctions between the axonal and adaxonal Schwann cell membrane (Fig. 
16B). These were even observed at regions, where paranodal loops were enlarged 
due vesicular accumulations. Furthermore, contact sides between individual loops 
were intact, indicated by the presence of electron-dense autotypic junctions (Fig. 16C). 
To understand the occurrence of electrophysiological changes, the distribution of nodal 
ion channels was analyzed in sciatic nerve fibers from 2 and 9 months old mice. 
Immunohistochemistry of voltage-gated sodium (Nav1.6) and potassium (Kv7.2) 
channels showed normal localization at nodes, flanked by paranodal CASPR (Fig. 
16D). This was evidenced by normal distribution of their axonal anchoring molecules 
ankyrinG (ANKG) and βiV-spectrin (Fig. 16E). These findings demonstrate intact axo-
glial interaction at paranodes and excluded disturbed nodal sodium channels as a 
cause of diminished nerve responses.  
 




Fig. 16: Paranodal junctions are intact 
A) Immunofluorescent staining of teased sciatic nerve fibers of 2 and 9 months old mice. Paranodal contactin-
associated protein (CASPR, red) colocalized with its glial anchoring protein neurofilament 155 (NF155, green) in 
controls and conditional mutants. Scale bar, 10 µm. 
B) Electron microscopy demonstrates intact transverse bands (arrows), attaching the paranodal loops (PNL) of 
myelin (M) with the axon (Ax) of a mutant sciatic nerve aged 9 months. Scale bar, 500 nm. 
C) Electron microscopy reveals intact autotypic junctions between individual paranodal loops (inset, asterisk), even 
when filled with vesicular accumulations. Scale bar, 500 nm.  
D) Immunofluorescent teased fiber staining shows normal nodal sodium (Nav1.6) and potassium (Kv7.2) channels 
(green) flanked by paranodal CASPR (red). Scale bar, 5 µm.  
E) Axonal anchoring proteins of nodal ion channels are normally clustered in aged Cnp-Cre::Pex5flox/flox nerves. 
Scale bar, 5 µm. 
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2.4.2 Ectopic localization of juxtaparanodal Kv1.1 channels along internodes 
Besides voltage-gated sodium and potassium channels, juxtaparanodal Kv1.1 
channels influence nerve excitability (Rasband and Shrager, 2000). Therefore, the 
distribution of these channels was investigated by immunofluorescent teased fibers 
staining of sciatic nerves from 2 and 9 months old mice. Interestingly, conditional 
mutant nerves showed already at 2 months of age additional, ectopic internodal Kv1.1 
patches. When analyzing severely affected 9 months old nerves, this ectopic clustering 
was even more pronounced. Thus, aged animals showed considerably more Kv1.1 
patches in the internode, which were also observed far from juxtaparanodes (Fig. 17A). 
Nevertheless, normally localized Kv1.1 channels were still observed within the same 
fibers. However, these juxtaparanodal clusters were shorter in most of the cases. 
These findings suggest a secondary problem in the maintenance of juxtaparanodal Kv1 
channels rather than disturbed initial formation. This was in line with preserved 
mesaxonal localization of Kv1.1 even in nerves with many ectopic clusters (Fig. 17B). 
To examine the progressive internodal shift of Kv1.1, its distribution was monitored at 
earlier time points during development (P19 and 1 months). This analysis 
demonstrated that already at P19, when Kv1.1 are just clustered at juxtaparanodes, 
about 12% of nodes showed significant patches within internodes. Also, at 1 months 
of age, when myelination is completed, already 33% of nodes displayed internodal 
Kv1.1 clustering. This was progressive with age and affected almost 65% of nodes in 
9 months old conditional mutants (Fig. 17C). Enhanced Kv1.1 protein abundance was 
proven by western blot analysis of sciatic nerve lysates from 9 months old mice, 
demonstrating a 2-fold increase of Kv1.1 protein amount in mutant nerves (Fig. 17D). 
In conclusion, these observations illustrate secondary problems of Kv1.1 maintenance 
at juxtaparanodes due to disrupted peroxisomal function in Schwann cells, which 
suggests lipid metabolism-specific disturbances of axo-glial interaction.  




Fig. 17: Juxtaparanodal Kv1.1 proteins are progressively shifted towards internodes  
A) Representative immunofluorescent images of teased fibers from 2 months and 9 months old mice stained for 
nodal Nav1.6 (blue), paranodal CASPR (red) and juxtaparanodal Kv1.1 (green). 2 months old conditional mutant 
nerves show, in addition to normal juxtaparanodal Kv1.1 channels (arrow), clusters within the internode (white arrow 
head). This ectopic internodal clustering is even pronounced in 9 months old animals (bottom panel). Scale bar, 10 
µm. 
B) Immunofluorescent teased fiber staining for Nav1.6 (blue), CASPR (red) and Kv1.1 (green) shows preserved 
mesaxonal staining (non-filled arrow heads) of Kv1.1 even in severely affected nerves of 9 months old Cnp-
Cre::Pex5flox/flox animals. Scale bar, 10 µm. 
C) Percentage of Kv1.1 clusters in the paranode (PN) or internode (IN) at different ages. Quantification of Kv1.1 
clusters highlights a progressive shift to internodes and not paranodes, starting at P19. (P19 and 1 months, n=3, ≥ 
100 nodes counted per animal; 2 months, n=5, ~ 40 nodes counted per animal; >9 months, n=7, ~ 30 nodes counted 
per animal; error bars: mean + s.e.m; *p < 0.05, **p < 0.01, ***p < 0.001; Student’s T-test). 
D) Western blot analysis indicates a 2-fold increase of total Kv1.1 protein amount in nerve lysates from 9 months 
old mutants. Beta-III tubulin was used as loading control. (n=4 per genotype, error bars: mean + s.e.m, *p < 0.05, 
Student’s T-test). 
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2.4.3 Impaired anchoring of Kv1.1 channels 
Kv1.1 anchoring and maintenance at juxtaparanodes depend on the axonal adhesion 
molecules CASPR2 and TAG-1. Disruption of either protein causes redistribution of K+ 
channels evenly along internodes (Poliak and Peles, 2003). Co-staining of paranodal 
CASPR with either CASPR2 or TAG-1 revealed a shift of both proteins into the 
internode already at 2 months of age. Similar to Kv1.1 channels, both anchoring 
proteins progressively showed extra clusters within internodes, additional to their 
normal juxtaparanodal position (Fig. 18A, B). Co-labeling of Kv1.1 with either CASPR2 
(Fig. 18C) or TAG-1 (Fig. 18D) showed clear colocalization with Kv1.1, suggesting a 
shift of the entire juxtaparanodal complex into the internode. This was further verified 
by quantifying internodally located Kv1.1 that colocalized with TAG-1, demonstrating 
that the two proteins colocalized on 97% of ectopic patches (Fig. E). These results 
suggest impaired maintenance of juxtaparanodal proteins possibly due to defects in 
axo-glial interaction at these sites. 
 
Fig. 18: The entire juxtaparanodal complex drifts into internodes  
A-B) Representative immunofluorescent images of teased sciatic fibers, stained for paranodal CASPR (red) and 
juxtaparanodal CASPR2 or TAG-1 (green) reveals progressive internodal clustering of CASPR2 and TAG-1 (arrow 
head) in conditional mutants. TAG-1 occasionally shifts into paranodes (asterisk). Scale bar, 10 µm. 
C-D) Teased fiber staining of 9 months old conditional mutant nerves reveals clear colocalization of CASPR2 and 
TAG-1 (green) with normal juxtaparanodal (white arrow) or ectopic internodal (arrow head) Kv1.1 (red) clusters. 
Nodes are indicated by blue arrows. Scale bars, 10 µm. 
E) Quantification of ectopic Kv1.1 patches that colocalize with TAG-1. (~100 patches per animal were counted; error 
bars: mean + s.e.m). 
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2.5 Perturbation of gangliosides 
Gangliosides are abundant glycosphingolipids that stabilize the molecular composition 
of nodes and are associated with TAG-1 (Sheikh et al., 1999; Kasahara et al., 2000; 
Loberto et al., 2003). Moreover, they contain increased amounts of VLCFA in white 
matter regions of brains from X-ALD patients (Igarashi et al., 1976b). Lipid mass 
spectrometry was performed on sciatic nerve lysates from 9 months old mice to 
investigate the composition of gangliosides. This analysis clearly showed increased 
proportion of GD1 species that were bound to VLCFA in nerves obtained from Cnp-
Cre::Pex5flox/flox mice. Altogether, there was a 14-fold enrichment of GD1 species with 
more than 41 carbon atoms (Fig. 19A). Given the fact, that the sphingosine chain of 
mammalian brain gangliosides primarily contains 18 carbons and is bound to a 
saturated fatty acid (C18:0; Schnaar et al., 2014), there is a significant increase in GD1 
species bound to VLCFA (C23:0; C25:0; C26:0; C26:1). Moreover, only 0.74% of GD1 
species in control lysates contained 41 C-atoms (C23:0) and species with more than 
41 C-atoms were even absent (Fig. 19A).  
To further analyze whether this difference in ganglioside composition has an impact 
on subcellular distribution of gangliosides, teased fibers of 9 months old nerves were 
stained, using ganglioside-specific antibodies. In addition, specific binding of the B-
subunit of cholera toxin (CTB) to GM1 gangliosides was used to visualize GM1-
distribution within sciatic nerve fibers (Holmgren et al., 1975; Jobling et al., 2012). Co-
staining with an axonal marker (TUJ1) revealed CTB localization predominantly in 
close proximity to nodes of Ranvier. Thus, in control nerves the paranodal region was 
labeled by CTB. Mutant nerves interestingly demonstrated a more extended paranodal 
pattern (Fig. 19B). Similar differences at paranodes were observed with a GM1-specific 
antibody. Here, GM1 distribution at paranodes was even more distended towards 
internodes (Fig. 19C). Moreover, GM1 seemed to be more axonal compared to 
controls. GD1a another ganglioside that is produced from GM1 (Tettamanti et al., 
1973) also presented altered subcellular distribution at nodes. Control nerves showed 
specific paranodal staining, which was in mutant nerves more disperse and spread 
towards internodes (Fig. 19D). Since gangliosides are a typical substrate of lysosomes, 
co-labeling was performed with LAMP1. Astonishingly, conditional mutant nerves 
displayed massively enlarged GD1a-positive accumulates, which were associated with 
LAMP1. These accumulations were especially found within internodes and were only 
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rarely observed in control nerves (Fig. 19E, F). In conclusion, ganglioside metabolism 
is perturbed in these mice due to deficient peroxisomal β-oxidation. Additionally, 
ganglioside distribution is altered most probably due to their enrichment in VLCFA. 













Fig. 19: Ganglioside metabolism and their distribution at nodes of Ranvier is disturbed  
A) Mass spectrometry of sciatic nerve lysates from 9 months old mice reveals significantly increased percentage of 
GD1 species containing 41, 43, or 44 C-atoms (number of double bonds is separated by “:” and number of hydroxyl 
groups is separated with “;”). GD1 species with more than 41 C-atoms are absent in control nerve lysates. (n=4 per 
genotype, error bars: mean + s.e.m; *p < 0.05, ***p < 0.001; Student’s T-test). 
B) Teased fiber staining of fluorescently labeled cholera-toxin subunit B (CTB, red) and axonal TUJ1 (green) reveals 
an extended paranodal CTB pattern in 9 months old mutant nerves. Blue arrow indicates nodes of Ranvier. Scale 
bar, 10 µm. 
C) Control nerves show GM1 staining close to nodes of Ranvier (blue arrow), whereas in mutant nerves GM1 is 
increased and expands towards internodes. Dotted lines indicate myelinated fiber border. Scale bar, 10 µm. 
D) Paranodal staining of GD1a is more disperse and internodally diffused in mutant nerves. Dotted lines indicate 
myelinated fiber border. Scale bar, 10 µm. 
E) Co-labeling of GD1a (green) with LAMP1 (red) shows enlarged GD1a accumulates within internodes of mutant 
nerves that were also positive for LAMP1 (insets) and were very rarely observed in controls. Scale bars, 5 µm. 
F) Number of GDa1-positive vesicles (bigger than 1 µm) that colocalize with LAMP1 was significantly elevated in 
nerves from 9 months old Cnp-Cre::Pex5flox/flox mice. (~ 10% of total nerve material was analyzed, n=3, CTR; n=5, 
cKO; error bars: mean + s.e.m; **p < 0.01; Student’s T-test). 
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2.6 Secondary alterations of the endosomal-lysosomal system 
2.6.1 Lysosomes are in close contact with peroxisomes 
Recently, it has been shown that peroxisomes and lysosomes establish dynamic 
membrane contacts in vitro, through which cholesterol is transported from lysosomes 
to peroxisomes (Chu et al., 2015). According to this observation, the question arose if 
peroxisomes and lysosomes are also associated in vivo. Peroxisomes have been 
shown to be abundant in myelin rather than axons (Kassmann et al., 2011). To 
investigate whether lysosomes and peroxisomes are found in the same cellular 
compartments, which would at least afford spatial proximity, teased fiber preparations 
were stained for neurofilament 200 (NF200) and either peroxisomal membrane protein 
70 (PMP70) or lysosome-associated membrane protein 1 (LAMP1). Indeed, PMP70 
was highly abundant at SC nuclei and never colocalized with NF200, indicating myelin 
association (Fig. 20A, upper panel). Similar observations were made for LAMP1, which 
was particularly abundant at nodes and was also never observed within the axonal 
compartment (Fig. 20A, lower panel). Furthermore, co-labeling of PMP70 and LAMP1 
demonstrated close association of both organelles in the myelin compartment, which 
was most prominent at SC nuclei and nodes of Ranvier. Ring-like LAMP1-positive 
structures were observed at paranodes that were surrounded by PMP70-positive 
vesicles (Fig. 20B). These results strongly suggest in vivo interaction of peroxisomes 
and lysosomes. 
 
Fig. 20: Peroxisomes and lysosomes are closely associated in the paranodal Schwann cell compartment  
A) Immunofluorescent teased fiber staining for NF200 (red) and either PMP70 or LAMP1 (green) indicates 
association of both organelles with SC rather than axons. SC nuclei are stained with DAPI (blue). Arrow indicates 
the node. Scale bar, 10 µm. 
B) Peroxisomes (PMP70, green) and lysosomes (LAMP1, red) are highly abundant near nodes and show close 
association in 9 months old control sciatic nerves. Arrows indicate nodes. Scale bars, 10 µm. 
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2.6.2 Accumulation of lysosomes at paranodes 
Ganglioside metabolism is disturbed in Cnp-Cre::Pex5flox/flox mice due to deficient 
peroxisomal β-oxidation. As a consequence, these lipids are enriched at nodes and 
also within internodes (Fig. 19B-E). Interestingly, enlarged GD1a-positive vesicles 
colocalized with LAMP1 within internodes (Fig. 19E). Peripheral nerves of conditional 
mutants display paranodal swellings filled with vesicular inclusions and multivesicular 
bodies of so far unknown origin (Kassmann et al., 2011). In addition, we found 
peroxisomes and lysosomes closely associated at nodes of Ranvier (Fig. 20B). Thus, 
the question arose, if peroxisomal defects could provoke secondary problems in the 
lysosomal compartment, resulting in paranodal accumulations. To test whether 
paranodal vesicles are of lysosomal origin, immuno-electron microscopy and teased 
fiber staining for LAMP1 were performed. Indeed, electron microscopy of immunogold 
labeled ultrathin cryo sections identified LAMP1-positive vesicles within enlarged 
paranodal loops of 9 months old mutant nerves (Fig. 21A). Furthermore, 
immunofluorescent staining of teased fibers for LAMP1 (Fig. 21B) and lysosome-
integrated membrane protein 2 (LIMP2, Fig. 21C) evidenced abundant lysosome-
associated vesicles around nodes. These vesicles appeared extremely enlarged in 
mutant nerves already at 2 months of age. In addition to paranodes, indicated by 
CASPR staining, lysosome-associated vesicles were also observed in more 
juxtaparanodal or even internodal regions (Fig. 21B-C). These findings suggest a 
secondary problem of the endosomal-lysosomal pathway within the Schwann cell 
compartment due to peroxisomal dysfunction.  
Since the endosomal-lysosomal system is highly dynamic, it is difficult to clearly 
differentiate between primary lysosomes and late endosomes. Thus, LAMP1 is also 
expressed by late endosomes and autolysosomes (Clague, 1998; Huotari and 
Helenius, 2011). To validate the origin of paranodally accumulated vesicles, other 
components of the endosomal-lysosomal pathway were examined. Teased fiber 
staining of 9 months old nerves for Ras-related protein 7 (RAB7), a marker protein of 
late endosomes, and early endosome antigen 1 (EEA1) showed no increase of either 
protein at paranodes (Fig. 22A, B). Similar results were obtained for autophagy protein 
5 (ATG5), a marker for autophagy. Quantitative real-time PCR for MAP1LC3A, which 
is important in autophagosome formation, highlighted significantly less mRNA 
abundance in aged, but not young mutant nerves (Fig. 22D). 




Fig. 21: Accumulation of enlarged lysosome-associated vesicles at paranodes  
A) Immunogold labeling of ultrathin longitudinal sciatic nerve sections from 9 months old mice depicts enlarged 
paranodal loops (PNL) filled with LAMP1-positive vesicles (arrows) in conditional mutants. M, myelin; Ax, axon. 
Scale bar, 500 nm. 
B-C) Immunofluorescent images of teased sciatic nerves from 2 months old mice show abundant and enlarged 
LAMP1- and LIMP2-positive vesicles (green) near paranodes (CASPR, red) of mutant nerves. Scale bars, 10 µm. 
 




Fig. 22: Endosomal and autophagic vesicles are not accumulating at nodes of Cnp-Cre::Pex5flox/flox nerves 
A, B) Immunofluorescent staining of late (RAB7, green) and early (EEA1, green) endosomes at nodes of Ranvier 
(CASPR, red). Scale bar, 10 µm. 
C) Immunofluorescent staining of autophagy protein 5 (ATG5, green) at nodes of Ranvier (blue arrow). Scale bar, 
10 µm. 
D) Quantitative real-time PCR demonstrates significantly less mRNA expression of MAP1LC3A in sciatic nerve 
lysates from 9 months old Cnp-Cre::Pex5flox/flox mice. (n=6 per genotype; error bars: mean + s.e.m; n.s., not 
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2.6.3 Accumulation of lysosomes within enlarged Schmidt-Lanterman incisures 
Like paranodal loops, Schmidt-Lanterman incisures are a region of non-compact 
myelin that is involved in axo-glial interaction and metabolic exchange (Hall and 
Williams, 1970; Nave, 2010b). Considering paranodal accumulation of LAMP1, 
lysosomal abundance within SLI was investigated. LAMP1-positive vesicles were 
found within SLI (indicated by MAG co-staining) of control nerves and were massively 
elevated in Cnp-Cre::Pex5flox/flox nerves (Fig. 23A). Immunogold labeling of nerve 
sections from 9 months-aged mutants revealed abnormally enlarged SLI, which were 
filled with multivesicular bodies positive for LAMP1 (Fig. 23B). Immunofluorescent 
staining of MAG and 4.1G revealed a dramatically increased number of SLI in 9 months 
old conditional mutants. Thus, SLI were closely assembled and often spaced by only 
a few micrometer (Fig. 23C). Quantification of MAG-positive patches per 100 µm nerve 
length highlighted a 1.5-fold increase of SLI in 2 months old mutants and even a 3-fold 
increase of SLI in 9 months old mutants (Fig. 23D). Thus, the number of SLI increased 
progressively with age in Cnp-Cre::Pex5flox/flox mice. Moreover and as expected from 
the literature, this was even most prominent in large fibers. Assuming a role for SLI in 
SC-axon communication these observations suggest a compensatory mechanism of 
disturbed interaction.  
 




Fig. 23: Schmidt-Lanterman incisures are increased in number and contain LAMP1-positive vesicles 
A) Immunofluorescent teased fiber staining for myelin-associated glycoprotein (MAG) and LAMP1 in 2 and 9 months 
old sciatic nerves. Funnel-shaped Schmidt-Lanterman incisures (MAG, red) contain LAMP1-positive vesicles 
(green), both in controls and conditional mutants (arrows). The number of SLI, as well the abundance of LAMP1 
vesicles is progressively increased in conditional mutants. Scale bar, 10 µm. 
B) Immunogold labeling of ultrathin longitudinal sciatic nerve sections from 9 months old mice shows Schmidt-
Lanterman incisures (SLI) that contain multivesicular bodies, positive for LAMP1 (inset, arrow heads), in conditional 
mutants. M, myelin. Scale bars, 500 nm. 
C) Immunofluorescent staining for MAG and 4.1G reveals a massive increase of SLI in 9 months old conditional 
mutants. Some SLI were closely assembled into rows, which were considered as one SLI for quantitative analysis 
(asterisk). Scale bar, 50 µm. 
D) Quantification of SLI per 100 µm fiber length demonstrates increased number of SLI already at 2 months of age, 
which is further enhanced in 9 months old conditional mutants. (2 months, n=4; > 9 months, n=5; error bars: mean 
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Next, lysosomal accumulation was investigated by western blot analysis of total sciatic 
nerve lysates from 9 months old mice, confirming excessive LAMP1 and LIMP2 protein 
abundance in mutant nerves (Fig. 24A). Quantitative analysis revealed a 4-fold 
increase of LAMP1 protein amount and a 2-fold elevated LIMP2 protein abundances 
in conditional mutants (Fig. 24B). To investigate whether elevated LAMP1 and LIMP2 
protein amounts are related to higher mRNA expression, quantitative real-time PCR 
was applied. Interestingly, relative mRNA expression of LAMP1 and LIMP2 were 
significantly reduced in 2 months old mutant nerves. Moreover, LAMP1 showed 
significantly mRNA reduction even in 9 months old mutants (Fig. 24C). These results 




Fig. 24: Relative protein abundance and mRNA expression of LAMP1 and LIMP2  
A) Western blot analysis of sciatic nerve lysates from 9 months old mice showing results from 4 individual animals 
per genotype. β-III-tubulin was used as loading control. 
B) LAMP1 shows about 4-fold increased relative protein amount in conditional mutants. Relative LIMP2 protein 
amount is 2-fold elevated in mutants. (n=4 per genotype; error bars: mean + s.e.m; *p < 0.05, **p < 0.01; Student’s 
T-test). 
C) Quantitative real-time PCR reveals significantly reduced relative mRNA expression of Lamp1 and Limp2 in 2 
months and for Limp1 also in 9 months old mutant nerves. Values are represented as relative amounts of control 
results, which were set to one. (n=6 per genotype; error bars: mean + s.e.m; *p < 0.05, **p < 0.01; Student’s T-test). 
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2.6.4 Alterations of lysosomal function 
Lysosomal accumulation is a common feature of lysosomal storage disorders that 
mostly result from enzyme deficiencies (Jeyakumar et al., 2005; Braulke and 
Bonifacino 2009). Lysosomes contain a set of hydrolases to digest macromolecules. 
To study whether abundant lysosomes are still functional, the enzymatic activity of α-
mannosidase and β-hexosaminidase was measured in sciatic nerve lysates from 2 and 
9 months old mice. Both enzymes showed an elevated activity already in 2 months old 
mutant nerves. The increase in the enzymatic activity was further progressive with age 
and reached about 3-fold of control values in Cnp-Cre::Pex5flox/flox mice aged 9 months 
(Fig. 25A-B). Most interestingly, β-hexosaminidase is essential for digestion of GM2 
gangliosides (Sandhoff and Harzer, 2013), suspecting a direct link between disturbed 
ganglioside metabolism and elevated enzymatic activity.  
 
Fig. 25: Lysosomal enzyme activity is progressively enhanced in Cnp-Cre::Pex5flox/flox nerves 
A-B) Enzyme activity assay of sciatic nerves lysates from 2 and 9 months old mice reveals progressive elevation 
of α-mannosidase and β-hexosaminidase activity in Cnp-Cre::Pex5flox/flox nerves, reaching a 3-fold increase in 9 








  Results 
62 
 
2.7 Comparative analysis of ABCD1-deficient mice, a model of 
human adrenomyeloneuropathy  
To test whether the observed nerve pathology of conditional Pex5 mutants is also 
relevant for other peroxisomal mouse models of disease, a comparative analysis of 
Abcd1-/- mice, a model of X-linked adrenoleukodystrophy (X-ALD), was performed. 
These mice lack the peroxisomal ABCD1 transporter, which is required for import of 
very long-chain fatty acids into peroxisomes for subsequent degradation (van 
Roermund et al., 2008; Wiesinger et al., 2013). ABCD1-deficiency results in disturbed 
peroxisomal β-oxidation (Wanders, 2004a). Although, these mice lack cerebral 
symptoms, typical for the severe form of the disease (cerebral ALD), they develop a 
late-onset peripheral neuropathy, mimicking symptoms of the adult-onset form of the 
same disease, adrenomyeloneuropathy (AMN; (Forss-Petter et al., 1997; Lu et al., 
1997; Pujol et al., 2002).  
 
2.7.1 Behavioral analysis of nerve impairment in ABCD1-deficient mice 
First electrophysiological and myelin alterations of sciatic nerves were observed in 
Abcd1-/- mice between 15 and 16 months of age and the earliest motor impairment 
was recorded at 20 months of age, using the rotarod test (Pujol et al., 2002). Therefore, 
the aim was to find a more sensitive behavioral test, allowing earlier detection of 
possible motor defects. To this end, motor performance was assessed at three different 
time points: at 13 months of age, before detection of electrophysiological alterations; 
at 15 months, when neuropathy is obvious by electrophysiology; and at 18 months of 
age, just before behavior deficits became apparent by rotarod. The grid test was used 
to evaluate motor coordination (Fig. 26A). Mice had to run 1.5 m on a metal grid while 
their front and hind paw slips were counted. Abcd1-/- mice tended to slip more 
frequently already at 13 months of age, which was more pronounced at front paws, but 
these differences were not significant. Although the same trend was observed at 15 
months of age, there was no further increase in the number of slips. Only at 18 months 
of age, the mean number of slips had slightly risen. However, this was also observed 
in age-matched controls, indicating rather an aging than a genotype effect (Fig. 26A). 
Next, fore limb muscles strength was evaluated by the grip strength test. This test also 
failed to show significant differences between controls and Abcd1-/- mice at 13 and 15 
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months of age, but revealed age-dependent muscle weakness (Fig. 26B). Finally, the 
elevated beam test was used to assess motor coordination and balance. Mice had to 
reach a box by walking an elevated beam. The number of slips, as well as the time 
animals needed to reach the box, were comparable between controls and Abcd1-/- 
mice at 13 months of age. As expected, the walking speed was reduced in 15 months 
old animals of both genotypes. Thus, Abcd1-/- mice were as fast as controls, showing 
slightly, however not significantly, more slips (Fig. 26C). Taken together, none of the 
tests was challenging enough to show more subtle motor deficits. Moreover, high 
variances between individual animals possibly disguised genotype-specific 













Fig. 26: Behavioral assessment of motor performance 
A) Mouse performing on the grid (size of grid 1 x1 cm). There is no significant difference between genotypes at any 
tested time point. There is an age-dependent, non-significant increase of slips at 18 months of age within both 
groups. (13 months, n=9 (CTR), n=20 (Abcd1-/-); 15 months, n=13 (CTR), n=23 (Abcd1-/-); 18 months, n= 7 (CTR), 
n=8 (Abcd1-/-); error bars: mean ± s.e.m; Student’s T-test). 
B) A mouse is gently pulled at the tale, while grasping the bar of the grip strengths device. The grasping force is 
comparable between controls and Abcd1-/- mice at 13 and 15 months of age, but shows a significant age-dependent 
decline of grip strength (right graph). (13 months, n=5 (CTR), n=13 (Abcd1-/-); 15 months, n=10 (CTR), n=16 
(Abcd1-/-); error bars: mean + s.e.m, n.s. not significant, *p < 0.05; Student’s T-test). 
C) Mouse performing on the elevated beam. Abcd1-/- mice tend to make more hind limb slips than controls at the 
age of 15 months (left graph). Abcd1-/- mice are slower reaching in the house (right graph). At 13 months of age, 
Abcd1-/- performed similar to controls (13 months, n=4 (CTR), n=5-6 (Abcd1-/-); 15 months, n=10 (CTR), n=16 
(Abcd1-/-); error bars: mean ± s.e.m; n.s.; Student’s T-test). 
 
It has been shown that ABCD1-deficient mice develop reduced sensitive nerve 
conduction velocities at 20 months of age (Pujol et al., 2002). Furthermore, sensory 
impairment is a common feature of especially AMN patients (Moser et al., 2007). To 
associate published electrophysiological alterations with behavioral deficits, pressure 
and heat sensation was assessed in 13, 15 and 18 months old Abcd1-/- mice and 
compared to corresponding controls. Here, Abcd1-/- mice revealed slightly reduced 
reactions in response to mechanical stimuli at 13 months of age, which was however 
not significant. Moreover, at later time points (15 and 18 months of age) there was no 
distinct difference between controls and mutants (Fig. 27A). The same was true for 
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thermal stimuli. Although the latency was slightly increased at older ages (15 and 18 
mo), this was not significant and showed again high variances within groups (Fig. 27B). 
In summary, neither the dynamic plantar aesthesiometer test (pressure sensation) nor 
the plantar Hargreaves test (heat sensation) reflected sensory deficits. 
 
 
Fig. 27: Normal pressure and heat sensation in aged Abcd1-/- mice 
A) Behavioral assessment of pressure sensation, using the dynamic plantar aesthesiometer, reveals no significant 
difference between Abcd1-/- mice and controls at any tested time point. (13 months, n=3 (CTR), n=8 (Abcd1-/-); 15 
months, n=12 (CTR), n=17 (Abcd1-/-); 18 months, n=7 (CTR), n=8 (Abcd1-/-); error bars: mean ± s.e.m; Student’s 
T-test was applied for each time point).  
B)  Behavioral assessment of heat sensation, using the plantar Hargreaves test, shows no significant difference 
between Abcd1-/- mice and controls at all tested time points. (13 months, n=5 (CTR), n=8 (Abcd1-/-); 15 months, 
n=14 (CTR), n=18 (Abcd1-/-); 18 months, n=7 (CTR), n=8 (Abcd1-/-); error bars: mean ± s.e.m; Student’s T-test 
was applied for each time point).  
 
2.7.2 Absence of myelin alterations and axonal loss in aged Abcd1-/- mice 
Electrophysiological analysis of 20 months old Abcd1-/- mice revealed reduced nerve 
conduction velocity, but no decrease of compound muscle action potential amplitudes. 
This led to the assumption that myelin abnormalities, rather than axonal loss, are a 
substantial feature of their pathology (Pujol et al., 2002). Nevertheless, acute 
demyelination is neither observed in CNS nor PNS of Abcd1-/- mice until the age of 21 
months (Forss-Petter et al., 1997; Kobayashi et al., 1997; Pujol et al., 2002). 
Hypomyelinated axons, interpreted as a result of demyelination or remyelination, were 
detected in 22 months old mice (Pujol et al., 2002). Therefore, semithin sciatic nerves 
cross sections of 22 months old Abcd1-/- mice were stained for methylene blue/ azur 
II to analyze myelin sheaths. Also here, no signs of acute demyelination were observed 
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and myelin sheath thickness appeared comparable to age-matched controls (Fig. 
28A). This was further evaluated by g-ratio analysis, confirming normal myelin sheath 
thickness for all analyzed axonal diameters and a similar mean g-ratio in Abcd1-/- 
nerves (Fig. 28B). Besides potential demyelination, other myelin alterations could 
account for reduced nerve conduction velocities. Focal hypermyelination, as well as 
myelin infoldings, were observed in nerves from 16 and 21 months old Abcd1-/- mice 
(Pujol et al., 2002). We detected similar myelin inclusions in nerves of 22 months old 
mice of both genotypes at comparable frequency, assuming these were age-
dependent, not genotype-related effects (Fig. 28C). 
 
 
Fig. 28: Normal myelin thickness and age-related myelin inclusions 
A) Methylene blue/ azur II stained semithin cross sections of sciatic nerves from 22 months old mice reveal normally 
myelinated axons in Abcd1-/- nerves. Scale bar: 10 µm.  
B) Quantification of myelin sheath thickness by g-ratio analysis (axonal diameter divided by complete fiber diameter) 
from ultrathin sciatic nerve cross sections of 22 months old controls (black) and Abcd1-/- mice (grey). Myelin 
thickness is comparable between controls and mutants for all axonal diameters. Quantification of mean g-ratio 
depicts similar values for controls (0.55) and mutants (0.59). (n=3, ≥ 100 randomly chosen axons per animal, error 
bars: mean + s.e.m, Student’s T-test). 
C) EM micrograph showing myelin inclusions (arrow head) in axons of 22 months old control nerves. Quantification 
of axons with myelin inclusions indicates no significant difference between control and Abcd1-/- nerves. (n=4, error 
bars: mean + s.e.m, Student’s T-test). 
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Despite normal CMAP amplitudes, Pujol et al. suggested signs of axonal damage 
secondary to myelin abnormalities in 21 months old Abcd1-/- sciatic nerves. Moreover, 
axonal degeneration has been shown in spinal cord (Pujol et al., 2002). Therefore, 
axonal loss was investigated from complete sciatic nerve cross sections of 22 months 
old mice. Interestingly, the distribution of axons in Abcd1-/- nerves was comparable to 
that of controls (Fig. 29A). Furthermore, there was neither loss of small (axonal 
diameter <3 µm) nor of large (axonal diameter ≥5µm) caliber axons (Fig. 29B). Also, 
the number of myelinated axons per nerve was similar between both genotypes (Fig. 
29C). Taken together, Abcd1-/- sciatic nerves do not show considerable myelin 
alterations or axonal loss even at the age of 22 months of age. This suggests other 





Fig. 29: No axonal loss in Abcd1-/- sciatic nerves 
A) Analysis of axon distribution in complete cross sections of sciatic nerves from 22 months old mice shows normal 
axon distribution in Abcd1-/- nerves. (n=4 per group; error bars: mean ± s.e.m, Two-way ANOVA followed by 
Bonferroni test). 
B) Quantification of small caliber axons (diameter <3, left graph) and large caliber axons (diameter ≥5 µm; right 
graph) confirmed no axonal loss in 22 months old Abcd1-/- nerves. (n=4 per group; error bars: mean ± s.e.m; n.s., 
not significant; Student’s T-test). 
C) The number of myelinated axons is comparable between control and Abcd1-/- nerves. (n=4 per group; error 
bars: mean + s.e.m, Student’s T-test). 
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2.7.3 Kv1.1 channel clustering is impaired in aged Abcd1-/- mice 
Abcd1-/- mice develop reduced nerve conduction velocities at around 16 months of 
age (Pujol et al., 2002), but like Cnp-Cre::Pex5flox/flox animals they do not show 
considerable signs of peripheral demyelination or axonal degeneration (Fig. 28, 29). 
To test whether Abcd1-/- mice acquire juxtaparanodal potassium channel alterations, 
the molecular organization of nodes was analyzed on teased sciatic nerve fibers. 
According to Cnp-Cre::Pex5flox/flox mice, nodal ion channels (Nav1.6 and Kv7.2) and 
their anchoring proteins (βIV-spectrin and ANKG) were normally clustered even in 22 
months old mice. Also, paranodal CASPR was unchanged (Fig. 30A, B). In contrast, 
ectopic internodal Kv1.1 channel clustering was already observed at 2 months of age 
(Fig. 30 C). Similar to Cnp-Cre::Pex5flox/flox nerves, this was progressive with age, 
resulting in  around 24% of nodes that showed indernodal Kv1.1 clusters at 22 months 
of age (Fig. 30D). Interestingly and different from Cnp-Cre::Pex5flox/flox mice, aged 
ABCD1-deficient mice displayed significant Kv1.1 clustering not only at internodes, but 
also at paranodes (Fig. 30D). In summary, Abcd1-/- nerves show comparable, but less 
pronounced alterations of juxtaparanodal potassium channels like Cnp-Cre::Pex5flox/flox 









Fig. 30: Ectopic localization of juxtaparanodal Kv1.1 proteins despite intact paranodal junctions  
A) Immunofluorescent teased fiber staining of 22 months old mice shows normal nodal sodium (Nav1.6) and 
potassium (Kv7.2) channels (green) flanked by paranodal CASPR (red). Scale bar, 5 µm.  
B) Nodal anchoring proteins are normal in Abcd1-/- nerves. Scale bar, 5 µm. 
C) Immunofluorescent teased fiber staining for nodal Nav1.6 (blue), paranodal CASPR (red) and juxtaparanodal 
Kv1.1 (green) reveals Kv1.1 clusters (arrow head) in addition to normal juxtaparanodal patches (arrow) in 2 months 
and 22 months old Abcd1-/- nerves. Scale bar, 10 µm. 
D) Percentage of Kv1.1 clusters in the paranode (PN) or internode (IN) is slightly enhanced in 2 months old Abcd1-
/- nerves and gets significantly increased in 22 months old Abcd1-/- nerves. (2months, n=4, ~ 60 nodes counted 
per animal; 22 months, n=6, 20-40 nodes counted per animal; error bars: mean + s.e.m, n.s. not significant, *p < 
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2.7.4 Lysosomal alterations and abnormal Schmidt-Lanterman incisures  
Considering incorporation of VLCFA in gangliosides as one major step towards 
secondary lysosome accumulation in Cnp-Cre::Pex5flox/flox nerves, ABCD1-defciency 
was expected to induce similar problems in the lysosomal compartment. To test this 
hypothesis, teased sciatic nerve fibers were co-stained with CASPR and LAMP1 or 
LIMP2 respectively. Like in Cnp-Cre::Pex5flox/flox nerves, lysosome-associated vesicles 
were enlarged and enriched near nodes of Ranvier in nerves obtained from 22 months 
old Abcd1-/- mice (Fig- 31A, B). Furthermore, immuno-electron microscopy highlighted 
abnormally enlarged Schmidt-Lanterman incisures (SLI) that contained LAMP1-
positive accumulates (Fig. 31C). Additionally, immunofluorescent staining of MAG 
revealed increased number of SLI in 22 months old Abcd1-/- nerves (Fig. 31D). This 
was further confirmed by quantification of SLI, showing significantly more incisures in 
Abcd1-/- nerves aged 22 months, but not at 2 months of age (Fig. 31E). In conclusion, 
lysosomal alterations were also apparent in aged Abcd1-/- nerves, speaking for a role 
of deficient β-oxidation in disease progression.  
To clarify, if ABCD1-deficiency causes functional impairment of lysosomes, as in Cnp-
Cre::Pex5flox/flox mice, the enzymatic activity of α-mannosidase and β-hexosaminidase 
was measured in sciatic nerve lysates from 22 old mice. As expected from the less 
pronounced phenotype of SLI increase and ectopic Kv1.1 clusters, α-mannosidase 
enzyme activity was unaltered in aged Abcd1-/- nerves (Fig. 32A). However, β-
hexosaminidase enzyme activity almost reached significance, showing comparable 
values than 9 months old Cnp-Cre::Pex5flox/flox nerves (14.75 ± 1.61 mU/mg in Abcd1-
/- nerves compared to 16.54 ± 1.68 mU/mg in Cnp-Cre::Pex5flox/flox nerves, Fig. 25 and 
32B). In summary, these findings suggest secondary lysosome alterations due to 
defects in peroxisomal β-oxidation.  




Fig. 31: Accumulation of lysosome-associated vesicles in regions of non-compact myelin 
A-B) Immunofluorescent images of teased sciatic nerves from 22 months old mice shows abundant and enlarged 
LAMP1- and LIMP2-positive vesicles (green) at paranodes (CASPR, red) of Abcd1-/- nerves. Scale bars, 10 µm. 
C) Immuno-gold labeling of ultrathin longitudinal sciatic nerve sections from 22 months old Abcd1-/- mice 
demonstrates enlarged Schmidt-Lanterman incisures (SLI) that contain multivesicular bodies, positive for LAMP1 
(arrow head). M, myelin. Scale bars, 500 nm. 
D) Immunofluorescent staining for MAG indicates increased number of SLI in 22 months old Abcd1-/- nerves. Scale 
bar, 50 µm. 
E) Quantification of SLI per 100 µm fiber length demonstrates significantly increased number of SLI in Abcd1-/- 
mice aged 22 months, but not in 2 months old mice. (2 months, n=3 (CTR), n=4 (Abcd1-/-); 22 months, n=4 (CTR), 
n=5 (Abcd1-/-); error bars: mean + s.e.m, *p < 0.05; Student’s T-test). 




Fig. 32: Lysosomal enzyme activity in Abcd1-/- nerves 
A-B) Enzyme activity assay of sciatic nerves lysates from 22 months old mice reveals no differences in α-
mannosidase activity, but almost significantly elevated β-hexosaminidase activity in Abcd1-/- nerves (n=3 (CTR), 
n=4 (Abcd1-/-); error bars: mean + s.e.m; Student’s T-test). 
 
 




Electrical properties of myelinated axons depend on insulation through myelin and on 
the distinct molecular organization of ion channels at nodes of Ranvier (Waxman and 
Ritchie, 1985; Peles and Salzer, 2000). Complex interactions between axons and 
myelinating glia are required to achieve such properly functional myelination of axons 
(Pereira et al., 2012). Myelin membranes underlie continuous turnover (Ando et al., 
2003) and alterations in their composition result in neural dysfunctions. Myelin sheaths 
are highly enriched in lipids (~70% of dry mass; Garbay et al., 2000), which are likely 
particularly vulnerable to deficiencies in lipid metabolism. The essential role of 
peroxisomes for the nervous system is evidenced by peroxisomal disorders (Gould 
and Valle, 2000; Steinberg et al., 2006; Wanders and Waterham, 2006). These 
organelles are associated with cellular lipid metabolism, but underlying molecular 
mechanism of peroxisomal dysfunction causing myelin abnormalities, axon 
degeneration, and neuroinflammation are unresolved. Therefore, the Cnp-Pex5 mouse 
model was used to study the role of myelin-associated peroxisomes in SC-axon 
interaction. 
 
3.1 PEX5-deficiency disrupts peroxisomal function in SC 
Since PEX5 is the major import receptor of peroxisomal matrix proteins, its ablation 
causes widespread peroxisomal dysfunction (Gould and Valle, 2000; Stanley et al., 
2006). One major function of peroxisomes is chain-shortening of fatty acids through β-
oxidation. Since VLCFA are exclusively degraded by peroxisomes, they accumulate in 
plasma and tissue of patients with peroxisomal disorders and are therefore used as a 
biomarker for diagnosis (Wanders, 2004a; Wanders and Waterham, 2006). Using lipid 
mass spectrometry we verified disturbed peroxisomal β-oxidation by showing 
significantly enhanced C24:0 and C26:0 levels in sciatic nerves of Cnp-Cre::Pex5flox/flox 
mice (Fig. 8D). High concentrations of these saturated VLCFA disturb cellular Ca2+ 
homeostasis, cause mitochondrial dysfunction, and enhance oxidative stress in vitro 
(Fourcade et al., 2008; Baarine et al., 2012). Moreover, cytotoxic effects especially 
impair oligodendrocytes (Hein et al., 2008). Nevertheless, plasmatic VLCFA-levels of 
X-ALD patients are not sufficient to induce cell death and organelle dysfunction in vitro 
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(Baarine et al., 2012). Therefore, the actual role of excess VLCFA in the disease 
progression is still under debate.  
Ether phospholipid synthesis, another peroxisomal function, was also disturbed in 
conditional PEX5 mutants as evidenced by lipid mass spectrometry. Plasmalogens 
were reduced by almost 70% and phosphatidylethanolamines were significantly 
increased (Fig. 8A, B). In vivo studies showed that neurodegenerative symptoms, 
potentially caused by VLCFA-accumulation, can be modulated by plasmalogens 
(Brites et al., 2008). Since plasmalogens are highly abundant in myelin membranes, 
their reduction has further consequence for the nervous system, including progressive 
cerebral atrophy, myelin abnormalities and gliosis (Braverman and Moser 2012; 
Poulos et al., 1988). Structural membrane alteration as well signaling defects have 
been observed in fibroblast from patients with deficient plasmalogen synthesis (Thai 
2001; Perichon 1998). In vivo studies revealed myelin defects and disturbed axo-glial 
interaction at paranodes of plasmalogen-deficient mice (Teigler et al., 2009; 
Braverman and Moser 2012). Peroxisomal dysfunction causes oxidative stress due to 
elevated reactive oxygen species (ROS), such as hydrogen peroxide, a typical 
byproduct of peroxisomal β-oxidation that has to be degraded via peroxisomal catalase 
(Fransen et al., 2012). We found peroxisomal catalase no longer colocalized with the 
peroxisomal membrane marker PMP70, but distributed in the cytoplasm (Fig. 7C). 
Deficient import of catalase is a frequent finding of peroxisomal defects and has been 
shown to provoke multiple peroxisomal enzyme deficiencies due to elevated ROS 
(Sheikh et al., 1998). In summary, we clearly demonstrated a general dysfunction of 
SC peroxisomes upon PEX5 ablation as indicated by deficient peroxisomal β-
oxidation, reduced plasmalogen synthesis and cytoplasmic catalase. 
 
3.2 Impaired nerve function despite normal myelin and axon 
distribution 
Ex vivo electrophysiology revealed massively impaired sciatic nerve function in 2 
months old Cnp-Cre::Pex5flox/flox mice, which was comparable to electrophysiological 
alterations observed in myelin-deficient mice (e.g. shiverer, Sinha et al., 2005).  
Considering extensive lipid metabolism defects in sciatic nerves of conditional mutants 
and the recently published role of myelin-associated peroxisomes in myelin 
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maintenance (Kassmann et al., 2007), we analyzed sciatic nerves for myelin 
alterations as a potential cause of reduced nerve conduction. Astonishingly, 2 months 
old conditional mutants had preserved myelin, as indicated by g-ratio analysis and 
examination of methylene blue-stained complete nerve cross sections. Although axons 
with thinner myelin sheaths were occasionally observed in 9 months old conditional 
mutant nerves, g-ratio analysis did not show considerable differences in comparison 
to controls (Fig. 12A-C). Since g-ratio analysis includes only a fraction of nerve fibers 
due to technical restrictions of electron microscopy, analysis of complete nerve 
sections would potentially disclose minor differences of myelin sheath thickness in 
aged mutants, which however would not explain massive electrophysiological changes 
at 2 months of age. Myelin compaction and protein composition were normal, as 
evidenced by ultrastructural and western blot analysis (Fig. 13 A, B). Merely PLP, 
which comprises only 0.2% of total protein content in the PNS (Garbay et al., 2000; 
Patzig et al., 2011), showed significant reduction (Fig. 13C). Thus, reduced nerve 
conduction velocities that were already apparent at 2 months of age cannot be 
explained by myelin alterations. Assuming preserved myelin as a prerequisite of axon 
integrity, we did not expect significant axon loss in sciatic nerves. Indeed, axon 
distribution was not changed and also the total number of myelinated axons was 
comparable between controls and conditional mutants. Although very large caliber 
axons (Ø ≥ 7 µm) were absent from g-ratio analysis of 9 months old Cnp-
Cre::Pex5flox/flox sciatic nerves, examination of complete nerve cross sections excluded 
the loss of big axons (Fig. 14). This can be further explained by an underrepresentation 
of big axons in the g-ratio analysis due to technical restrictions of electron microscopy. 
Thus, we exclude axonal loss as a cause of reduced amplitudes.  
Interestingly, electrophysiological results of PEX5 conditional mutant sciatic nerves 
differ a lot between in vivo and the here performed ex vivo measurements, which were 
clearly more pronounced (Kassmann et al., 2011). Thus, we considered compensatory 
mechanisms at neuromuscular junctions (NMJs). However, quantification of NMJ 
number did not reveal significant differences (Fig. 10). Nevertheless, we cannot 
exclude other molecular changes at synapses that potentially influence ex vivo 
measurements. Most interestingly, peripheral neuropathy upon peroxisomal 
dysfunction differs fundamentally from CNS pathology, suggesting a rather minor role 
of peroxisomes in myelin maintenance of the PNS. It was shown that microglia invasion 
precedes myelin alterations, suspecting an inflammatory demyelination in the CNS of 
  Discussion 
76 
 
Cnp-Cre::Pex5flox/flox mice (Kassmann et al., 2007). In addition, studies on Nes-
Cre::Pex5flox/flox brains also demonstrated activation of the innate immune system upon 
peroxisome deficiency as the major cause of CNS demyelination (Bottelbergs et al., 
2012). Considering only moderate levels of neuroinflammation in sciatic nerves of 
conditional mutants (Fig. 15), this potentially explains substantial differences between 
CNS and PNS concerning myelin maintenance. Furthermore, the PNS has a much 
higher regenerative ability than the CNS (Jessen and Mirsky, 2016). Recently, the 
capability of SC to degrade myelin after nerve injury was published (Gomez-Sanchez 
et al., 2015). Another possible explanation for less myelin alterations in the PNS is the 
distinct expression of PLP. In the CNS, PLP is the major myelin protein that is involved 
in stabilizing myelin membranes and is thereby essential for axonal function, whereas 
in the PNS, PLP plays only a minor role and is replaced by P0 (Garbay et al., 2000). 
Although PLP incorporates VLCFA (Bizzozero et al., 1991), this would have minor 
impacts on PNS myelin stability. In addition, it has been shown that reduced PLP 
protein amount has less serious consequences for the integrity of myelin than 
overexpression or mutations in the PLP gene (Seitelberger, 1995; Simons et al., 2002). 
We therefore conclude that neither demyelination nor axon degeneration are 
substantial features of PNS pathology in Cnp-Cre::Pex5flox/flox mice. 
 
3.3 Ectopic juxtaparanodal proteins and potential effects on nerve 
excitability 
Fast signal propagation is ensured by distinct molecular domains of myelinated axons 
that restrict action potentials to nodes of Ranvier (Arroyo et al., 2004; Salzer et al., 
2008). These are highly enriched in voltage-gated sodium channels (Nav1.6) that 
mediate action potential generation (Caldwell et al., 2000). We speculated that 
disturbed lipid metabolism in SC might alter axo-glial interactions and thereby causes 
differences in electrophysiological properties. There is evidence that reduced 
plasmalogen levels affect paranodal junctions through alterations in the synthesis and 
raft distribution of GPI-anchored contactin (Gorgas et al., 2006; Teigler et al., 2009). 
Disruption of paranodal junctions in contactin- or CASPR-deficient mice impairs axonal 
integrity and reduces nerve conduction velocity despite normal myelin compaction 
(Boyle et al., 2001; Bhat et al., 2001). An essential role of myelin galactolipids 
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(cerebroside and sulfatide) in the maintenance of axo-glial interactions became evident 
from mice deficient in galactosyltransferase (CGT-/-; Dupree et al., 1999) and 
galactosylceramide sulfotransferase (CST-/-, Ishibashi et al., 2002). Although 
structural changes are less pronounced in the PNS, all of these mutants display a shift 
of juxtaparanodal Kv1.1/2 channels into the paranodal region. However, the integrity of 
paranodal junctions was verified by intact transverse bands and preserved autotypic 
junctions between individual loops of Cnp-Cre::Pex5flox/flox sciatic nerves (Fig. 16A-C). 
Furthermore, nodal ion channels and their axonal anchoring proteins were normally 
formed and maintained (Fig. 16D, E). In contrast, juxtaparanodal Kv1.1 channels were 
progressively shifted with age into internodes of Cnp-Cre::Pex5flox/flox sciatic nerves 
(Fig. 17A, C). This unexpected observation was already apparent in 12% of nodes at 
P19, when potassium channels are just clustered. In compliance with intact paranodal 
junctions, a prerequisite for juxtaparanodal clustering, Kv1.1 channels were never 
found within paranodes of conditional mutant nerves. Interestingly, ectopic clusters 
most frequently appeared in addition to normally located juxtaparanodal patches. 
Moreover, the mesaxonal pattern of Kv1.1 was still obvious in conditional mutants (Fig. 
17B). This let to assume that their initial formation is normal. Hence, their internodal 
distribution is likely a consequence of deficient maintenance that correlates with 
disease progression.  
Juxtaparanodal Kv1.1 clustering and maintenance depend on CASPR2 and TAG-1, 
which form a heterodimer that is attached to the glial membrane via TAG-1 (Poliak and 
Peles, 2003; Traka et al., 2003). Immunofluorescent staining of teased fibers for 
CASPR2 and TAG-1 showed internodal clustering of both anchoring proteins, which 
was progressive with age (Fig. 18A, B). Costaining with Kv1.1 as well as quantification 
of TAG-1/Kv1.1 colocalization in ectopic patches clearly showed a shift of the complete 
juxtaparanodal complex to internodes (Fig. 18C-E). This is in line with published data 
obtained from Caspr2-/- and Tag-1-/- mice, demonstrating that juxtaparanodal 
clustering of both proteins is interdependent and deficiencies in either protein impair 
juxtaparanodal clustering of K+ channels (Poliak and Peles, 2003; Traka et al., 2003). 
Analyzing mice with a Schwann cell-specific defect, we hypothesized that disturbed 
juxtaparanodal clustering in conditional mutant nerves is provoked by deficient 
membrane anchoring of glial TAG-1 (Traka et al., 2002; 2003). Although this 
assumption cannot be proven by TAG-1 immunofluorescence, it has been shown by 
Savvaki et al. that glial TAG-1 is sufficient for juxtaparanodal organization and 
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maintenance of CASPR2 and Kv1.1 in the CNS (Savvaki et al., 2010). Additionally, 
Zhang et al. demonstrated that adhesion molecules are freely diffusible within 
membranes and accumulate through interactions with Schwann cell ligands, whereas 
ion channels and cytoskeletal proteins are rather immobile and rely on selective 
anterograde transport from neuronal cell bodies (Jensen et al., 2011; Zhang et al., 
2012). These observations let assume that glial TAG-1 likely diffuses into internodes 
as a result of SC-specific signals. It has been shown that TAG-1 is a 
glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecule that is associated 
with ganglioside-rich lipid rafts (Kasahara et al., 2000; Loberto et al., 2003). Since 
cholesterol is a major component of lipid rafts and is enriched in conditional mutant 
nerves, we suspect that this could further stabilize raft-associated binding of TAG-1. 
Consequently, the whole juxtaparanodal complex would drift into internodes. This 
would imply that newly synthesized Kv1.1, which is transported to nodes, is trapped at 
ectopic TAG-1/CASPR2 clusters. Western blot analysis highlighted elevated Kv1.1 
protein amounts in sciatic nerves of aged conditional mutants (Fig. 17D). However, to 
confirm enhanced Kv1.1 expression its mRNA abundance in mutant sciatic nerves has 
to be analyzed by quantitative real-time PCR. Furthermore, it would be interesting to 
check for protein abundance and mRNA expression of TAG-1 and CASPR2 to evaluate 
the cause of additional ectopic clusters.  
Despite their important role in nerve excitability during development (Vabnick et al., 
1999), the function of juxtaparanodal Kv1.1 channels in mature myelinated fibers is still 
elusive. However, they are supposed to maintain the resting potential and prevent 
repetitive and aberrant firing. Thus, it has been shown that Kv1.1 ablation, as well as 
specific blocking with 4-aminopyridine (4-AP) or dendrotoxin-K (DTX-K), result in nerve 
hyperexcitability by decreasing firing thresholds (Sherratt et al., 1980; Smart et al., 
1998; Chi and Nicol, 2007). Reduced or even absent juxtaparanodal clustering of Kv1-
channels is also associated with nerve hyperexcitability in type 2 diabetes mellitus 
(Zenker et al., 2012). Sensory behavior tests highlighted increased responses to 
mechanical stimulation (mechanical allodynia) in conditional mutants, but failed to 
show differences in heat sensation (Fig. 11). Interestingly, similar findings were 
observed after decreased Kv1.1 expression or inhibition of Kv1.1 by DTX-K-injection 
into paws. These findings demonstrated that Kv1.1 is capable of regulating sensitivity 
of fibers associated with mechanical perception (Hao et al., 2013). Elevated Kv1.1 
activity is associated with reduced nerve conduction velocities, smaller amplitudes, 
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reduced excitability, and even high-frequency conduction failure in myelin deficiencies 
due to exposure of juxtaparanodal Kv1.1 channels (Sinha et al., 2005; Bagchi et al., 
2014). Assuming a role for juxtaparanodal Kv1.1 channels in dampening the 
conduction of myelinated fibers to prevent aberrant excitation, we suggest that 
additional internodal Kv1.1 clusters could have similar effects on nerve excitability due 
to gradual membrane hyperpolarization. This in turn would slow nerve conduction 
through elevated thresholds and, in severely affected fibers, may even cause 
conduction blocks. To directly proof this hypothesis, the functionality of internodal Kv1.1 
channels has to be evaluated. However, voltage-clamp recordings of single axons 
underneath compact myelin is to our knowledge impossible so far. Another potential 
approach to check for the contribution of additional Kv1.1 channels on nerve excitability 
would be the specific block of these channels through 4-AP or DTX-K administration 
and subsequent recording of nerve responses upon stimulation. Nevertheless, it has 
been shown that intact compact myelin prevents the inhibitory effect that these 
blockers have on Kv1.1 channels (Vabnick et al., 1999).  
 
3.4 Peroxisomal dysfunction disturbs ganglioside homeostasis 
Gangliosides make up 10-12% of neuronal membrane lipids and rely on lysosomal 
degradation (Sandhoff and Harzer, 2013). It has been demonstrated that they 
incorporate excessive VLCFA (Saito and Saito, 1991). Accordingly, we detected an 
elevated portion of GD1-species bound to VLCFA (Fig. 19A). In compliance with 
suspected degradation defects of VLCFA-bound gangliosides, we found dispersed and 
elevated GM1 and GD1a staining in sciatic nerves (Fig. 19B-D). In line with our 
findings, brain gangliosides of X-ALD patients contain high percentages of fatty acids 
with chain lengths exceeding 22 C-atoms (Igarashi et al., 1976a) and secondary 
storage of GM1 and GM2 gangliosides were observed in Zellweger and infantile 
Refsum patients (Tatsumi et al., 2001). It is further speculated that VLCFA-esterified 
gangliosides trigger immune responses and impede membrane turnover, potentially 
provoking destabilization of myelin membranes in the brain (Ho et al., 1995). This in 
turn potentially disturbs axo-glial interaction and eventually causes axonal loss due to 
deficient support (Berger et al., 2014). Although GM1 accumulation can elicit neuronal 
cell death through the activation of an unfolded protein response (Vitner et al., 2010), 
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the number of axons was not changed in Cnp-Cre::Pex5flox/flox nerves (Fig. 14). Due to 
its widespread influence on intracellular signaling, GM1 abundance might however 
have further effects on cellular homeostasis (de Chaves and Sipione, 2010). Since 
gangliosides regulate membrane dynamics and organize myelinated fibers (Susuki et 
al., 2007; Labasque and Faivre-Sarrailh, 2010), we propose that ganglioside 
perturbations likely cause juxtaparanodal alterations. This is supported by studies that 
show interaction of TAG-1 with GM3, GM1, and GD1b in vitro (Loberto et al., 2003; 
Prioni et al., 2004). Influence of gangliosides on TAG-1 activity in the cerebellum 
indicates similar functions in myelinated fibers (Kasahara et al., 2000; de Chaves and 
Sipione, 2010). Verifying the interaction of TAG-1 and GM1 in PEX5-deficient nerves 
would require immunofluorescent colabeling, which is however difficult to achieve in 
vivo. To approach the assumption of ectopic internodal TAG-1 due to altered 
ganglioside distribution, the proportion of gangliosides within the glial membrane will 
be analyzed in sciatic nerve membrane fractions using lipid mass spectrometry.  
 
3.5 Pex5-deficiency in SC mimics symptoms of lysosomal storage 
disorders   
Peroxisomal and lysosomal disorders share common pathological features (Faust et 
al., 2010) and deficiencies in either organelle appear to influence the other (Launay et 
al., 2015; Schedin et al., 1997; Haq et al., 2006). Recently, it has been shown that 
cholesterol is transported from peroxisomes to lysosomes through dynamic membrane 
contacts in vitro. These contacts appeared to be less prominent upon peroxisomal 
dysfunction, resulting in cholesterol accumulation within lysosomes (Chu et al., 2015). 
According to these findings, we could confirm close association of both organelles at 
paranodal regions in vivo (Fig. 20). In support of an in vivo interaction of the two 
organelles, peroxisome proliferator-activated receptor-α (PPAR-α), a transcription 
factor that is involved in regulating peroxisomal abundance (Mandard et al., 2004), is 
downregulated in Krabbe disease, a lysosomal storage disorder (Haq et al., 2006). In 
addition, peroxisomal β-oxidation as well as catalase activity are decreased in 
Niemann-Pick disease (NPC1; Schedin et al., 1997). Based on the perturbation of 
gangliosides, a common cause of lysosomal storage disorders, we suspected 
secondary alterations of the lysosomal compartment in Cnp-Cre::Pex5flox/flox nerves. 
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Indeed, fluorescent teased fiber staining highlighted enlarged GD1a-positive vesicles 
that were engulfed by LAMP1-positive structures (Fig. 19E, F). This observation 
strongly indicates a backlog of lysosomal substrates due to a primary defect in 
peroxisomal lipid metabolism. Accordingly, gangliosides get stuck within lysosomes as 
a consequence of deficient VLCFA degradation in SC peroxisomes. In compliance with 
a secondary lysosomal problem, staining for lysosomal membrane proteins as well as 
western blot analysis revealed enlargement and increased number of lysosomes (Fig. 
21, 24). Interestingly, abundant lysosomes occurred despite down-regulation of 
relative mRNA expression of Lamp1 and Limp2, suggesting a secondary accumulation 
rather than an overproduction. Using endosomal-related markers, the lysosomal 
identity of accumulated vesicles was verified (Fig. 22). Decreased relative mRNA 
expression of MAP1LC3 in aged Cnp-Cre::Pex5flox/flox nerves potentially demonstrates 
less autophagic activity (Fig. 22). Inhibition of autophagy due to impaired 
autophagosome formation was recently shown in X-ALD-related in vivo and in vitro 
models (Launay et al., 2015). Moreover, lysosomal storage also elicits autophagy 
blocks due to deficient fusion of autophagosomes with lysosomes (Settembre et al., 
2008). However, if autophagic flux is indeed impaired in conditional mutant nerves has 
to be clarified. This could be achieved by the investigation of LC3-II levels, using 
western blot analysis or immunofluorescent staining. In addition, hampered 
autophagosome-lysosome fusion would become evident by subcellular analysis of 
LC3-II colocalization with LAMP1.  
Finding enlarged and excess lysosome-associated vesicles within cytoplasmic SC 
regions (i.e. within paranodal loops and SLI), the essential role of non-compacted 
myelin in SC metabolism and consequential support of axons was stressed. According 
to this, lysosomal origin of previously described paranodal inclusions was evidenced 
by immuno-electron microscopy (Fig. 21A). Similar secondary axonal abnormalities 
(e.g. spheroids) are typical observations in gangliosidoses (Walkley, 2004). Secondary 
and progressive lysosomal storage problems were also evidenced by significantly 
increased numbers of lipid-laden macrophages in 9 months old Cnp-Cre::Pex5flox/flox 
nerves (Fig. 15B, C). GM1/GM2 gangliosidoses are known to elicit an inflammatory 
response through recruitment of macrophages (Jeyakumar et al., 2003). Similar to 
Cnp-Cre::Pex5flox/flox nerves, T-cell infiltration plays only a minor role in GM1/GM2 
gangliosidoses and is only barely detected in advanced disease situations (Fig. 15D, 
(Jeyakumar et al., 2003). Our hypothesis of secondary endosomal-lysosomal 
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perturbation was supported by the upregulation of lysosomal β-hexosaminidase and 
α-mannosidase activity, which is a typical compensatory mechanism of lysosomal 
storage disorders (Jeyakumar et al., 2005). Since β-hexosaminidase hydrolyses GM2 
gangliosides, a precursor of GM1 and GD1a, we assume that its elevated enzyme 
activity attempts to compensate the secondary storage of these gangliosides in 
conditional mutant nerves.  
Since most peroxisomal disorders as well as lysosomal storage disorders result in CNS 
pathology (Vellodi, 2005; Wanders and Waterham, 2006), one next step is to analyze 
whether peroxisomal dysfunction in oligodendrocytes has similar effects on lysosomal 
abundance and function in the CNS of Cnp-Cre::Pex5flox/flox mice. Thus, the most 
important question is to which extend lysosomal alterations might affect disease 
progression in the CNS of conditional mutants. Potential in vivo interactions of 
peroxisomes and lysosomes in the brain would also facilitate the understanding of 
other neurodegenerative disorders, such as Alzheimer’s disease or Niemann-Pick 
disease. 
 
3.6 Increased number of SLI- a consequence of lysosomal storage? 
Schmidt-Lanterman incisures provide a direct and fast radial diffusion pathway through 
myelin and are therefore supposed to have a metabolic function in myelin maintenance 
(Balice-Gordon et al., 1998; Arroyo and Scherer, 2000). Interestingly, morphology and 
increase of SLI, especially in 9 months old Cnp-Cre::Pex5flox/flox mice, was comparable 
to observations made in sciatic nerves of shiverer mice. Gould et al. discussed that 
closely apposed SLI, either represent newly formed SLI or result from biochemical 
disturbances and subsequent defects in membrane-cytoskeleton interaction (Gould et 
al., 1995). It has been shown that the number of SLI correlates with the axonal diameter 
(Hiscoe, 1947; Small et al., 1980; Ghabriel and Allt, 1981) and is markedly increased 
when SC-axon interactions are disturbed (Gould et al., 1995; Dupree et al., 1998; 
Hoshi et al., 2007). Also, alterations of SLI play a role during Wallerian degeneration 
(Ghabriel and Allt, 1979). Thus, it is presumed that SLI protect peripheral nerves from 
mechanical stress by providing flexibility (Singer and Bryant, 1969). Myelin-associated 
glycoprotein (MAG), which is abundant in SLI, binds axonal gangliosides (GD1a, 
GT1b) to mediate adhesion to axonal membrane (Yang et al., 1996; Collins et al., 1997; 
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Pan et al., 2005). We therefore speculate that perturbed GD1a distribution likely affects 
this interaction. Thus, increased number of SLI may either result from excess GD1a or 
might be a compensatory process to sustain SC-axon interaction and thereby ensure 
axon stability. Studies on Mag-null mice revealed its essential function in controlling 
axon outgrowth, diameter, and integrity (McKerracher et al., 1994; Yin et al., 1998). In 
vitro studies further demonstrated that MAG protects neurons from acute toxicity 
through ganglioside-mediated signaling (Mehta et al., 2010). Another potential cause 
of enlarged and increased SLI is providing additional space for storage of excess lipid-
containing vesicles. This hypothesis is underpinned by massive presence of LAMP1-
positive accumulations within incisures (Fig. 23B). Regardless of the underlying reason 
of SLI abnormalities, increased portion of non-compacted myelin presumably adds to 
the observed nerve impairment by causing a decreased resistance, especially in aged 
conditional mutant nerves.  
 
3.7 ABCD1-deficiency results in similar, but less severe neuropathy  
Neuropathy of Abcd1-/- mice is suggested to be triggered by early-onset oxidative 
stress rather than neuroinflammation (Fourcade et al., 2008; Galea et al., 2012). In 
consistence with previous studies, demyelination was not observed even in nerves of 
22 months old Abcd1-/- mice (Fig. 28A, B; Forss-Petter et al., 1997; Kobayashi et al., 
1997). Moreover, focal hypermyelination and myelin infoldings, which had been 
observed in an X-ALD mouse model earlier (Pujol et al., 2002), were found to similar 
extent in age-matched controls (Fig. 28C). This let assume that in the here analyzed 
Abcd1-/- mouse model these late-onset abnormalities are not genotype-specific but 
age-related. In line with this, several age-dependent myelin alterations have been 
described in monkeys and rats (Peters, 2002; Xie et al., 2014). The here reported age-
dependent decline of motor performance, and especially grip strength when assessed 
in 13, 15, and 18 months was not a result of axonal loss (Fig. 26 and Fig. 29). These 
findings contradict previously published results, proposing axonal damage in 21 
months old Abcd1-/- sciatic nerves (Pujol et al., 2002). We assume that these distinct 
findings, regarding myelin alterations and axonal damage, might result from different 
technical approaches and the analysis of two different ABCD1 mouse models. Thus, 
the ABDC1 mouse model generated by Forss-Petter et al. was analyzed in the present 
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study, whereas Pujol et al. investigated the ABCD1 mouse model generated from Lu 
et al. (Forss-Petter et al., 1997; Lu et al., 1997; Pujol et al., 2002).  
Despite different primary peroxisome defects, Abcd1-/- and Cnp-Cre::Pex5flox/flox sciatic 
nerves show similar pathological features, assuming a common pathomechanism 
related to dysfunction of peroxisomal β-oxidation that secondarily involves lysosomes. 
Thus, aged Abcd1-/- mice display ectopic Kv1.1 channels and lysosomal impairment 
(Fig. 30, 31 and 32). Nevertheless, Abcd1-/- mice are less affected and show 
abnormalities only very late. This can be further explained by a complete loss of 
peroxisomal function in Cnp-Cre::Pex5flox/flox nerves, whereas Abcd1-/- nerves exhibit 
only a partial defect of peroxisomal β-oxidation. Synergistic effects of disturbed 
peroxisomal β-oxidation and plasmalogen-deficiency on neurodegeneration have been 
shown in other in vivo mouse models and might explain the more pronounced 
neuropathology of Cre::Pex5flox/flox nerves (Brites et al., 2008). Moreover, besides 
ABCD1, two other peroxisomal transporters (ABCD2 and ABCD3) are present in the 
peroxisomal membrane (Kamijo et al., 1990; Lombard-Platet et al., 1996). Although 
ABCD3 is less efficient than ABCD1 in mediating the peroxisomal import of VLCFA-
CoA, it was shown to partially compensate the loss of ABCD1 and rescue metabolic 
defects in X-ALD patient’s fibroblasts when overexpressed (Netik et al., 1999; 
Wiesinger et al., 2013). Also, ABCD2 overexpression prevents VLCFAs accumulation 
as well as neurodegenerative features of Abcd1-/- mice (Pujol et al., 2004).  
Electrophysiological measurements are commonly used in X-ALD patients to 
discriminate between demyelinating and axonal neuropathy. Our analysis of Cnp-
Cre::Pex5flox/flox however demonstrated that electrophysiological changes can result 
from other pathological features than myelin alterations or axonal loss. Therefore, 
additional diagnostic tools, such as nerve biopsies might help to precisely categorize 
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3.8 Model of Cnp-Pex5-deficiency  
This work showed that peroxisomal dysfunction in Schwann cells elicits secondary 
problems in other compartments of lipid metabolism such as lysosomes. We propose 
a model of deficient ganglioside digestion within lysosomes due to the incapability of 
PEX5-deficient SC to degrade VLCFA, including those that are incorporated into 
gangliosides. Consequently, VLCFA-esterified gangliosides are stored within 
lysosomes and will accumulate in myelin membranes. As a result of altered lipid 
composition of the glial membrane, glial GPI-anchored TAG-1 eventually shifts towards 
internodes. Subsequently, the complete juxtaparanodal complex, besides glial TAG-1, 
consisting of axonal TAG-1, CASPR2, and Kv1.1-channels, drifts into the internode. 
Assuming intactness of extra Kv1.1-channels, more K+ ions are shuttled into the 
periaxonal space, provoking gradual membrane hyperpolarization, which 
consequently reduces nerve conduction (Fig. 33). Hence, this study expand the 
importance of SC lipid metabolism for normal nerve function, independent of myelin. 
Whether disturbed potassium channel clustering also plays a role in lysosomal storage 
disorders has to be investigated.  
 
 
Fig. 33: Hypothetical model of Cnp-Pex5-meditated pathomechanism in myelinated fibers 
Normal lipid metabolism (left) comprises the degradation of VLCFA within peroxisomes (green) through β-oxidation 
and ganglioside digestion within lysosomes (purple). Both organelles reside within cytoplasmic SC regions and are 
closely associated. When SC lipid metabolism is impaired (right) due to peroxisomal dysfunction (orange), 
gangliosides incorporate excess VLCFA, are consequently stored within lysosomes, and accumulate within 
membranes. The juxtaparanodal complex is thereby shifted towards internodes, resulting in additional Kv1.1 
channels and potential membrane hyperpolarization.  
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Axio Observer. Z1 (HXP120 UV-lamp,    Zeiss 
Power Supply 23, SMC 2009 stage control)       
Axiophot       Zeiss 
LEO EM 912AB electron microscope Zeiss 
Stereomicroscope Stemi DV4 Zeiss 
Behavior 
Dynamic Plantar Aesthesiometer    ugo basile 
Elevated beam      In-house made 
Grid        In-house made 
Plantar Hargreaves Apparatus    ugo basile 
Software 
Adobe Illustrator CS5 
Fiji 
GraphPad Prism 5 
Mekentosj Papers 3 
Microsoft Excel 2013 
Microsoft Power Point 2013 
Microsoft Word 2013 
Zen 2012 (Zeiss) 
 
4.2 Molecular biology 
DNAse-Mix 
10 µl  DNAse 
70 µl  RDD buffer 
10 mM dNTP (50x stock)  
2.5 mM each nucleotide (dATP, dCTP, dGTP, dTTP) (Boehringer-Ingelheim)  
200 μM final concentration in a PCR reaction (50 μM each nucleotide)  
TBE 20x (stock solution)  
1.8 M   TrisBase  
1.8 M   Boric acid  
200 mM  EDTA 
  Material 
89 
 
2 % agarose gel  
3.5 g  agarose 
350 ml 1 x TBE buffer 
Enzymes 
GOTaq DNA polymerase  (Promega) 
Superscript III-reverse transcriptase (Thermo Fisher Scientific 
 
4.3 Protein biochemistry 
Modified Ripa buffer (protein lysis buffer) 
50 mM  Tris-HCl (pH 7.5) 
150 mM  NaCl 
1% [v/v] NP-40 
1% [v/v] Triton X-100 
Complete Mini protease inhibitor (Roche Diagnostics GmbH, Mannheim, Germany) 
was added freshly before use (1 tablet/10ml of RIPA buffer). 
SDS separating gel (1.5 mm thickness)  
10/15% [v/v] Acrylamide / Bisacrylamide 29: 1  
0.4 M   Tris-HCl pH 8.8  
0.1% [w/v]  SDS  
0.03% [v/v]  Ammonium persulfate  
0.08% [v/v]  TEMED  
SDS stacking gel (1.5 mm thickness) 
4% [v/v]  Acrylamide / Bisacrylamide 29: 1  
125 mM  Tris-HCl pH 6.8  
0.1% [w/v]  SDS  
0.05% [w/v]  Ammonium persulfate  
0.1% [v/v]  TEMED  
4x SDS sample buffer  
40% [v/v]  Glycerol  
240 mM  Tris/HCl pH 6.8  
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8% [w/v]  SDS  
0.04% [w/v]  Bromophenol blue  
1x SDS running buffer (Laemmli buffer) 
25 mM  Tris (hydroxymethyl)-aminomethan (Tris) 
192 mM  Glycine 
1% [w/v] SDS 
Dissolved in ddH2O 
10x Transfer buffer  
390 mM  Glycine 
480 mM  Tris-Base 
10% Methanol was added directly before use and dissolved in ddH2O to obtain a 1x 
transfer buffer. 
20x Tris buffered saline (TBS) 
1 M   Tris/HCl, pH 7.4  
3 M   NaCl 
1x TBS with Tween-20 (TBST)  
50 mM  Tris/HCl, pH 7.5  
150 mM  NaCl  
0.05%  [v/v] Tween-20 
Blocking buffer   
5% [w/v] nonfat dry milk 
Dissolved in 1 x TBS 
 
4.4 Lysosomal enzyme assay  
Lysis buffer 
1% [v/v] Triton X-100 
50 mM  Tris-HCl pH 7.5 
150 mM  NaCl 
1% [v/v] NP-40 
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Complete Mini protease inhibitor (Roche Diagnostics GmbH) was added freshly before 
use (1 tablet/10ml of lysis buffer). 
0.2 M Citrate buffer (pH 4.6) 
38.4 g  Citric acid (M=210,14g/mol) 
0.8 g   Sodium azide 
4 g  Bovine albumin serum (BSA) 
0.9% NaCl solution 
0.9 g  NaCl 
Dissolved in 100 ml ddH2O. 
0.4 M Glycine/ NaOH (Stop solution) 
15 g  Glycine 
Dissolved 500ml ddH2O, pH was adjusted with 1 M NaOH (~200 ml) to 10.4. 
Substrates (10 mM) 


















2 g   2,2,2 Tribromethanol 99% 
2 ml   tert-Amylalkohol 
96 ml   H2O (40°C) 
Avertin was stirred for 30 min and was sterile filtered. The solution was stored at -20°C 
and heated to 37°C before usage. 
Paraformaldehyde (4%)  
400 ml  0.2 M NaH2PO4 solution 
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100 ml  0.2 M Na2HPO4 solution 
100 ml  37% Formaldehyde solution 
400 ml  ddH2O 
10x Phosphate buffered saline (PBS)    
1.7 M   NaCl 
0.04 M  KCl 
0.04 M  Na2HPO4 
0.018 M  KH2PO4 
Dissolved in ddH2O and adjusted to pH 7.2 with 1 M NaOH.  
Blocking buffer teased fibers 
10% [v/v]  Horse Serum 
0.05% [v/v] Triton X-100 
Dissolved in 1 x PBS 
Blocking buffer cryo sections 
0.5% [w/v]  Bovine albumin serum (BSA) 
0.25% [v/v] Triton X-100 
1% [v/v] Horse serum 
0.01 M Citrate buffer (pH 6.0)  
1.8 mM  Citric acid  
8.2 mM Sodium citrate  
Prepared freshly before use. 
BSA/PBS  
0.04 M  NaH2PO4 
0.16 M  Na2HPO4  
1.8% [w/v] NaCl 
1.0% [w/v] Bovine serum albumin (BSA)  
Tris buffer (pH 7.6) 
50 mM  Tris/HCl, pH 7.6 
0.9% [w/v] NaCl 
Prepared freshly before usage. 
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Mayer’s haematoxylin solution 
0.1% [w/v] Haematoxylin 
0.02% [w/v] NaIO3 
5% [w/v] K2Al2(SO4)4 ∙ 24H2O 
Were added under constant shaking.  
5% [w/v] Chloral hydrate 
0.1% [w/v] Citric acid added 
Added and filtered before usage. 
Scott’s solution 
0.2% [v/v] KHCO3 
2% [w/v] MgSO4 
HCl - alcohol 
0.09% [v/v]  HCl 
70% [v/v] Ethanol 
Artificial cerebrospinal fluid (ACSF) 
126 mM NaCl 
3 mM  KCl 
1.25 mM NaH2PO4 
26 mM NaHCO3 
2 mM  MgSO4 
10 mM Glucose 
2 mM  CaCl2 
Dissolved in ddH2O. CaCl2 was added after 10-20 min oxygenation.The pH was 
adjusted to 7.2 using 37% HCl.  
Mounting media  
Aqua-Poly/Mount (Polysciences) 
ProLong®Gold (Thermo Fisher Scientific) 
Eukitt (Kindler)  
Tissue-Tek® O.C.T. Compound (VWR) 
 
  Material 
94 
 
4.6 Immuno-electron microscopy 
Fixing solution (Immuno Karlsson-Schultz fixative)  
4%   Formaldehyde solution 
0.25%  Glutaraldehyde  
0.5%   NaCl 
Dissolved in ddH2O.  
Sucrose (2.3 M)    
80 g   Sucrose 
100 ml  Phosphate buffer (0.1 M) 
Blocking Buffer 
1%   BSA 
Dissolved in 1 x PBS 
Uranyl acetate  
4% [w/v] Uranyl acetate  
Filtered before use.  
 
4.7 Electron microscopy 
Karlsson-Schultz fixative  
4% [w/v] PFA  
2.5% [v/v] Glutaraldehyde  
0.1 M Phosphate buffer 
Epon  
171.3 g  Glycidether 100  
115 g   DDSA (Dodecenyl succinic anhydride)  
89 g   MNA (Methyl nadic anhydride)  
Mixed for 10 min using a magnet stirrer. 
6.5 ml  DMP-30  
Added and again mixed for 20 min. 
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Methylene blue/ azure II 
1%  Na-tetraborat (Borax)  
1%  Methylen blue 
1%  Azure II  
Methylene blue and Azure II were freshly mixed 1:1 before use. 
Formvar solution  
1.25% [w/v]  Formvar  
50 ml   Chloroform  
Stir for at least 30 min. Protect from light. Store at room temperature. 
 
4.8 Antibodies  
Primary antibodies 
4.1G 1:100 IHC (Ivanovic et al., 2012) 
AnkG 1:100 IHC Prof Matthew Rasband, PhD 
ATG5 1:100 IHC Covalab pab50264 
βIV-spectrin 1:400 IHC Matthew Rasband 
CASPR 1:1000 IHC NeuroMab 75-001 
CASPR2 1:500 IHC Prof. Elior Peles, PhD 
Catalase 1:200 IHC Sigma C0979 
CD3 1:150 IHC Serotec MCA1477 
EEA1 1:300 IHC Abcam ab2900 
Kv1.1 1:50 IHC Santa Cruz sc11184 
Kv1.1 1:50 IHC NeuroMab clone 20/78 
Kv7.2 1:1000 IHC ThermoScientific PA1-929 
LAMP1 1:200, 1:400 IHC, IEM, WB BD Biosciences 553792 
LIMP2 1:1000 IHC Dr. Judith Blanz 
MAC-3 1:400 IHC BD Bioscience 564844 







Hugh J Willison 
Hugh J Willison 
Nav1.6 1:500 IHC Alomone labs ASC-009 
NF155 1:000 IHC Prof. Peter Brophy, PhD 
NF200 1:100 IHC Sigma N4142 
P0 1:1000 IHC, WB (Archelos et al., 1993) 
P2 1:5000 WB Santa Cruz sc-49304 
PLP 1:5000 WB (Jung et al., 1996) 
PMP70 1:600 IHC Abcam ab3421 
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Rab7 1:500 IHC Sigma R4779 




IHC, WB Covance MMS-435P 
 
Secondary antibodies 
α-rabbit-HRP 1:10000 WB Dianova 
α-mouse-HRP 1:10000 WB Dianova 
α-rabbit-Alexa488 1:2000 IHC ThermoScientific A-21206 
α-rabbit-Alexa555 1:2000 IHC ThermoScientific A-31572 
α-mouse-Alexa488 1:2000 IHC ThermoScientific A-21202 
α-mouse-Alexa555 1:2000 IHC ThermoScientific A-31570 
α-rat-Alexa488 1:2000 IHC ThermoScientific A-21208 
α-rat-Alexa594 1:2000 IHC ThermoScientific A-21209 
α-goat-Alexa488 1:2000 IHC ThermoScientific A-11055 
α-goat-Alexa555 1:2000 IHC ThermoScientific A-21432 
α-rabbit-Dyelight633 1:1000 IHC Yo proteins 356 
 
4.9 Dyes and marker  
DAPI         Roche 
GeneRuler 100 bp DNA ladder      Thermo Fisher Scientific 
PageRuler™ Plus Prestained Protein Ladder   Thermo Fisher Scientific 
Cholera Toxin Subunit B, Alexa Fluor® 555 conjugate Thermo Fisher Scientific 
α-Bungarotoxin, Alexa Fluor® 647 conjugate    Thermo Fisher Scientific 
 
4.10 Primer  
Genotyping PCR primer 
Alds  
7408:  3’-CCCTTCCTGCCACTTTCATC-5’ 
7409:  3’- TCTCAACCTGCCCCACCTCA-5’ 
1747:  3’- TCTCAACCTGCCCCACCTCA-‘5 
Cnce 
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1955:  3’- CATAGCCTGAAGAACGAGA-5‘ 
2016:  3‘-GCCTTCAAACTGTCCATCTC-5‘ 
7315:  3‘-CCCAGCCCTTTTATTACCAC-5‘ 
Pex5-loxp 
2870:  3‘-CGGGGAGTACGACAAGGCTGTGGACT-5‘ 
2871:  3’- TCTGGTTCCCATTGGCCAGGGTGGC-5’ 

















4.11 Mouse lines 
Cnp-Cre::Pex5flox/flox (Lappe-Siefke et al., 2003; Kassmann et al., 2011) 
Abcd1-/- (Forss-Petter et al., 1997) 
 
 




5.1 Animals  
All mice used in this study were bred and kept in individually ventilated cages under 
SPF conditions in the animal facility of the Max Planck Institute (MPI) for Experimental 
Medicine. All animal experiments were performed in compliance with animal policies 
of the State of Lower Saxony, Germany. Mice were sacrificed by cervical dislocation 
or by perfusion after deep anesthesia. Mice from both sex were analyzed for all 
experiments. 
 
5.1.1 Tail digest and genotyping PCR 
To evaluate the genotypes of mice, tail biopsies were taken from every animal at 
around P21 (after weaning). Tails were digested using the nexttecTM kit (Nexttec 
Biotechnology) according to manufacturer’s instructions. Each tail was digested for 75 
min on a shaker (1050 rpm) at 62°C. After equilibration of columns, 120 µl of tail digest 
were added and centrifuged for 1 min at 2158 rpm. Samples were eluted in 800 µl 
ddH2O and stored at 4°C.  
Pex5 loxP 
1 µl   DNA (diluted 1:5) 
0.5 µl  Primer (2870) 
0.5 µl  Primer (2971) 
2 µl  dNTP’s (2 mM) 
4 µl  Go-Taq buffer (5x) 
0.1 µl  Go-Taq 
ddH2O was added to total of 21 μl. 
PCR program: 
95°C  3 min 
60°C  30 sec 
72°C  90 sec 35x 
95°C  1 min 
60°C  1 min 
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72°C  10 min 
4°C  break 
CNCE 
1 µl   DNA (diluted 1:5) 
0.5 µl  Primer (1955) 
0.75 µl Primer (2016) 
0.25 µl Primer (7315) 
2 µl  dNTP’s (2 mM) 
4 µl  Go-Taq buffer (5x) 
0.1 µl  Go-Taq 
ddH2O was added to total of 21 μl. 
PCR program: 
95°C  3 min 
50°C  30 sec 
72°C  1 min  35x 
95°C  30 sec 
50°C  1 min 
72°C  10 min 
4°C  break 
ALDS 
1 µl   DNA (diluted 1:5) 
1 µl  Primer (7408) 
1 µl  Primer (7409) 
0.25 µl Primer (1747) 
2.2 µl  dNTP’s (2 mM) 
4.4 µl  Go-Taq buffer (5x) 
1.1 µl  MgCl2 
1.1 µl  Q 
0.1 µl  Go-Taq 
ddH2O was added to total of 21 μl. 
PCR program: 
95°C  3 min 
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56°C  30 sec 
72°C  1 min  36x 
95°C  30 sec 
56°C  2 min 
72°C  10 min 
4°C  break 
To visualize DNA fragments under UV light, 5 µl of GelRed (1:40.000) was added to 
each PCR reaction. Samples were loaded to a 2% agarose gel. Gel electrophoresis 
was done in a running chamber filled with 1x TBE buffer for 90-120 min at 120 V. 
 
5.2 Molecular biology 
5.2.1 RNA isolation from sciatic nerves 
RNA isolation was performed using the RNeasy Mini kit (Qiagen). Sciatic nerves were 
transferred into 2 ml Precelly’s tubes filled with 500 µl QIAzol lysis reagent and 1.4 mm 
ceramic (zirconium oxide) beads. Homogenization was done via Precellys® 24 (10 sec 
at 5500 rpm, break on ice, 10 sec at 5500 rpm). After incubation at room temperature 
for 5 min, 100 µl of chloroform were added to nerve lysates and incubated for 2-3 min 
at room temperature. Lysates were centrifuged for 15 min at 13,000 rpm and 
supernatants were transferred to new tubes. One volume of 70% ethanol was added, 
directly mixed and applied to RNeasy columns. After centrifugation at 13,000 rpm for 
15 s, 350 µl RW1 buffer were added and again centrifuged for 1 minute at 13,000 rpm. 
80 µl of DNAse-Mix were added and incubated for 15 minutes at room temperature. 
After another washing and centrifugation with RW1 buffer, columns were washed three 
times with 500 µl of RPE buffer. Finally, RNA was eluted with 30 μl of RNase-free 
ddH2O. RNA quality and concentration was determined using the Agilent RNA 6000 
Nano KIT and the Agilent 2100 Bioanalyzer according to company’s instructions. Only 
samples with a RNA integrity number >8.5 were further used for cDNA synthesis. 
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5.2.2 Complementary single stranded DNA (cDNA) synthesis 
To further analyze RNA expression, a complementary single stranded DNA (cDNA) 
library was generated from isolated RNA using a reverse transcriptase (SuperScript III, 
Thermo Fisher Scientific). First strand cDNA was synthetized at 55°C as follows: 
2 μl   RNA (1 µg) 
1 μl   dT mix Primer (0.6 pmol/μl) 
1 μl   N9 (random nonamers 120 pmol/μl) 
Samples were incubated at 70°C for 2 minutes and then put on ice.  
The following mix was added to the reaction: 
1.5 µl   ddH2O 
2 μl   5x first strand buffer 
0.5 μl   dNTP (10 mM) 
1 μl   DTT (100 mM) 
1 μl   SuperScript III reverse transcriptase (200 U/μl) 
The final 10μl reaction mixture was briefly spun down and incubated in a thermocycler 
(lid 65°C) with the following settings: 
25ºC   10 min 
50ºC   45 min 
55ºC   45 min 
Synthesized cDNA was diluted with ddH2O to a final concentration of 0.5 ng/µl. 
 
5.2.3 Quantitative real-time PCR (qRT-PCR) 
qRT-PCR was done using six biological replicates per genotype. SYBR® Green Master 
Mix (Applied Biosystems) was used according to the manufacturer’s instructions to 
perform qRT-PCR. The mix contained: 
4 μl  cDNA (0.5 ng/μl)  
5 μl   SYBR® Green  
0.1 μl   each primer (10 pmol/μl) 
0.8 µl   ddH2O 
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Reactions were performed in quadruplicates using the following PCR protocol: 
50°C   120 s warm up  
95°C   600 s melting  
60°C   20 s annealing  
72°C   30 s elongation and detection  
95°C   10 s melting  back to step 3  45 cycles 
Measurements were analyzed with the Applied Biosystems 7500 Fast Real-Time PCR 
System resulting in histograms of relative RNA abundance with respect to cyclophilinA 
(Ppia). Values were normalized to β-actin abundance using Microsoft Excel 2013. 
Quantification was done with GraphPad Prism 5, applying Student’s t-test. Values were 
related to control values that were set to one. 
 
5.2.4 Enzyme activity assay 
Sciatic nerves were homogenized on ice in 150 µl lysis buffer (1% Triton X-100, 50 
mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, with protease inhibitor (Complete, 
Roche) using Precellys® 24 (2 x 20 sec at 5000 rpm). Nerve lysates were centrifuged 
for 15 min at 12,000 rpm. Supernatants were incubated at 37°C with corresponding 
substrates (see table 4.4). Reactions were stopped with 500 µl 0.4 M Glycine-NaOH 
(pH 10.4, adjusted with 1 M NaOH). After centrifugation at 13,000 rpm for 10 minutes, 
the supernatant was measured at 405 nm with an Eon microplate spectrophotometer 
(BioTek). In each experiment two technical replicates were measured. Student's T-test 
was applied to evaluate statistical significances. 
 
5.2.5 Mass spectrometry 
Sciatic nerves were homogenized in 200 µl 0.29 M sucrose with complete Mini 
protease inhibitor (Roche Diagnostics GmbH) using the Precellys® 24 (10 sec at 5000 
rpm, break on ice, 5 sec at 5500 rpm). Lysates were centrifuged at 4000 rpm for 10 
minutes to remove cell nuclei. To separate samples into a cytosolic and a membranous 
fraction, lysates were centrifuged at 34,000 rpm for 1 h at 4 °C. The pellet 
(membranous fraction) was diluted in 50 µl 1 X PBS. Both eluted pellet and supernatant 
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(cytosolic fraction) were stored at -80°C. Samples were sent for mass spectrometry to 
Dr. Britta Brügger (Biochemistry Center, Heidelberg). Experiments were performed 
with six biological replicates per genotype. Quantification was done in GraphPad Prism 
5, applying Student’s T-test. 
 
5.3 Protein biochemistry 
5.3.1 Sample preparation 
Sciatic nerves were dissected and frozen on either dry ice or in liquid nitrogen. Nerves 
were stored at -80°C. Frozen nerves were transferred into 2 ml tubes filled with 200 µl 
RIPA buffer and 1.4 mm ceramic (zirconium oxide) beads. Homogenization was done 
via Precellys® 24 (10 sec at 5000 rpm, break on ice, 5 sec at 5500 rpm). Nerve lysates 
were centrifuged for 10 min at 4000 rpm to remove cell nuclei. Supernatants were used 
for protein biochemistry. 
 
5.3.2 Lowry protein assay 
The Bio-Rad DC Protein Assay kit was used according to the Lowry method to 
measure protein concentrations. 5 µl of samples were pipetted in a 96-well plate into 
25 µl of solution A. After submission of 200 µl of solution B, the reaction was incubated 
for 15 min at RT. Standards with defined protein concentrations were used to calculate 
sample concentrations. Absorbance was measured at 650 nm with an Eon microplate 
spectrophotometer (BioTek). 
 
5.3.3 Protein separation using SDS-PAGE 
SDS-polyacrylamide gels with an acrylamide concentration of 10 or 15% (for myelin 
proteins) and a thickness of 1.5 mm were prepared using the Bio-rad system. The 
separating gel was filled into the gel cassettes and covered with isopropanol to prevent 
air bubbles. The isopropanol was carefully removed after 1h polymerization and the 
stacking gel was added. After inserting a 10 well comb the gel was polymerized for 
another 30-60 min at RT. Gels were either directly used or stored in wet tissues for up 
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to 3 days at 4°C. Nerve lysates were diluted in 2x SDS sample buffer, containing 5% 
2-Mercaptoethanol to break down disulfide bonds. After incubation on a thermo shaker 
for 10 min at 40°C, appropriate amounts of samples, as well as 5 µl of the marker 
(PageRuler™ Plus Prestained Protein Ladder), were loaded on the gel. The Mini-
Protean 3 system (BIO-RAD) was used to separate proteins according to their size by 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The chamber and gels were 
assembled according to the manufacturer’s instructions and filled with 1 X SDS running 
buffer. The gel was run at 80 V and 40-50 mA for approximately 10 min and voltage 
was then increased to 120 V and 60-70 mA at RT for 1-2 h.  
 
5.3.4 Western blotting 
Transfer of proteins from the SDS gel to a polyvinylidene difluoride membrane (Hybond 
P, Amersham Biosciences, pore size 0.45 μm) was done using a semi-dry (Novex® 
Semi-Dry Blotter, Thermo Fisher Scientific) or wet blotting system. Therefore, 
membranes were activated for 1 min in 100% methanol, washed briefly in ddH2O, and 
kept in transfer buffer until blotting. Blotting was done for approximately 70 min at RT 
applying a constant voltage of approximately 30-40 V and a current of 250 mA. 
Membranes were blocked with 5% milk powder in TBST (0.05% Tween-20 in TBS) at 
room temperature for 1 h. Primary antibodies (4.8), diluted in blocking solution, were 
incubated overnight at 4°C. HRP-conjugated secondary antibodies (see 4.8, 1:5000) 
were incubated for 1h at room temperature after three times washing for 15 min each 
in TBS-T (0.1% Tween-20 in TBS). Membranes were again washed three times in 
TBS-T. 2 ml of Western-Lighting Plus-ECL Reagent (PerkinElmer) were applied for 1 
min. Chemiluminescence was detected by scanning the membranes for 15 min with 
the Intas ChemoCam Imager. Signals were normalized to loading controls and 
analyzed using Fiji software. Protein abundance of control animals were set to 1 and 
mutant values were displayed as relative protein amounts. 
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5.4 Fluorescence microscopy 
5.4.1 Teased fiber preparation 
Sciatic nerves were dissected and directly transferred into 1x PBS. The epineurium 
was removed with fine forceps (Dumont #5) under a binocular and each nerve was 
pre-teased into 10 equal fiber bundles. Each bundle was transferred onto a glass slide 
and teased into single axons. Finally, the slides were dried at room temperature and 
stored at -20°C. 
5.4.2 Immunofluorescence of teased fibers 
Slides were directly taken from -20°C and fixed for 5 min with 4% PFA at room 
temperature and then incubated for 3-5 min in methanol at -20°C. After three times 
washing in 1x PBS, samples were incubated for 1 h at room temperature in 10% horse 
serum in 0.05% Triton X-100 to block unspecific bindings. Slides were incubated with 
primary antibodies (diluted in blocking solution, see 4.8) at 4°C overnight or for 90 
minutes at room temperature. After washing in PBS, secondary antibodies (diluted in 
blocking solution) and DAPI (1:10,000), were incubated for 1h at room temperature. 
After washing in PBS and H2O, the slides were mounted with ProLong®Gold or Aqua 
Poly Mount and stored at 4°C. Fluorescence light microscopy was done with the Axio 
Observer (Zeiss) equipped with an Axiocam MRm (Zeiss). Images were processed 
with the Zen 2012 software (Zeiss). The number of Schmidt-Lanterman incisures and 
the localization of Kv1.1 clusters was analyzed and quantified using Fiji (Schindelin et 
al., 2012) and GraphPad Prism 5. 
 
5.4.3 Ex vivo fluorescent staining of gangliosides 
Sciatic nerves were dissected and pre-teased in oxygenated artificial cerebrospinal 
fluid (ACSF) solution. Monoclonal anti-ganglioside antibodies specific for GM1 and 
GD1a (kindly provided by R. McGonigal and H. Willison) or CTB were diluted in ASCF 
and incubated at room temperature for 1.5 h. After three times washing in ACSF 
solution, samples were incubated with isotype-specific fluorescent secondary 
antibodies (Alexa-488 IGg3 and IG2b goat anti-mouse, Life Technologies). After 
washing, samples were fixed in 4% PFA for 5 min at room temperature. After 
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consecutive washing in 1x PBS and 0.1 M glycine, fibers were teased on glass slides, 
dried and finally stored at -20°C. Slides were treated according the teased fiber 
protocol for co-labeling. For quantification of GDa1 colocalization with LAMP1, about 
10% of total nerve material was analyzed from three (controls) or five (conditional 
mutants) independent 9 months old animals. The number of GDa1-positive vesicles 
that were bigger than 1 µm and colocalized with LAMP1 was quantified and statistically 
analyzed by Student’s T-test using GraphPad Prism 5. 
 
5.4.4 Immunofluorescence of cryo sections 
Gastrocnemius muscles were dissected and were fixed overnight in 4 % PFA at 4°C. 
For dehydration, muscles were transferred to 10% glucose overnight and then 
incubated it 30% sucrose for approximately 6 h. Muscles were mounted in Tissue-
Tek® O.C.T. Compound media and stored at -20°C. Cryo sections (40 µm) were 
obtained with cryostat (Leica Jung Cryocut CM3000). Sections were washed for 30 
min in 1x PBS and then permeabilized in precooled 95% methanol with 5% acetone 
for 15 at -20°C. Sections were washed in 1x PBS (3 x 5 min) and were then 
permeabilized in cryofix (7 ml Polyethylenglycol, 50 ml 100% Ethanol in 47 ml ddH2O) 
for 7 min at room temperature. After another washing in 1x PBS, unspecific bindings 
were blocked (0.5% BSA, 1% horse serum, 0.25% Triton X-100) for 30 min. Slides 
were consecutively washed in 1x PBS (3 x 10 min), followed by 15 min 0.5% BSA in 1 
% horse serum. α-Bungarotoxin was diluted in 0.5% BSA and 1 % horse serum in DAPI 
solution (1:10.000) and were applied for 1.5 h. After washing in 1 x PBS and distilled 
water, slides were mounted with AquaPolymount and imaged with the Axio Observer. 
Z1 (Zeiss) equipped with an Axiocam MRm (Zeiss). Images were processed with the 
Zen 2012 software (Zeiss) and the number of neuromuscular junctions (NMJs) per 
mm2 was counted with Fiji and quantified with GraphPad Prism5.  
 




5.5.1 Perfusion and paraffin embedding 
Mice were intraperitoneally anesthetized with 0.2 ml/ 10 g avertin and intracardially 
perfused with 50 ml HBSS, containing 750 µl EDTA (0.5 M). Fixation with 4% PFA, 
was performed for approximately 15 minutes. Sciatic nerves were dissected and post-
fixed in 4% PFA for 2 h and in 1% PFA o/n at 4°C. Fixed nerves were washed in 1X 
PBS and transferred to tissue cassettes. For paraffin embedding, the paraplast 
embedding station was used with the following program: 
50% Ethanol   1 h 
70% Ethanol   2x 2 h 
96% Ethanol   2x 2 h 
100% Ethanol   2x 2 h 
Isopropanol    1 h 
Xylol     2x 2 h 
Paraffin    2x 2 h 
Subsequently, nerves were transferred to metal forms and casted in blocks with 60°C 
warm paraffin. Paraffin blocks were cooled to dry and stored at RT. Nerves were cut 
in 10 μm thick sections using the microtome (HM 400, MICROM) and dried at RT.  
 
5.5.2 DAB staining of paraffin sections 
Paraffin sections were deparaffinized by the following steps:  
60°C     10 min  
Xylol     2x 10 min  
Xylol/Isopropanol (1:1)  10 min  
100% Ethanol   5 min  
90% Ethanol   5 min  
70% Ethanol   5 min  
50% Ethanol   5 min  
ddH2O    5 min 
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For MAC-3 and CD3 staining, deparaffinized sections were incubated and cooked in 
TE buffer (650 watts, 10 min). Samples were cooled for about 20 min and then 5 min 
incubated in Tris buffer containing 2% milk powder. Shandon coverplates (Thermo 
Fisher Scientific) were used for even distribution of solutions. Slides were rinsed again 
with Tris buffer containing 2% milk powder and then blocked for 10 min in inactivated 
goat serum (1:5). Slides were again washed with Tris buffer containing 2% milk 
powder. Slides were incubated with the α-rat-biotinylated antibody (1:100) for 30 min. 
Subsequently, the Vector Elite ABC Kit (Vector Labs) was incubated for 30min. After 
removal of coverplates, slides were washed with Tris buffer without milk-powder and 
the HRP substrate 3, 3'-Diaminobenzidine (DAB) was applied for 10 min by using the 
DAB Zytomed Kit (Zytomed Systems GmbH). Antibody binding was apparent by brown 
labeling. After washing with ddH2O, blue nuclear staining was achieved by 5 min 
incubation with 0.1% Haematoxylin. Samples were consecutively rinsed with ddH2O, 
HCl-Alcohol for 5-10 sec, Scott’s solution for 5 min and finally ddH2O. Sections were 
dehydrated by an increasing alcohol gradient (50%, 70%, 90%, and 100% for 5 min 
each) followed by Xylol/Isopropanol (1:1, 5 min) and two times Xylol (5 min). Finally, 
sections were mounted using Eukitt. 
 
5.6 Immuno-electron microscopy  
5.6.1 Perfusion and tissue preparation 
Mice were intraperitoneally anesthetized with 0.2 ml/ 10 g avertin and intracardially 
perfused with 50 ml HBSS, containing 750 µl EDTA (0.5 M). Fixation with Karlsson-
Schultz (Schultz and Karlsson, 1965), containing 0.25% glutaraldehyde, was 
performed for approximately 15 minutes. Sciatic nerves were dissected and post-fixed 
in 4% PFA for 2 h. Dissected nerves were stored in 1% PFA at 4°C. For dehydration, 
nerves were incubated on a rotator in 2.3 M sucrose at 4°C overnight. Finally, nerves 
were trimmed into small fractions, were put on degreased aluminum pins and stored 
in liquid nitrogen. 
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5.6.2 Preparation of ultrathin cryo sections  
Ultrathin cryo sections were obtained according to the “Tokuyasu technique” 
(Tokuyasu, 1973). Sciatic nerves were trimmed such that surface of around 230x350 
µm was obtained. A diamond knife (Diatome) was used to obtain longitudinal ultrathin 
section (50 nm) at -120°C in an Ultracut S ultramicrotome (Leica). Sections were 
picked up with a loop containing a small drop of sucrose solution (2.3 M sucrose, 2% 
methylcellulose in H2O) and transferred onto formvar film-coated and carbon-stabilized 
copper grids. Grids were stored at 4°C.  
 
5.6.3 Immunolabeling of ultrathin cryo sections  
Staining was performed at RT on parafilm stripes according to the “Tokuyasu 
technique” (Tokuyasu, 1973). To remove the pick-up-solution, grids were first washed 
in PBS (3 x 2 min) and then treated with 0.1% glycine in PBS (3 x 2 min). After 3 
minutes blocking with 1% BSA in PBS, samples were incubated for 1 h with an anti-
LAMP1 antibody (mk, rat; 1:200). Grids were washed in PBS (5 x 2 min) and then 
incubated for 30 min with a species-specific secondary rabbit antibody (1:200). After 
washing in 0.1 % BSA in PBS, sections were incubated with protein-A-gold (1:60 in 
blocking solution, 10 nm) for 20 min. After another washing with PBS, antibodies were 
fixed for 5 min with 1% glutaraldehyde in PBS. Grids were cleared of phosphates by 
repetitive washing (10 x 1min) with distilled water. Samples were treated on ice with 
neutral uranylacetate and methylcellulose-uranylacetate for 5 min each to contrast and 
embed sections. Eventually, grids were picked up with a loop, dried and stored at 4°C. 
Sections were examined with a LEO EM 912AB electron microscope (Zeiss) equipped 
withh an on-axis 2048 X 2048 CCD camera (Proscan). 
 
5.7 Electron microscopy 
5.7.1 Perfusion and epon embedding 
Mice were intraperitoneally anesthetized, intracardially perfused and fixed with 
Karlsson-Schultz (Schultz and Karlsson, 1965). Sciatic nerves were dissected and 
post-fixed in 4% PFA for 2 h. Dissected nerves were stored in 1% PFA at 4°C. Epon 
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embedding was done with an automated system (EMTP, Leica) using the following 
protocol: 
Phosphate buffer   3 x 10 min 
2% OsO4     4 hours 
ddH2O     3 x 10 min 
30% Ethanol    20 min  4°C 
50% Ethanol    20 min  
70% Ethanol    20 min 
90% Ethanol    20 min 
100% Ethanol    4 x 10 min 
Propylenoxid    3 x 10 min  
Propylenoxid/Epon 2:1   2 hours 
Propylenoxid/Epon 1:1   2 hours  RT 
Propylenoxid/Epon 1:2   4 hours 
Epon     4 hours 
Samples were then polymerized o/n at 60ºC. 
 
5.7.2 Preparation of semi- and ultra-thin sections 
Semi-thin (500 nm) and ultra-thin (50 nm) cross sections of epon embedded sciatic 
nerves were obtained with a Ultracut S microtome (Leica) equipped with an Ultra 45º 
diamond knife (Diatome). Semi-thin sections were transferred to glass slide and dried 
on a hot plate (60°C). Ultra-thin sections were placed on formvar polyvinyl-coated 
copper grids. 
 
5.7.3 Staining of semi-thin sections and quantification of axon number 
Semi-thin sections were incubated with methylene blue/ azure II for approximately 1 
min on a 60°C hot plate to visualize myelin sheaths. After washing with ddH2O, slides 
were dried and mounted with Eukitt. Samples were imaged with the Zeiss Axiophot 
using a Plan NEOFLUAR 100x/1.30 oil objective (Zeiss). Total number of axons per 
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nerve was counted from 2 individual sections of at least three animals per group using 
Fiji. Axon distribution was quantified using GraphPad Prism5.  
 
5.7.4 Contrasting of ultra-thin sections 
Grids were incubated for 30 min with 4% uranyl acetate (protected from light), washed 
3 times for 1 min in ddH2O and the incubated for 6 min with Reynolds lead citrate. After 
4 times washing with ddH2O, grids were carefully dried using filter papers. 
 
5.7.5 Electron microscopy and g-ratio analysis 
Images of ultra-thin sections were obtained with the Zeiss EM900 (Zeiss) and digital 
equipped with a wide-angle dual speed 2K-CCD-Camera (TRS). Myelin thickness was 
evaluated by g-ratio analysis (dividing the axonal by the fiber diameter) using Fiji 
software. Results derived from at least 100 randomly chosen fibers per nerve. 




Sciatic nerves were dissected and transferred into a perfusion chamber filled with 
ACSF (pH of 7.4) and continuous gassing (95% O2, 5% CO2). The length of nerve was 
measured and placed into suction electrodes for stimulation and recording. 
Electrophysiological measurements were performed by Jenniffer Günther. After an 
adaptation of approximately 30 minutes, electrical stimulation was performed at 
different intensities (0.13 mA - 0.3 mA). The stimulus intensities were increased 
manually in step-width of 0.05 mA, with inter-stimulus intervals of 3 seconds. Each 
stimulus intensity was used 10 times, while compound action potentials (CAP) were 
continuously measured. Recorded signals were acquired at 100 kHz, amplified x100 
by Ext-2F (NPI Electronic), and a further 50-fold by SR560 (Stanford Research 
Systems), and filtered. Patchmaster software equipped with an EPC9 amplifier 
interface (HEKA) was used to control recordings. Stimulus intensities were altered 
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using Stimulus Isolator A385 (World Precision Instruments). Data analysis was done 
by Dr. Livia de Hoz. Each nerve was analyzed separately using Matlab by averaging 
same stimulus repetitions. Nerve conduction velocity was calculated for each stimulus 
intensity as the mean across trials of the ratio between the length of the nerve and the 




5.9.1 Grid test 
Mice were put on a metal grid (49.5 x 15 x 13 cm) with a distance of 1 x 2 cm between 
single rods. Animals had to run a distance of 1.5 m and their slips were counted. Mice 
were habituated to the device before they were tested on 3 consecutive days. This test 
was used to evaluate motor performance and coordination. Values were analyzed with 
Student's T-test. 
 
5.9.2 Grip strength 
This test was used to evaluate muscle strength. Therefore, animals had to grasp a grid, 
connected to a sensor measuring the force, with their forelimbs. The mice were gently 
pulled horizontally by their tail. Thereby, the maximal grip strength was measured by 
the device. This procedure was consecutively repeated seven times per animal 
 
5.9.3 Elevated beam 
This test was used to assess motor coordination and balance. Mice have to walk 
across an elevated narrow beam (1 m length) to reach a safe and light protected box. 
Mice were trained and then tested three times on one day. Their performance was 
evaluated by the number of hind limb slips they made and the time they needed to 
reach the box.  
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5.9.4 Dynamic plantar aesthesiometer 
The dynamic plantar aestesiomether (ugo basile) was used to investigate the 
mechanical sensitivity threshold. Therefore, animals were put on a grid, each 
surrounded by plastic side glass enclosures. After a habituation period of about 1 h, 
the mechanical sensitivity threshold of hind paws was determined by the use of 
electronic von Frey filaments. This filament automatically recorded through a blunt 
probe the maximum vertical contact force (in grams) when mice lifted their hind paw. 
Each measurement was carried out 5 times per hind paw. A cut-off in the amount of 
30 grams prevents injuries of the hind paws.  
 
5.9.5 Plantar Hargreaves Test 
The plantar Hargreaves test (ugo basil) was used to determine the thermal sensitivity 
threshold. For this purpose, mice are sitting on an acrylic glass bottom each 
surrounded by plastic side glass enclosures. Mice were habituated for about an hour 
before the measurements started. The threshold determination was made by the use 
of an electronic punctual infrared heat source that is positioned underneath the hind 
paw. The device automatically determined the time needed until the animal lifts the 
paw. Each measurement was performed 5 times per hind paw. A cut-off infrared 
intensity of 99 units (380 mW / cm2 / sec) prevents injuries on the hind paws.  
 




Adamo AM, Aloise PA, Pasouini JM (1986) A possible relationship between 
concentration of microperoxisomes and myelination. Int J Dev Neurosci 4:513–517. 
Ahlemeyer B, Neubert I, Kovacs WJ, Baumgart-Vogt E (2007) Differential expression 
of peroxisomal matrix and membrane proteins during postnatal development of mouse 
brain. J Comp Neurol 505:1–17. 
Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Molecular Biology 
of the Cell; Peroxisomes. 4th edition. New York: Garland Science.  
Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in neurodegenerative 
diseases. Immunology 129:154–169. 
Ando S, Tanaka Y, Ono YT, Kon K (2003) Turnover of Myelin Lipids in Aging Brain. 
Neurochem Res 28:5–13. 
Arancibia-Carcamo IL, Attwell D (2014) The node of Ranvier in CNS pathology. Acta 
Neuropathol 128:161–175 Available at: http://link.springer.com/10.1007/s00401-014-
1305-z. 
Archelos JJ, Roggenbuck K, Scheider-Schaulies J, Linington C, Toyka KV, Hartung 
HP (1993) Production and characterization of monoclonal antibodies to the 
extracellular domain of P0. J Neurosci Res 35:46–53. 
Arroyo EJ, Scherer SS (2000) On the molecular architecture of myelinated fibers. 
Histochem Cell Biol 113:1–18. 
Arroyo EJ, Sirkowski EE, Chitale R, Scherer SS (2004) Acute demyelination disrupts 
the molecular organization of peripheral nervous system nodes. J Comp Neurol 
479:424–434. 
Baarine M, Ragot K, Athias A, Nury T, Kattan Z, Genin EC, Andreoletti P, Ménétrier F, 
Riedinger J-M, Bardou M, Lizard G (2012) Incidence of Abcd1 level on the induction of 
cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-
α on oligodendrocytes and astrocytes. Neurotoxicology 33:212–228. 
Baes M, van Veldhoven PP (2012) Mouse models for peroxisome biogenesis defects 
and β-oxidation enzyme deficiencies. Biochim Biophys Acta 1822:1489–1500. 
Bagchi B, Al-Sabi A, Kaza S, Scholz D, O'Leary VB, Dolly JO, Ovsepian SV (2014) 
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal 
Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination. 
PLoS ONE 9:e87736. 
Balice-Gordon RJ, Bone LJ, Scherer SS (1998) Functional Gap Junctions in the 
Schwann Cell Myelin Sheath. J Cell Biol 142:1095–1104. 
Ballabio A, Ballabio A, Ballabio A, Ballabio A, Ballabio A (2009) Lysosomal disorders: 
From storage to cellular damage. Biochim Biophys Acta 1793:684–696. 
  References 
115 
 
Barry DS, O’Keeffe GW, Barry DS, O’Keeffe GW, Barry DS, Barry DS, Barry DS (2013) 
Peroxisomes: The neuropathological consequences of peroxisomal dysfunction in the 
developing brain. Int J Biochem Cell Biol 45:2012–2015. 
Berger J, Forss-Petter S, Eichler FS (2014) Pathophysiology of X-linked 
adrenoleukodystrophy. Biochimie 98:135–142. 
Berger J, Gärtner J (2006) X-linked adrenoleukodystrophy: Clinical, biochemical and 
pathogenetic aspects. Biochim Biophys Acta 1763:1721–1732. 
Beyenbach KW, Wieczorek H (2006) The V-type H+ ATPase: molecular structure and 
function, physiological roles and regulation. J Exp Biol 209:577–589. 
Bezman L, Moser HW (1998) Incidence of X-linked adrenoleukodystrophy and the 
relative frequency of its phenotypes. Am J Med Genet 76:415–419. 
Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, Martin MS, Li J, Einheber S, 
Chester M, Rosenbluth J, Salzer JL, Bellen HJ (2001) Axon-Glia Interactions and the 
Domain Organization of Myelinated Axons Requires Neurexin IV/Caspr/Paranodin. 
Neuron 30:369–383. 
Bizzozero OA, Zuñiga G, MB Lees (1991) Fatty Acid Composition of Human Myelin 
Proteolipid Protein in Peroxisomal Disorders. J Neurochem 56:872. 
Bottelbergs A, Verheijden S, Hulshagen L, Gutmann DH, Goebbels S, Nave K-A, 
Kassmann CM, Baes M (2010) Axonal integrity in the absence of functional 
peroxisomes from projection neurons and astrocytes. Glia 58:1532–1543. 
Bottelbergs A, Verheijden S, Just W, Van Veldhoven PP, Devos R, Baes M (2012) 
Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of 
the innate immune system and axonal loss in the central nervous system. J 
Neuroinflammation 9:1–21. 
Bowen P, Lee CS, Zellweger H, Lindenberg R (1964) A familial syndrome of multiple 
congenital defects. Bull Johns Hopkins Hosp 114:402–414. 
Boyle MET, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B (2001) Contactin 
Orchestrates Assembly of the Septate-like Junctions at the Paranode in Myelinated 
Peripheral Nerve. Neuron 30:385–397. 
Braulke T, Bonifacino JS (2009) Sorting of lysosomal proteins. Biochim Biophys Acta 
1793:605-614. 
Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and 
disease. Biochim Biophys Acta 1822:1442–1452. 
Bremer J, Norum KR (1982) Metabolism of very long-chain monounsaturated fatty 
acids (22:1) and the adaptation to their presence in the diet. J Lipid Res 23:243–256. 
Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T, Wende H, Stassart RM, 
Nawaz S, Humml C, Velanac V, Radyushkin K, Goebbels S, Fischer TM, Franklin RJ, 
Lai C, Ehrenreich H, Birchmeier C, Schwab MH, Nave KA (2008) Neuregulin-1/ErbB 
Signaling Serves Distinct Functions in Myelination of the Peripheral and Central 
Nervous System. Neuron 59:581–595. 
  References 
116 
 
Brites P, Mooyer PAW, Mrabet el L, Waterham HR, Wanders RJA (2008) 
Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 
132:482–492. 
Brites P, Waterham HR, Wanders RJA (2004) Functions and biosynthesis of 
plasmalogens in health and disease. Biochim Biophys Acta 1636:219–231. 
Clague MJ (1998) Molecular aspects of the endocytic pathway. Biochem J 336:271–
282. 
Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR (2000) Sodium channel 
Nav1.6 is localized at nodes of Ranvier, dendrites, and synapses. PNAS 97:5616–
5620. 
Chen C-S, Patterson MC, O'Brien JF, Pagano RE, Wheatley CL (1999) Broad 
screening test for sphingolipid-storage diseases. Lancet 354:901–905. 
Chi XX, Nicol GD (2007) Manipulation of the Potassium Channel Kv1.1 and Its Effect 
on Neuronal Excitability in Rat Sensory Neurons. J Neurophysiol 98:2683–2692. 
Chu B-B, Liao Y-C, Qi W, Xie C, Ximing du, Wang J, Yang H, Miao H-H, Li B-L, Song 
B-L (2015) Cholesterol Transport through Lysosome-Peroxisome Membrane 
Contacts. Cell 161:291–306. 
Cifuentes-Diaz C, Chareyre F, Garcia M, Devaux J, Carnaud M, Levasseur G, Niwa-
Kawakita M, Harroch S, Girault J-A, Giovannini M, Goutebroze L (2011) Protein 4.1B 
Contributes to the Organization of Peripheral Myelinated Axons Chédotal A, ed. PloS 
ONE 6:1–15. 
Collins BE, Yang LJ-S, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar 
RL (1997) Sialic Acid Specificity of Myelin-associated Glycoprotein Binding. J Biol 
Chem 272:1248–1255. 
Davis JQ, Lambert S, Bennett V (1996) Molecular composition of the node of Ranvier: 
identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third 
FNIII domain-) and NrCAM at Nodal Axon Segments. J Cell Biol 135:1355–1367. 
De Chaves E P, Sipione S (2010) Sphingolipids and gangliosides of the nervous 
system in membrane function and dysfunction. FEBS Lett 584:1748-1759. 
De Duve C, Baudhuin P (1966) Peroxisomes (microbodies and related particles). 
Physiol Rev 46:323–357. 
Devaux JJ, Kleopa KA, Cooper EC, Scherer SS (2004) KCNQ2 Is a Nodal K+ Channel. 
J Neurosci 24:1236–1244. 
Dupree JL, Coetzee T, Suzuki K, Popko B (1998) Myelin abnormalities in mice deficient 
in galactocerebroside and sulfatide. J Neurocyt 27:649–659. 
Dupree JL, Girault J-A, Popko B (1999) Axo-glial Interactions Regulate the Localization 
of Axonal Paranodal Proteins. J Cell Biol 147:1–7. 
Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, Salzer JL (1997) The 
Axonal Membrane Protein Caspr, a Homologue of Neurexin IV, Is a Component of the 
  References 
117 
 
Septate-like Paranodal Junctions That Assemble during Myelination. J Cell Biol 
139:1495–1506. 
Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The B 
(2012) X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for 
diagnosis, follow-up and management. J Rare Dis 7:51. 
Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR 
Jr., Peles E (2005) Gliomedin Mediates Schwann Cell-Axon Interaction and the 
Molecular Assembly of the Nodes of Ranvier. Neuron 47:215–229. 
Faivre-Sarrailh C, Devaux JJ (2013) Neuro-glial interactions at the nodes of Ranvier: 
implication in health and diseases. Front Cell Neurosci 7:1–13. 
Fang Y, Morrell JC, Jones JM, Gould SJ (2004) PEX3 functions as a PEX19 docking 
factor in the import of class I peroxisomal membrane proteins. J Cell Biol 164:863–
875. 
Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL Jr, Colman DR 
(1995) Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell 
architecture is stabilized by autotypic adherens junctions. J Cell Biol 129:189–202. 
Faust PL, Kaye EM, Powers JM (2010) Myelin lesions associated with lysosomal and 
peroxisomal disorders. Rev Neurother 10:1449–1466. 
Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple 
sclerosis lesions. Brain 120:393–399. 
Ferrer I, Aubourg P, Pujol A (2010) General Aspects and Neuropathology of X-Linked 
Adrenoleukodystrophy. Brain Pathol 20:817–830. 
Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer 
H, Zimmermann F, Nave K-A (1997) Targeted inactivation of the X-linked 
adrenoleukodystrophy gene in mice. Journal of Neuscience Research 50:829–843. 
Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, Kemp S, Villarroya 
F, Ferrer I, Pamplona R, Portero-Otin M, Pujol A (2008) Early oxidative damage 
underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 17:1762–
1773. 
Fransen M, Nordgren M, Wang B, Apanasets O (2012) Role of peroxisomes in 
ROS/RNS-metabolism: Implications for human disease. Biochim Biophys Acta 
1822:1363–1373. 
Fünfschilling U et al. (2012) Glycolytic oligodendrocytes maintain myelin and long-term 
axonal integrity. Nature 485:517–521. 
Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P, Ferrer I, Pujol 
(2012) Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A 
paradigm for multifactorial neurodegenerative diseases?. Biochim Biophys Acta 
1822:1475–1488. 
Garbay B, Heape AM, Sargueil F, Cassagne C (2000) Myelin synthesis in the 
peripheral nervous system. Prog Neurobiol 61:267–304. 
  References 
118 
 
Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, 
Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) 
Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-
dependent axonal degeneration in the absence of demyelination and inflammation. 
Brain 125:551–561. 
Garratt AN, Voiculescu O, Topilko P, Charnay P, Birchmeier C (2000) A Dual Role of 
erbB2 in Myelination and in Expansion of the Schwann Cell Precursor Pool. J Cell Biol 
148:1035. 
Gatzinsky KP, Berthold CH (1990) Lysosomal activity at nodes of Ranvier during 
retrograde axonal transport of horseradish peroxidase in alpha-motor neurons of the 
cat. J Neurocyt 19:989–1002. 
Gatzinsky KP, Persson GH, Berthold CH (1997) Removal of retrogradely transported 
material from rat lumbosacral alpha-motor axons by paranodal axon-schwann cell 
networks. Glia 20:115–126. 
Ghabriel MN, Allt G (1979) The role of Schmidt-Lanterman incisures in Wallerian 
degeneration. Acta Neuropathol 48:83–93. 
Ghabriel MN, Allt G (1981) Incisures of Schmidt-Lanterman. Progr Neurobiol 17:25–
58. 
Ghaedi K, Tamura S, Okumoto K, Matsuzono Y, Fujiki Y (2000) The Peroxin Pex3p 
Initiates Membrane Assembly in Peroxisome Biogenesis. Mol Biol Cell 11:2085–2102. 
Ghosh A, Manrique-Hoyos N, Voigt A, Kreutzfeldt M, Merkler D, Simons M (2011) 
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage. PLoS ONE 
6:e22735. 
Ghosh P, Dahms NM, Kornfeld S (2003) Mannose 6-phosphate receptors: new twists 
in the tale. Nat Rev Mol Cell Biol 4:202–212. 
Giese KP, Martini R, Lemke G, Soriano P, Schachner M (1992) Mouse P0 gene 
disruption leads to hypomyelination, abnormal expression of recognition molecules, 
and degeneration of myelin and axons. Cell 71:565–576. 
Goldman BM, Blobel G (1978) Biogenesis of peroxisomes: intracellular site of 
synthesis of catalase and uricase. PNAS 75:5066–5070. 
Gomez-Sanchez JA, Carty L, Iruarrizaga-Lejarreta M, Palomo-Irigoyen M, Marta 
Varela-Rey M, Griffith M, Hantke J, Macias-Camara N, Azkargorta M, Aurrekoetxea I, 
Gutiérrez De Juan V, Jefferies HBJ, Aspichueta P, Elortza F, Aransay AM, Martínez-
Chantar ML, Baas F, Mato JM, Mirsky R, Woodhoo A, Jessen KR (2015) Schwann cell 
autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol 
210:153–168. 
Gorgas K, Teigler A, Komljenovic D, Just WW (2006) The ether lipid-deficient mouse: 
Tracking down plasmalogen functions. Biochim Biophys Acta 1763:1511–1526. 
Gould RM, Byrd AL, Barbarese E (1995) The number of Schmidt-Lanterman incisures 
is more than doubled in shiverer PNS myelin sheaths. J Neurocyt 24:85–98. 
  References 
119 
 
Gould SG, Keller GA, Subramani S (1987) Identification of a peroxisomal targeting 
signal at the carboxy terminus of firefly luciferase. J Cell Biol 105:2923–2931. 
Gould SJ, Valle D (2000) Peroxisome biogenesis disorders: Genetics and cell biology. 
Genet 16:340–345. 
Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. 
Nat Rev Mol Cell Biol 10:597–608. 
Greenfield S, Brostoff S, Eylar EH, Morell P (1973) Protein composition of myelin of 
the peripheral nervous system. J Neurochem 20:1207–1216. 
Griffin JW, Thompson WJ (2008) Biology and pathology of nonmyelinating Schwann 
cells. Glia 56:1518–1531. 
Griffiths G, Simons K (1986) The trans Golgi network: sorting at the exit site of the 
Golgi complex. Science 234:438–443. 
Griffiths I (2011) Axonal Swellings and Degeneration in Mice Lacking the Major 
Proteolipid of Myelin. Science 280:1610–1613. 
Hall SM, Williams PL (1970) Studies on the “Incisures” of Schmidt and Lanterman. J 
Cell Sci 6:767–791. 
Hanson MG, Fregoso VL, Vrana JD, Tucker CL, Niswander LA, Hanson MG, Fregoso 
VL, Vrana JD, Tucker CL, Niswander LA (2014) Peripheral nervous system defects in 
a mouse model for peroxisomal biogenesis disorders. Dev Biol 395:84–95. 
Hao J, Padilla F, Dandonneau M, Lavebratt C, Lesage F, Noël J, Delmas P, Hao J, 
Padilla F, Dandonneau M, Lavebratt C, Lesage F, Noël J, Delmas P (2013) Kv1.1 
Channels Act as Mechanical Brake in the Senses of Touch and Pain. Neuron 77:899–
914. 
Haq E, Contreras MA, Giri S, Singh I, Singh AK (2006) Dysfunction of peroxisomes in 
twitcher mice brain: A possible mechanism of psychosine-induced disease. Biochem 
Biophys Res Commun 343:229–238. 
Hein S, Schonfeld P, Kahlert S, Reiser G (2008) Toxic effects of X-linked 
adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and 
neurons from rat hippocampus in culture. Hum Mol Genet 17:1750–1761. 
Hirsch NP (2007) Neuromuscular junction in health and disease. Br J Anaesth 99:132–
138. 
Hiscoe HB (1947) Distribution of nodes and incisures in normal and regenerated nerve 
fibers. Anat Rec 99:447–475. 
Hivert B, Pinatel D, Labasque M, Tricaud N, Goutebroze L, Faivre-Sarrailh C (2016) 
Assembly of juxtaparanodes in myelinating DRG culture: Differential clustering of the 
Kv1/Caspr2 complex and scaffolding protein 4.1B. Glia 64:840–852. 
Ho JK, Moser H, Kishimoto Y, Hamilton JA (1995) Interactions of a very long chain 
fatty acid with model membranes and serum albumin. Implications for the 
pathogenesis of adrenoleukodystrophy. J Clin Invest 96:1455–1463. 
  References 
120 
 
Hoepfner D, Schildknegt D, Braakman I, Philippsen P, Tabak HF (2005) Contribution 
of the Endoplasmic Reticulum to Peroxisome Formation. Cell 122:85–95. 
Holmgren J, Lönnroth I, Mansson JE, Svennerholm L (1975) Interaction of cholera 
toxin and membrane GM1 ganglioside of small intestine. PNAS 72:2520–2524. 
Hoshi T, Suzuki A, Hayashi S, Tohyama K, Hayashi A, Yamaguchi Y, Takeuchi K, 
Baba H (2007) Nodal protrusions, increased Schmidt-Lanterman incisures, and 
paranodal disorganization are characteristic features of sulfatide-deficient peripheral 
nerves. Glia 55:584–594. 
Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, Vora AJ, Brophy 
PJ, Reynolds R (2006) Disruption of neurofascin localization reveals early changes 
preceding demyelination and remyelination in multiple sclerosis. Brain 129:3173–3185. 
Hu Y-B et al. (2015) The endosomal-lysosomal system: from acidification and cargo 
sorting to neurodegeneration. Transl Neurodegener 4:1–10. 
Huang J, Lam GY, Brumell JH (2011) Autophagy Signaling Through Reactive Oxygen 
Species. Antioxid Redox Signal 14:2215–2231. 
Hughes RAC, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366:1653–1666. 
Hulshagen L, Krysko O, Bottelbergs A, Huyghe S, Klein R, van Veldhoven PP, de Deyn 
PP, D'Hooge R, Hartmann D, Baes M (2008) Absence of Functional Peroxisomes from 
Mouse CNS Causes Dysmyelination and Axon Degeneration. J Neurosci 28:4015–
4027. 
Huotari J, Helenius A (2011) Endosome maturation. EMBO J 30:3481–3500. 
Huxley AF, Stämpeli R (1949) Evidence for saltatory conduction in peripheral 
myelinated nerve fibres. J Physiol 108:315–339. 
Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodny E, Suzuki K (1976a) 
Brain gangliosides in adrenoleukodystrophy. J Neurochem 27:327–328. 
Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodny E, Suzuki K (1976b) 
Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26:851–860. 
Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Popko B, 
Suzuki K, Suzuki K, Nishino H, Nishino H, Baba H (2002) A Myelin Galactolipid, 
Sulfatide, Is Essential for Maintenance of Ion Channels on Myelinated Axon But Not 
Essential for Initial Cluster Formation. J Neurosci 22:6507–6514. 
Ivanovic A, Horresh I, Spiegel I, Golan N, Sabanay H, Frechter S, Ohno S, Terada N, 
Möbius W, Rosenbluth J, Brose N, Peles E (2012) The cytoskeletal adapter protein 
4.1G organizes the internodes in peripheral myelinated nerves. J Cell Biol 196:337–
344. 
Jenkins SM, Bennett V (2002) Developing nodes of Ranvier are defined by ankyrin-G 
clustering and are independent of paranodal axoglial adhesion. Proc Natl Acad Sci U 
S A 99:2303–2308. 
Jennings JJ, Zhu JH, Rbaibi Y, Luo X, Chu CT, Kiselyov K (2006) Mitochondrial 
Aberrations in Mucolipidosis Type IV. J Biol Chem 281:39041–39050. 
  References 
121 
 
Jensen CS, Rasmussen HB, Misonou H (2011) Neuronal trafficking of voltage-gated 
potassium channels. Mol Cell Neurosci 48:288–297. 
Jessen KR, Mirsky R (1992) Schwann cells: early lineage, regulation of proliferation 
and control of myelin formation. Curr Opin Neurobiol 2:575–581. 
Jessen KR, Mirsky R (1999) Schwann cells and their precursors emerge as major 
regulators of nerve development. Neurosci 22:402–410. 
Jessen KR, Mirsky R (2005) The origin and development of glial cells in peripheral 
nerves. Nat Rev Neurosci 6:671–682. 
Jessen KR, Mirsky R (2016) The repair Schwann cell and its function in regenerating 
nerves. J Physiol 594:3521–3531. 
Jeyakumar M, Dwek RA, Butters TD, Platt FM (2005) Storage solutions: treating 
lysosomal disorders of the brain. Nat Rev Neurosci 6:713–725. 
Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry 
VH, Butters TD, Dwek RA, Platt FM (2003) Central nervous system inflammation is a 
hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 
126:974–987. 
Jobling MG, Yang Z, Kam WR, Lencer WI, Holmes RK (2012) A Single Native 
Ganglioside GM1-Binding Site Is Sufficient for Cholera Toxin To Bind to Cells and 
Complete the Intoxication Pathway. mBio 3:e00401–00412. 
Jung M, Sommer I, Schachner M, Nave K-A (1996) Monoclonal Antibody O10 Defines 
a Conformationally Sensitive Cell-Surface Epitope of Proteolipid Protein (PLP): 
Evidence that PLP Misfolding Underlies Dysmyelination in Mutant Mice. J Neurosci 
16:7920–7929. 
Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological 
effects on Guillain-Barre syndrome and related disorders. Glycobiology 19:676–692. 
Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T (1990) The 70-kDa 
peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-
binding protein superfamily. J Biol Chem 265:4534–4540. 
Kasahara K, Watanabe K, Takeuchi K, Kaneko H, Oohira A, Yamamoto T, Sanai Y 
(2000) Involvement of Gangliosides in Glycosylphosphatidylinositol-anchored 
Neuronal Cell Adhesion Molecule TAG-1 Signaling in Lipid Rafts. J Biol Chem 
275:34701–34709. 
Kassmann CM (2014) Myelin peroxisomes – Essential organelles for the maintenance 
of white matter in the nervous system. Biochimie 98:111–118. 
Kassmann CM, Lappe-Siefke C, Baes M, Brügger B, Mildner A, Werner HB, Natt O, 
Michaelis T, Prinz M, Frahm J, Nave K-A (2007) Axonal loss and neuroinflammation 
caused by peroxisome-deficient oligodendrocytes. Nat Genet 39:969–976. 
Kassmann CM, Quintes S, Rietdorf J, Möbius W, Sereda MW, Nientiedt T, Saher G, 
Baes M, Nave K-A (2011) A role for myelin-associated peroxisomes in maintaining 
paranodal loops and axonal integrity. FEBS Lett 585:2205–2211. 
  References 
122 
 
Kemp S, Wanders R (2010) Biochemical Aspects of X-Linked Adrenoleukodystrophy. 
Brain Pathol 20:831–837. 
Jung CH, Ro SH, Cao J, Otto MN, Kim DH. (2010) mTOR regulation of autophagy. 
FEBS Lett 584:1287-1295. 
Kim PK, Mullen RT, Schumann U, Lippincott-Schwartz J (2006) The origin and 
maintenance of mammalian peroxisomes involves a de novo PEX16-dependent 
pathway from the ER. J Cell Biol 173:521–532. 
Kobayashi T, Shinnoh N, Kondo A, Yamada T (1997) Adrenoleukodystrophy Protein-
Deficient Mice Represent Abnormality of Very Long Chain Fatty Acid Metabolism. 
Biochem Biophys Res Commun 232:6311–6636. 
Komada M, Soriano P (2002) βIV-spectrin regulates sodium channel clustering through 
ankyrin-G at axon initial segments and nodes of Ranvier. J Cell Biol 156:337–348. 
Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH (1999) 
Elevation of Intracellular Glucosylceramide Levels Results in an Increase in 
Endoplasmic Reticulum Density and in Functional Calcium Stores in Cultured Neurons. 
J Biol Chem 274:21673–21678. 
Labasque M, Devaux JJ, Leveque C, Faivre-Sarrailh C (2011) Fibronectin Type III-like 
Domains of Neurofascin-186 Protein Mediate Gliomedin Binding and Its Clustering at 
the Developing Nodes of Ranvier. J Biol Chem 286:42426–42434. 
Labasque M, Faivre-Sarrailh C (2010) GPI-anchored proteins at the node of Ranvier. 
FEBS Lett 584:1787–1792. 
Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave 
K-A (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support 
and myelination. Nat Genet 33:366–374. 
Launay N, Aguado C, Fourcade S, Ruiz M, Grau L, Riera J, Guilera C, Giròs M, Ferrer 
I, Knecht E, Pujol A (2015) Autophagy induction halts axonal degeneration in a mouse 
model of X-adrenoleukodystrophy. Acta Neuropathol 129:399–415. 
Levine B, Kroemer G (2008) Autophagy in the Pathogenesis of Disease. Cell 132:27–
42. 
Loberto N, Prioni S, Prinetti A, Ottico E, Chigorno V, Karagogeos D, Sonnino S, 
Braverman NE, Braverman NE, Moser AB (2003) The adhesion protein TAG-1 has a 
ganglioside environment in the sphingolipid-enriched membrane domains of neuronal 
cells in culture. J Neurochem 85:224–233. 
Lombard-Platet G, Savary S, Sarde CO, Mandel JL, Chimini G (1996) A close relative 
of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a 
specific expression pattern. PNAS 93:1265–1269. 
Lu J-F, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) 
A mouse model for X-linked adrenoleukodystrophy. PNAS 94:9366–9371. 
Ma C, Agrawal G, Subramani S (2011) Peroxisome assembly: matrix and membrane 
protein biogenesis. J Cell Biol 193:7–16. 
  References 
123 
 
Ma Q, Kobayashi M, Sugiura M, Ozaki N, Nishio K, Shiraishi Y, Furukawa K, Furukawa 
K, Sugiura Y (2003) Morphological study of disordered myelination and the 
degeneration of nerve fibers in the spinal cord of mice lacking complex gangliosides. 
Arch Histol Cytol 66:37–44. 
Maccioni HJF (2007) Glycosylation of glycolipids in the Golgi complex. J Neurochem 
103:81–90. 
Mandard S, Mller M, Kersten S (2004) Peroxisome proliferator-activated receptor a 
target genes. Cell Mol Life Sci 61:393–416. 
Marshansky V, Futai M (2008) The V-type H+-ATPase in vesicular trafficking: 
targeting, regulation and function. Curr Opin Cell Biol 20:415–426. 
Matsuzaki T, Fujiki Y (2008) The peroxisomal membrane protein import receptor 
Pex3p is directly transported to peroxisomes by a novel Pex19p- and Pex16p-
dependent pathway. J Cell Biol 183:1275–1286. 
Maxfield FR, Yamashiro DJ (1987) Endosome Acidification and the Pathways of 
Receptor-Mediated Endocytosis. Adv Exp Med Biol 225:189–198. 
McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE (1994) 
Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of 
neurite growth. Neuron 13:805–811. 
McNew JA, Goodman JM (1994) An oligomeric protein is imported into peroxisomes 
in vivo. J Cell Biol 127:1245–1257. 
Mehta NR, Nguyen T, Bullen JW, Griffin JW, Schnaar RL (2010) Myelin-Associated 
Glycoprotein (MAG) Protects Neurons from Acute Toxicity Using a Ganglioside-
Dependent Mechanism. ACS Chem Neurosci 1:215–222. 
Meinecke M, Cizmowski C, Schliebs W, Krüger V, Beck S, Wagner R, Erdmann R 
(2010) The peroxisomal importomer constitutes a large and highly dynamic pore. Nat 
Cell Biol 12:273–277. 
Meresse S, Gorvel JP, Chavrier P (1995) The rab7 GTPase resides on a vesicular 
compartment connected to lysosomes. J Cell Sci 108:3349–3358. 
Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role 
L, Lai C, Schwab MH, Nave KA (2004) Axonal Neuregulin-1 Regulates Myelin Sheath 
Thickness. Science 304:700–703. 
Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y (2003) In Vivo Analysis 
of Autophagy in Response to Nutrient Starvation Using Transgenic Mice Expressing a 
Fluorescent Autophagosome Marker. Mol Biol Cell 15:1101–1111. 
Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat 
Clin Pract Neurol 3:140–151. 
Mosser J, Douar A-M, Sarde C-O, Kioschis P, Feil R, Moser H, Poustka A-M, Mandel 
J-L, Aubourg P (1993) Putative X-linked adrenoleukodystrophy gene shares 
unexpected homology with ABC transporters. Nature 361:726–730. 
  References 
124 
 
Mousavi SA, MalerØd L, Berg T, Kjeken R (2004) Clathrin-dependent endocytosis. 
Biochem J 377:1–16. 
Mullock BM, Bright NA, Fearon CW, Gray SR, Luzio J (1998) Fusion of Lysosomes 
with Late Endosomes Produces a Hybrid Organelle of Intermediate Density and Is NSF 
Dependent. J Cell Biol 140:591–601. 
Tasaki I (1939) The electro-saltatory transmision of the nerve impulse and the effect of 
narcosis upon the nerve fiber. Am J Physiol 127:211–227. 
Naguib M, Flood P, McArdle JJ, Brenner HR (2002) Advances in Neurobiology of the 
Neuromuscular Junction: Implications for the Anesthesiologist. Anesthesiology 
96:202–231. 
Nave K-A (2010a) Myelination and support of axonal integrity by glia. Nature 468:244–
252. 
Nave K-A (2010b) Myelination and the trophic support of long axons. Nat Rev Neurosci 
11:275–283. 
Nave K-A, Sereda MW, Ehrenreich H (2007) Mechanisms of Disease: inherited 
demyelinating neuropathies—from basic to clinical research. Nat Clin Pract Neurol 
3:453–464. 
Neefjes J, van der Kant R (2014) Stuck in traffic: an emerging theme in diseases of the 
nervous system. Cell 37:66–76. 
Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J (1999) 
Adrenoleukodystrophy-related protein can compensate functionally for 
adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum Mol 
Genet 8:907–913. 
Noda T, Ohsumi Y (1998) Tor, a Phosphatidylinositol Kinase Homologue, Controls 
Autophagy in Yeast. J Biol Chem 273:3963–3966. 
Nuttall JM, Motley A, Hettema EH (2011) Peroxisome biogenesis: recent advances. 
Curr Opin Cell Biol 23:421–426. 
Oswald RE, Freeman JA (1981) Alpha-bungarotoxin binding and central nervous 
system nicotinic acetylcholine receptors. Neuroscience 6:1–14. 
Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL (2005) 
Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, 
mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in 
single- and double-null mice. Exp Neurol 195:208–217. 
Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev 
J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Mobius 
W, Nave KA, Werner HB (2011) Quantitative and Integrative Proteome Analysis of 
Peripheral Nerve Myelin Identifies Novel Myelin Proteins and Candidate Neuropathy 
Loci. J Neurosci 31:16369–16386. 
Peles E, Salzer JL (2000) Molecular domains of myelinated axons. Curr Opin Neurobiol 
10:558–565. 
  References 
125 
 
Pereira JA, Lebrun-Julien F, Suter U (2012) Molecular mechanisms regulating 
myelination in the peripheral nervous system. Trends Neurosci 35:123–134. 
Périchon R, Moser AB, Wallace WC, Cunningham SC, Roth GS, Moser HW (1998) 
Peroxisomal Disease Cell Lines with Cellular Plasmalogen Deficiency Have Impaired 
Muscarinic Cholinergic Signal Transduction Activity and Amyloid Precursor Protein 
Secretion. Biochem Biophy Re Com 248:57-61. 
Peters A (2002) The effects of normal aging on myelin and nerve fibers: A review. J 
Neurocyt 8/9:581–593. 
Pham-Dinh D, Birling M-C, Roussel G, Dautigny A, Nussbaum J-L (1991) Proteolipid 
DM-20 predominates over PLP in peripheral nervous system. Neuroreport 2:89–92. 
Platt FM, Boland B, van der Spoel AC, Bol B (2012) The cell biology of disease: 
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction. J Cell Biol 
199:723–734. 
Platta HW, Erdmann R (2007) Peroxisomal dynamics. Trends Cell Biol 17:474–484. 
Platta HW, Magraoui El F, Schlee D, Grunau S, Girzalsky W, Erdmann R (2007) 
Ubiquitination of the peroxisomal import receptor Pex5p is required for its recycling. J 
Cell Biol 177:197–204. 
Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Schrager 
P, Peles E (1999) Caspr2, a New Member of the Neurexin Superfamily, Is Localized 
at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels. Neuron 
24:1037–1047. 
Poliak S, Peles E (2003) The local differentiation of myelinated axons at nodes of 
Ranvier. Nat Rev Neurosci 4:968–980. 
Poulos A, Sheffield L, Sharp P, Sherwood G, Johnson D, Beckman K, Fellenberg AJ, 
Wraith JE, Chow CW, Usher S, Singh H (1988) Rhizomelic chondrodysplasia punctata: 
Clinical, pathologic, and biochemical findings in two patients. J Pediatr 113:685–690. 
Prioni S, Mauri L, Loberto N, Casellato R, Chigorno V, Karagogeos D, Prinetti A, 
Sonnino S (2004) Interactions between gangliosides and proteins in the exoplasmic 
leaflet of neuronal plasma membranes: A study performed with a tritium-labeled GM1 
derivative containing a photoactivable group linked to the oligosaccharide chain. 
Glycoconj J 21:461–470. 
Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, Ruiz M, Pampols T, 
Giros M, Mandel JL (2004) Functional overlap between ABCD1 (ALD) and ABCD2 
(ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 
13:2997–3006. 
Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL (2002) Late onset 
neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for 
adrenomyeloneuropathy. Hum Mol Genet 11:499–505. 
Quarles RH (2002) Myelin sheaths: glycoproteins involved in their formation, 
maintenance and degeneration. Cell Mol Life Sci 59:1851–1871. 
  References 
126 
 
Rasband MN, Shrager P (2000) Ion channel sequestration in central nervous system 
axons. J Physiol 525:63–73. 
Rasband MN, Trimmer JS, Schwarz TL, Levinson SR, Ellisman MH, Schachner M, 
Shrager P (1998) Potassium Channel Distribution, Clustering, and Function in 
Remyelinating Rat Axons. J Neurosci 18:36–47. 
Reddy JK, Mannaerts GP (1994) Peroxisomal Lipid Metabolism. Ann Rev Nutr 14:343–
370. 
Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, Valle 
D, Gould SJ, Wraith JE (1997) Mutations in PEX1 are the most common cause of 
peroxisome biogenesis disorders. Nat Genet 17:445–448. 
Rink J, Ghigo E, Kalaidzidis Y, Zerial M (2005) Rab Conversion as a Mechanism of 
Progression from Early to Late Endosomes. Cell 122:735–749. 
Rios JC, Rubin M, Martin MS, Downey RT, Einheber S, Rosenbluth J, Levinson SR, 
Bhat M, Salzer JL (2003) Paranodal Interactions Regulate Expression of Sodium 
Channel Subtypes and Provide a Diffusion Barrier for the Node of Ranvier. J Neurosci 
23:7001–7011. 
Rosenbluth J (2009) Multiple functions of the paranodal junction of myelinated nerve 
fibers. J Neurosci Res 87:3250–3258. 
Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in 
neurodegeneration. Nature 443:780–786. 
Saito M, Saito M (1991) Incorporation of Very-Long-Chain Fatty Acids into 
Sphingolipids of Cultured Neural Cells. J Neuchem 57:465. 
Salzer JL, Brophy PJ, Peles E (2008) Molecular domains of myelinated axons in the 
peripheral nervous system. Glia 56:1532–1540. 
Salzer JL, Bunge RP (1980) Studies of Schwann cell proliferation. I. An analysis in 
tissue culture of proliferation during development, Wallerian degeneration, and direct 
injury. J Cell Biol 84:739–752. 
Sandhoff K, Harzer K (2013) Gangliosides and Gangliosidoses: Principles of Molecular 
and Metabolic Pathogenesis. J Neurosci 33:10195–10208. 
Savvaki M, Theodorakis K, Zoupi L, Stamatakis A, Tivodar S, Kyriacou K, 
Stylianopoulou F, Karagogeos D (2010) The Expression of TAG-1 in Glial Cells Is 
Sufficient for the Formation of the Juxtaparanodal Complex and the Phenotypic 
Rescue of Tag-1 Homozygous Mutants in the CNS. J Neurosci 30:13943–13954. 
Schedin S, Sindelar PJ, Pentchev P, Brunk U, Dallner G (1997) Peroxisomal 
Impairment in Niemann-Pick Type C Disease. J Biol Chem 272:6245–6251. 
Scherer SS (1997) The biology and pathobiology of Schwann cells. Curr Opin Neurol 
10:386–397. 
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch 
S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, 
  References 
127 
 
Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image 
analysis. Nat Meth 9:676–682. 
Schnaar RL, Gerardy-Schahn R, Hildebrandt H (2014) Sialic Acids in the Brain: 
Gangliosides and Polysialic Acid in Nervous System Development, Stability, Disease, 
and Regeneration. Physiol Rev 94:461–518. 
Schrader M, Bonekamp NA, Islinger M, (2012) Fission and proliferation of 
peroxisomes. Biochim Biophys Acta 1822:1343–1357. 
Schrader M, Fahimi HD (2004) Mammalian peroxisomes and reactive oxygen species. 
Histochem Cell Biol 122:383–393. 
Schultz RL, Karlsson U (1965) Fixation of the central nervous system for electron 
microscopy by aldehyde perfusion: II. Effect of osmolarity, pH of perfusate, and fixative 
concentration. J Ultrasctruct Res 12:187–206. 
Seitelberger F (1995) Neuropathology and Genetics of Pelizaeus-Merzbacher 
Disease. Brain Pathol 5:267–273. 
Settembre C, Ballabio A, Settembre C, Ballabio A, Settembre C, Ballabio A (2014) 
Lysosome: regulator of lipid degradation pathways. Trends Cell Biol 24:743–750. 
Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, de Pablo R, 
Tacchetti C, Rubinsztein DC, Ballabio A (2008) A block of autophagy in lysosomal 
storage disorders. Hum Mol Genet 17:119–129. 
Sheikh FG, Pahan K, Khan M, Barbosa E, Singh I (1998) Abnormality in catalase 
import into peroxisomes leads to severe neurological disorder. PNAS 95:2961–2966. 
Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL 
(1999) Mice lacking complex gangliosides develop Wallerian degeneration and 
myelination defects. PNAS 96:7532–7537. 
Sherratt RM, Bostock H, Sears TA (1980) Effects of 4-aminopyridine on normal and 
demyelinated mammalian nerv fibres. Nature 283:570–572. 
Simons M, Krämer E-M, Macchi P, Rathke-Hartlieb S, Trotter J, Nave K-A, Schulz JB 
(2002) Overexpression of the myelin proteolipid protein leads to accumulation of 
cholesterol and proteolipid protein in endosomes/lysosomes. J Cell Biol 157:327–336. 
Singer M, Bryant SV (1969) Movements in the Myelin Schwann Sheath of the 
Vertebrate Axon. Nature 221:1148–1150. 
Singh AK, Dhaunsi GS, Gupta MP, Orak JK, Asayama K, Singh I (1994) Demonstration 
of Glutathione Peroxidase in Rat Liver Peroxisomes and Its Intraorganellar Distribution. 
Arch Biochem Biophys 315:331–338. 
Singh I, Pujol A (2010) Pathomechanisms Underlying X-Adrenoleukodystrophy: A 
Three-Hit Hypothesis. Brain Pathol 20:838–844. 
Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, 
Czaja MJ (2009) Autophagy regulates lipid metabolism. Nature 458:1131–1135. 
  References 
128 
 
Sinha K, Karimi-Abdolrezaee S, Velumian AA, Fehlings MG (2005) Functional 
Changes in Genetically Dysmyelinated Spinal Cord Axons of Shiverer Mice: Role of 
Juxtaparanodal Kv1 Family K+ Cannels. J Neurophys 95:1683–1695. 
Small JR, Ghabriel MN, Allt G (1980) The development of Schmidt-Lanterman 
incisures: an electron microscope study. Journal of Anatomy 150:277–286. 
Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, 
Messing A, Tempel BL (1998) Deletion of the KV1.1 Potassium Channel Causes 
Epilepsy in Mice. Neuron 20:809–819. 
Sonnino S, Mauri L, Chigorno V, Prinetti A (2006) Gangliosides as components of lipid 
membrane domains. Glycobiology 17:1–13. 
Spiegel I, Peles E (2002) Cellular junctions of myelinated nerves (Review). Mol Membr 
Biol 19:95–101. 
Stanley WA, Filipp FV, Kursula P, Schüller N, Erdmann R, Schliebs W, Sattler M, 
Wilmanns M (2006) Recognition of a Functional Peroxisome Type 1 Target by the 
Dynamic Import Receptor Pex5p. Mol Cell 24:653–663. 
Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW (2006) 
Peroxisome biogenesis disorders. Biochim Biophys Acta 1763:1733–1748. 
Susuki K, Rasb MN, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, 
Hirata K, Baba H, Yuki N (2007) Anti-GM1 Antibodies Cause Complement-Mediated 
Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers. J Neurosci 
27:3956–3967. 
Swinkels BW, Gould SJ, Bodnar AG, Rachubinski RA, Subramani S (1991) A novel, 
cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-coA 
thiolase. EMBO J 10:3255–3262. 
Tatsumi K, Saito M, Lin B, Iwamori M, Ichiseki H, Shimozawa N, Kamoshita S, Igarashi 
T, Sakakihara Y (2001) Enhanced expression of a-series gangliosides in fibroblasts of 
patients with peroxisome biogenesis disorders. Biochim Biophys Acta 5135:285–293. 
Teigler A, Komljenovic D, Draguhn A, Gorgas K, Just WW (2009) Defects in 
myelination, paranode organization and Purkinje cell innervation in the ether lipid-
deficient mouse cerebellum. Hum Mol Genet 18:1897–1908. 
Tessitore A, del P. Martin M, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler 
DA, Hendershot LM, d’Azzo A (2004) GM1-Ganglioside-Mediated Activation of the 
Unfolded Protein Response Causes Neuronal Death in a Neurodegenerative 
Gangliosidosis. Mol Cell 15:753–766. 
Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the 
extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 
296:160–170. 
Thai T-P  Rodemer C, Jauch A, Hunziker A, Moser A, Gorgas K, Just WW (2001) 
Impaired membrane traffic in defective ether lipid biosynthesis. Hum Mol Genet 
10:127-136. 
  References 
129 
 
Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T, Wright JE (1996) Isolation and 
characterization of early endosomes, late endosomes and terminal lysosomes: their 
role in protein degradation. J Cell Sci 109:2905–2914. 
Tokuyasu KT (1973) A technique for ultracryotomy of cell suspensions and tissues. 
The Journal of Cell Biology 57:551–565. 
Traka M, Dupree JL, Popko B, Karagogeos D (2002) The Neuronal Adhesion Protein 
TAG-1 Is Expressed by Schwann Cells and Oligodendrocytes and Is Localized to the 
Juxtaparanodal Region of Myelinated Fibers. J Neurosci 22:3016–3024. 
Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, Havaki S, Iwakura Y, 
Fukamauchi F, Watanabe K, Soliven B, Girault J-A, Karagogeos D (2003) Association 
of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal 
regions of myelinated fibers. J Cell Biol 162:1161–1172. 
Trapp BD (1990) Myelin-Associated Glycoprotein Location and Potential Functions. 
Ann N Y Acad Sci 605:29–43. 
Trapp BD, Andrews SB, Wong A, O'Connell M, Griffin JW (1989) Co-localization of the 
myelin-associated glycoprotein and the microfilament components, F-actin and 
spectrin, in Schwann cells of myelinated nerve fibres. J Neurocyt 18:47–60. 
Uyemura K, Tobari C, Hirano S, Tsukada Y (1972) Comparative studies on the myelin 
proteins of bovine peripheral nerve and spinal cord. Acta Neuropathol 19:2607–2614. 
Vabnick I, Trimmer JS, Schwarz TL, Levinson SR, Risal D, Shrager P (1999) Dynamic 
Potassium Channel Distributions during Axonal Development Prevent Aberrant Firing 
Patterns. J Neurosci 19:747–758. 
van der Zand A, Braakman I, Tabak HF (2010) Peroxisomal Membrane Proteins Insert 
into the Endoplasmic Reticulum. Mol Biol Cell 21:2057–2065. 
van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and 
treatment of Guillain-Barré syndrome. The Lancet Neurology 7:939–950. 
van Roermund CWT, Visser WF, IJlst L, van Cruchten A, Boek M, Kulik W, Waterham 
HR, Wanders RJA (2008) The human peroxisomal ABC half transporter ALDP 
functions as a homodimer and accepts acyl-CoA esters. FASEB J 22:4201–4208. 
Vellodi A (2005) Lysosomal storage disorders. Br J Haematology 128:413–431. 
Verity C, Winstone AM, Stellitano L, Will R, Nicoll A (2009) The epidemiology of 
progressive intellectual and neurological deterioration in childhood. Arch Dis Child 
95:361–364. 
Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, Gross RW, Milbrandt 
J (2013) Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits 
Leads to Axon Degeneration and Neuropathy. Neuron 77:886–898. 
Vitner EB, Platt FM, Futerman AH (2010) Common and uncommon pathogenic 
cascades in lysosomal storage diseases. J Biol Chem 285:20423-20427. 
Walkley SU (2004) Secondary accumulation of gangliosides in lysosomal storage 
disorders. Seminars in Cell & Developmental Biology 15:433–444. 
  References 
130 
 
Wanders RJA (2004a) Metabolic and molecular basis of peroxisomal disorders: A 
review. Am J Med Genet 126A:355–375. 
Wanders RJA (2004b) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol 
Genet Metab 83:16–27. 
Wanders RJA, Waterham HR (2006a) Peroxisomal disorders: The single peroxisomal 
enzyme deficiencies. Biochim Biophys Acta 1763:1707–1720. 
Wang H, Tempel BL (1993) Heteromultimeric K+ channels in terminal and 
juxtaparanodal regions of neurons. Nature 365:75–79. 
Waxman SG (1980) Determinants of conduction velocity in myelinated nerve fibers. 
Muscle Nerve 3:141–150. 
Waxman SG, Ritchie JM (1985) Organization of ion channels in the myelinated nerve 
fiber. Science 228:1502–1507. 
Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J (2013) Impaired Very 
Long-chain Acyl-CoA  -Oxidation in Human X-linked Adrenoleukodystrophy 
Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction. J Biol Chem 
288:19269–19279. 
Wiggins RC, Benjamins JA, Morell P (1975) Appearance of myelin proteins in rat sciatic 
nerve during development. Brain Res 89:99–106. 
Wilkins A, Majed H, Layfield R, Compston A, Chandran S (2003) Oligodendrocytes 
Promote Neuronal Survival and Axonal Length by Distinct Intracellular Mechanisms: A 
Novel Role for Oligodendrocyte-Derived Glial Cell Line-Derived Neurotrophic Factor. J 
Neurosci 23:4967–4974. 
Wraith JE (2002) Lysosomal disorders. Semin Neonatol 7:75–83. 
Xie F, Liang P, Fu H, Zhang J-C, Chen J (2014) Effects of normal aging on myelin 
sheath ultrastructures in the somatic sensorimotor system of rats. Mol Med Rep 
10:459–466. 
Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) 
Gangliosides are neuronal ligands for myelin-associated glycoprotein. PNAS 93:814–
818. 
Yang Y, Lacas-Gervais S, Morest DK, Solimena M, Rasband MN (2004) IV Spectrins 
Are Essential for Membrane Stability and the Molecular Organization of Nodes of 
Ranvier. J Neurosci 24:7230–7240. 
Yin X, Crawford TO, Griffin JW, Tu P-H, Li C, Roder J, Trapp BD (1998) Myelin-
Associated Glycoprotein is a Myelin Signal that Modulates the Caliber of Myelinated 
Axons. J Neurosci 18:1953–1962. 
Yu RK, Tsai Y-T, Ariga T, Yanagisawa M (2011) Structures, Biosynthesis, and 
Functions of Gangliosides-an Overview. J Oleo Sci 60:537–544. 
Zenker J, Poirot O, de Preux Charles AS, Arnaud E, Medard JJ, Lacroix C, Kuntzer T, 
Chrast R (2012) Altered Distribution of Juxtaparanodal Kv1.2 Subunits Mediates 
  References 
131 
 
Peripheral Nerve Hyperexcitability in Type 2 Diabetes Mellitus. J Neurosci 32:7493–
7498. 
Zhang Y, Bekku Y, Dzhashiashvili Y, Armenti S, Meng X, Sasaki Y, Salzer J, Milbrandt 
J (2012) Assembly and Maintenance of Nodes of Ranvier Rely on Distinct Sources of 











Surname:   Kleinecke 
First name:   Sandra 
 
Date of birth:   09.02.1988, Blankenburg (Harz) 
Nationality:   German 
 
Home address:  Kasseler Landstraße 87 
    37081 Göttingen 
 
Work address:  MPI of Experimental Medicine  
Department of Neurogenetics  
Hermann-Rein Str. 3, 37075 Göttingen, Germany 
Tel. +49 551 3899-744 




01/2013 - present  Graduate student at the Max PIanck Institute  
of Experimental Medicine, Department of Neurogenetics  
Thesis: “Cellular and subcellular analysis of peripheral 
neuropathy caused by peroxisomal dysfunction in mice” 
Student of the Molecular Medicine program (University Medical 
Center, Göttingen) 
10/2012   Master of Science (grade: 1.2) 
10/2010 - 10/2012 Master student of the “Developmental, Neural and Behavioral 
Biology” program, Georg-August University, Göttingen  
Master thesis: „Analysis of the peripheral pathology in mouse 
models of peroxisomal disorders“, Max PIanck Institute of 
Experimental Medicine, Department of Neurogenetics  
09/2010   Bachelor of Science (grade: 1.6) 
  Curriculum vitae 
133 
 
10/2007 - 09/2010 Bachelor student of the Biology program, Georg-August 
University, Göttingen  
Bachelor thesis: “Charakterisierung cis-regulatorischer 
Elemente für funktionelle Motoneuron-Subtypen“, European 
Neuroscience Institute 
2007 Allgemeine Hochschulreife (Abitur), Europagymnasium Richard 




06/2015   “Academic writing”, University Medical Center, Göttingen 
06/2012 “Schizophrenia“, Max Planck Institute of Experimental Medicine, 
Göttingen 





01/2016 Women’s Careers and Networks, Georg-August University, 
Göttingen  
12/2014 PerFuMe (Peroxisome Formation, Function, Metabolism), 




Richert S, Kleinecke S, Günther J, Schaumburg F, Edgar J, Nienhaus GU, Nave KA, 
Kassmann CM. In vivo labeling of peroxisomes by photoconvertible mEos2 in myelinating 
glia of mice. Biochimie. 2014 Mar; 98:127-34 
S. Kleinecke, S. Richert, L. de Hoz, B. Brügger, S. Quintes, J. Blanz, R. McGonigal, K. 
Naseri, T. Sachsenheimer, C. Lüchtenborg, E. Asadollahi, W. Möbius, H. Willison, M. Baes, 
K.-A. Nave, and C. M. Kassmann. Peripheral neuropathy caused by impaired peroxisomal-
lysosomal lipid metabolism. In preparation 
